0001140361-23-042304.txt : 20230901 0001140361-23-042304.hdr.sgml : 20230901 20230901143749 ACCESSION NUMBER: 0001140361-23-042304 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230901 DATE AS OF CHANGE: 20230901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROOF Acquisition Corp I CENTRAL INDEX KEY: 0001853070 STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, NONSCHEDULED [4522] IRS NUMBER: 862707040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41104 FILM NUMBER: 231232080 BUSINESS ADDRESS: STREET 1: 11911 FREEDOM DRIVE STREET 2: SUITE 1080 CITY: RESTON STATE: VA ZIP: 20190 BUSINESS PHONE: 7035634100 MAIL ADDRESS: STREET 1: 11911 FREEDOM DRIVE STREET 2: SUITE 1080 CITY: RESTON STATE: VA ZIP: 20190 10-Q/A 1 brhc20058310_10qa.htm 10-Q/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q/A

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended June 30, 2023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______to _______

Commission file number: 001-41104

PROOF ACQUISITION CORP I
(Exact Name of Registrant as Specified in Its Charter)

Delaware
 
86-2707040
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

11911 Freedom Drive, Suite 1080
Reston, VA
 
20190
(Address of principal executive offices)
 
(Zip Code)

(571) 310-4949
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol(s)
 
Name of each exchange on
which registered
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
 
PACI.U
 
The New York Stock Exchange
Class A common stock, par value $0.0001 per share (included as part of the Units)
 
PACI
 
The New York Stock Exchange
Redeemable Warrants (included as part of the Units)
 
PACI.WS
 
The New York Stock Exchange

Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has (1) submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (check one).

Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company

 
Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☐

As of September 1, 2023, the Registrant had 6,443,098 shares of its Class A common stock, $0.0001 par value per share, and 6,900,000 shares of its Class B common stock, $0.0001 par value per share, outstanding.



EXPLANATORY NOTE

This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (the Amendment”) amends the Quarterly Report on Form 10-Q of PROOF Acquisition Corp I (the “Company,” “we,” “our” or “us”), as filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2023 (the “Original Filing”). This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing but that had previously been restated in Note 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS of the Company’s Annual Report on Form 10-K filed with the SEC on February 27, 2023.

In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (“Exchange Act”), new certifications by the Company’s principal executive officer and principal financial officer are filed as exhibits hereto.

Except as described above, the Amendment does not modify or update the disclosures presented in, or exhibits to, the Original Filing in any way. The Amendment continues to speak as of the date of the Original Filing. Furthermore, the Amendment does not reflect events occurring after the filing of the Original Filing. Accordingly, the Amendment should be read in conjunction with the Original Filing, as well as the Company’s other filings made with the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act subsequent to the filing of the Original Filing.


PROOF ACQUISITION CORP I

FORM 10-Q/A FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS

 
 
Page
PART 1 - FINANCIAL INFORMATION
 
 
 
 
Item 1.
1
 
 
 
 
1
 
 
 
 
2
 
 
 
 
3
 
 
 
 
4
 
 
 
 
5
 
 
 
Item 2.
25
 
 
 
Item 3.
29
 
 
 
Item 4.
29
 
 
 
30
 
 
 
Item 1.
30
 
 
 
Item 1A.
30
 
 
 
Item 2.
30
 
 
 
Item 3.
31
 
 
 
Item 4.
31
 
 
 
Item 5.
31
 
 
 
Item 6.
31
 
 
 
33

PART I - FINANCIAL INFORMATION
 
ITEM 1.
CONDENSED FINANCIAL STATEMENTS

PROOF ACQUISITION CORP I
CONDENSED BALANCE SHEETS

   
June 30, 2023
(unaudited)
   
December 31,
2022
(audited)
 
ASSETS
           
Current assets:
           
Cash
 
$
2,029,532
   
$
1,342,435
 
Prepaid expenses
   
263,271
     
467,021
 
Total current assets
   
2,292,803
     
1,809,456
 
Investments held in Trust
   
68,615,845
     
285,581,779
 
Total Assets
 
$
70,908,648
   
$
287,391,235
 
                 
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT)
               
Current Liabilities:
               
Accrued expenses
   
357,328
     
132,417
 
Excise tax payable
    2,209,958       -  
Income tax payable
    1,852,353
      455,833
 
Total current liabilities
   
4,419,639
     
588,250
 
Deferred income taxes
    59,640       317,426  
Total Liabilities
   
4,479,279
     
905,676
 
                 
Commitments and contingencies (Note 5)
           
                 
Temporary Equity:
               
Class A common stock subject to possible redemption; $0.0001 par value; 6,443,098 and 27,600,000 shares at redemption value of $10.59 and $10.31 at June 30, 2023 and December 31, 2022, respectively
   
68,217,016
     
284,449,019
 
                 
Stockholders’ Equity (Deficit):
               
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
   
     
 
Class A common stock, $0.0001 par value; 70,000,000 shares authorized; none issued and outstanding (excluding 6,443,098 and 27,600,000 at June 30, 2023 and December 31, 2022, respectively, shares subject to possible redemption)
   
     
 
Class B common stock, $0.0001 par value; 12,500,000 shares authorized; 6,900,000 shares issued and outstanding
   
690
     
690
 
(Accumulated Deficit) Retained earnings
   
(1,788,337
)
   
2,035,850
 
Total Stockholders’ (Deficit) Equity
   
(1,787,647
)
   
2,036,540
 
Total Liabilities, Temporary Equity and Stockholders’ (Deficit) Equity
 
$
70,908,648
   
$
287,391,235
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

PROOF ACQUISITION CORP I
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
 
   
For the Three Months Ended
June 30, 2023
   
For the Three Months Ended
June 30, 2022
 
             
Formation and operating expenses
 
$
698,927
    $ 499,429  
Operating loss
   
(698,927
)
    (499,429 )
                 
Interest income - investments held in Trust Account
   
2,482,403
      373,148  
Other income
   
2,482,403
      373,148  
Income (loss) before income tax     1,783,476       (126,281 )
Income tax expense     (513,156 )     (29,860 )
Net income (loss)
 
$
1,270,320
    $ (156,141 )
Class A common stock - weighted average shares outstanding, basic and diluted
   
17,835,276
      27,600,000  
Class A common stock - basic and diluted net income (loss) per share
  $ 0.05     $  
Class B common stock - weighted average shares outstanding, basic and diluted 
   
6,900,000
      6,900,000  
Class B common stock - basic and diluted net income (loss) per share
 
$
0.05
    $  

   
For the Six Months Ended
June 30, 2023
    For the Six Months Ended
June 30, 2022
 
             
Formation and operating expenses
  $ 1,223,029    
$
993,103
 
Operating loss
    (1,223,029 )    
(993,103
)
                 
Interest income - investments held in Trust Account
    5,511,344
     
399,913
 
Other income
    5,511,344
     
399,913
 
                 
Income (loss) before income tax     4,288,315
      (593,189 )
Income tax expense
    (1,138,734 )     (29,860 )
Net income (loss)
  $ 3,149,581    
$
(623,050
)
Class A common stock - weighted average shares outstanding, basic and diluted
    22,690,664
      27,600,000
 
Class A common stock - basic and diluted net income (loss) per share
  $ 0.11     $ (0.02 )
Class B common stock - weighted average shares outstanding, basic and diluted 
    6,900,000
      6,900,000
 
Class B common stock - basic and diluted net income (loss) per share
  $ 0.11     $ (0.02 )

The accompanying notes are an integral part of these unaudited condensed financial statements.
PROOF ACQUISITION CORP I
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the Three and Six Months Ended June 30, 2023 and 2022
 
   
Class B Common Stock
   
Additional
Paid-in
Capital
   
Retained
Earnings (Accumulated Deficit)
   
Total
Stockholders’
Equity (Deficit)
 
   
Shares
   
Amount
   

   

   

 
Balance, December 31, 2022
   
6,900,000
   
$
690
   
$
   
$
2,035,850
   
$
2,036,540
 
Remeasurement of Class A Common Stock to redemption value
   
     
     
     
(2,353,363
)
   
(2,353,363
)
Net income
   
     
     
     
1,879,261
     
1,879,261
 
Balance, March 31, 2023
   
6,900,000
     
690
     
     
1,561,748
     
1,562,438
 
Excise tax on Class A Common Stock redemptions
   
     
     
     
(2,209,958
)
   
(2,209,958
)
Remeasurement of Class A Common Stock to redemption value
   
     
     
     
(2,410,447
)
   
(2,410,447
)
Net income
   
     
     
     
1,270,320
     
1,270,320
 
Balance, June 30, 2023
   
6,900,000
   
$
690
   
$
   
$
(1,788,337
)
 
$
(1,787,647
)

   
Class B Common Stock
   
Additional
Paid-in
Capital
   
Accumulated
Deficit
   
Total
Stockholders’
Deficit
 
   
Shares
   
Amount
   

   

   
 
Balance, December 31, 2021
   
6,900,000
   
$
690
   
$
   
$
(6,245,863
)
 
$
(6,245,173
)
Net loss
   
     
     
     
(466,910
)
   
(466,910
)
Balance, March 31, 2022
   
6,900,000
     
690
     
     
(6,712,773
)
   
(6,712,083
)
Remeasurement of Class A Common Stock to redemption value
                      (141,596 )     (141,596 )
Net loss                       (156,141 )     (156,141 )
Balance, June 30, 2022     6,900,000     $ 690     $     $ (7,010,509 )   $ (7,009,819 )

The accompanying notes are an integral part of these unaudited condensed financial statements.
 
PROOF ACQUISITION CORP I
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

   
For the
Six Months Ended
June 30,
2023
   
For the
Six Months Ended
June 30,
2022
 
Cash flows from operating activities:
           
Net income (loss)
 
$
3,149,581
   
$
(623,050
)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
Income earned on Trust assets
   
(5,511,344
)
   
(399,913
)
Changes in operating assets and liabilities:
               
Prepaid expenses
   
203,750
     
252,062
 
Income taxes payable
   
1,254,447
     
 
Deferred income taxes
   
(115,713
)
   
 
Accrued expenses
   
224,911
     
55,953
 
Net cash used in operating activities
   
(794,368
)
   
(714,948
)
                 
Cash flows from investing activities:
               
Deposit into Trust Account for extension
   
(480,000
)
   
 
Withdrawal from Trust Account for redemptions
   
220,995,813
     
 
Withdrawal from Trust Account for working capital and tax
   
1,961,465
     
 
Net cash provided by investing activities
   
222,477,278
     
 
                 
Cash flows from financing activities:
               
Trust redemptions
   
(220,995,813
)
   
 
Net cash used in financing activities
   
(220,995,813
)
   
 
                 
                 
Net change in cash
   
687,097
     
(714,948
)
Cash at beginning of period
   
1,342,435
     
2,579,658
 
Cash at end of period
 
$
2,029,532
   
$
1,864,710
 
                 
Non-cash financing activities:
               
Excise tax on redemption of Class A common stock subject to possible redemption
 
$
2,209,958
   
$
 
Remeasurement of Class A common stock subject to possible redemption
 
$
4,763,810
   
$
141,596
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 1 - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN

PROOF Acquisition Corp I (the “Company”) was incorporated in Delaware on March 16, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (collectively, the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had limited operations and no operating revenues. All activity for the period from March 16, 2021 (inception) through June 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).

The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 30, 2021. On December 3, 2021, the Company consummated the Initial Public Offering of 27,600,000 units (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), generating gross proceeds of $276,000,000, which is described in Note 4.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 15,226,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement transaction to PROOF Acquisition Sponsor I, LLC (the “Sponsor”) and certain funds and accounts managed by subsidiaries of BlackRock, Inc. (“BlackRock”).

Following the closing of the Initial Public Offering on December 3, 2021, an amount of $281,520,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 5) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.

Transaction costs related to the IPO amounted to $15,623,739 consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable (which was originally held in a Trust Account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”)) and $443,739 of other offering costs. These costs were charged to additional paid-in capital upon completion of the Initial Public Offering. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 8).

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management agreed to place an amount equal to $10.20 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants, located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account, plus any pro rata interest then in the Trust Account, net of taxes payable. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination, and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance with ASC 470-20. The common stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The re-measurement will be treated as an adjustment to adjust the temporary equity to the redemption amount. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.

If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares (and Public Shares with respect to our Sponsor and officers and directors of the Company) held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined in the Amended and Restated Certificate of Incorporation of the Company) or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

On May 19, 2023, the Company convened a Special Meeting. The shareholders of the Company approved proposals to amend the Certificate of Incorporation (the “Extension Amendment Proposal”) and to amend the Trust Agreement (the “Trust Agreement Amendment Proposal”) to extend the date by which the Company must consummate a Business Combination from June 3, 2023 to September 3, 2023, or to October 3, November 3, or December 3, 2023, as applicable, if the Company deposits additional $160,000 in the Trust Account for each one-month extension of the end of the Completion Window.


In connection with the approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, shareholders holding 21,156,902 shares of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $220,995,813 was withdrawn from the Trust Account to pay such redeeming holders.

In connection with approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, PACI deposited $480,000 in the Trust Account in connection with the exercise of the first three-month extension of the end of the Completion Window to September 3, 2023.

In connection with the redemption, the Company recorded excise tax of approximately $2.2 million. To the extent the Company issues shares during the year ended December 31, 2023, including in connection with a business combination, it likely will reduce the excise tax liability.

If the Company has not completed a Business Combination within 21 months (or up to 24 months, if applicable) from the closing of the Initial Public Offering, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Completion Window.

The holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the holders of Founder Shares acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriter agreed to waive its rights to the deferred underwriting commission (see Note 8) held in the Trust Account and, as a result, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of a distribution in liquidation, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit of $10.00.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share following the closing of this offering, or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00, due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of June 30, 2023, the Company had approximately $2.0 million in its operating bank account and a working capital deficit of approximately $2.0 million.

The Company’s liquidity needs up to June 30, 2023 had been satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, the loan under the promissory note from the Sponsor of approximately $110,000 (the “Note”) (see Note 7) to the Company, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Note from the Sponsor was repaid in full on December 6, 2021.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until September 3, 2023 (unless extended to October 3, November 3, or December 3, 2023, as applicable) to complete a Business Combination. It is uncertain that the Company will be able to consummate an initial Business Combination by this time. If an initial Business Combination is not consummated by this date and the Company has not exercised its option to extend the deadline in accordance with the terms of its Certificate of Incorporation, there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.


Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS


This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing.
The following tables summarize the effect of the previous restatement on each financial statement line item as of the dates, and for the period, indicated:

   
As previously reported
   
Adjustments
   
As restated
 
Statement of changes in stockholders’ deficit for the six months ended June 30, 2022
                 
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Accumulated Deficit - June 30, 2022
   
(7,292,517
)
   
282,008
     
(7,010,509
)
Total Stockholders’ Deficit
   
(7,291,827
)
   
282,008
     
(7,009,819
)
                         
Statement of operations for the three months ended June 30, 2022
                       
Formation and operating cost
   
619,518
     
(120,089
)
   
499,429
 
Operating loss
   
619,518
     
(120,089
)
   
499,429
 
Loss before income tax
   
(246,370
)
   
120,089
     
(126,281
)
Net loss
   
(276,230
)
   
120,089
     
(156,141
)
Class A common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
Class B common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
                         
Statement of operations for the six months ended June 30, 2022
                       
Formation and operating cost
   
1,275,111
     
(282,008
)
   
993,103
 
Operating loss
   
1,275,111
     
(282,008
)
   
993,103
 
Loss before income tax
   
(875,197
)
   
282,008
     
(593,189
)
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Class A common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
Class B common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
                         
Statement of cash flows for the six months ended June 30, 2022
                       
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Change in prepaid expenses
   
534,070
     
(282,008
)
   
252,062
 

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Presentation
 
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.


In the opinion of the Company’s management, the unaudited financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of June 30, 2023 and its results of operations and cash flows for the three and six months ended June 30, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2023 or any future interim period.

Emerging Growth Company
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates
 
The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
 
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Cash and Cash Equivalents
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Cash was $2,029,532 and $1,342,435 as of June 30, 2023 and December 31, 2022, respectively.
 
Investments held in Trust Account
 
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At June 30, 2023 and December 31, 2022, the Company had $68,615,845 and $285,581,779, respectively, in investments held in the Trust Account.
 
Offering Costs associated with a Public Offering
 
The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering.” Offering costs of $15,623,739 consist principally of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable and $443,739 of other offering costs. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 7).

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company’s effective tax rate was 29% and 0% for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was 27% and 0% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21.0% for the three and six months ended June 30, 2023 and 2022, due to changes in the valuation allowance on the deferred tax assets.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

While ASC 740 identifies usage of the effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant unusual or infrequent. Computing the ETR for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants for any other change in fair value of a complex financial instrument), the timing of any potential Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expenses in the current period based on 740-270-25-3 which states, “if an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (or benefit) but is otherwise able to make a reliable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the unusual elements that can impact its annualized book income and its impact on ETR. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2023.


Class A common stock subject to possible redemption
 
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the shares of Class A common stock subject to possible redemption in the amount of $68,217,016 and $284,449,019 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s balance sheets at June 30, 2023 and December 31, 2022. The increases of $2,410,447 and $4,763,810 during the three and six months ended June 30, 2023, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value. The increases of $141,596 and $141,596 during the three and six months ended June 30, 2022, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value.
 
Immediately upon the closing of the Initial Public Offering, the Company recognized the re-measurement from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment.

Net Income (Loss) per Common Share
 
The Company has two classes of common stock, Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of June 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period presented. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):

    For the Three Months     For the Three Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
915,959
   
$
354,361
    $ (124,913 )   $ (31,228 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
17,835,276
     
6,900,000
      27,600,000       6,900,000  
                                 
Basic and diluted net income (loss) per share
 
$
0.05
   
$
0.05
    $   $

    For the Six Months     For the Six Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
2,415,156
   
$
734,425
    $ (498,440 )   $ (124,610 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
22,690,664
     
6,900,000
      27,600,000
      6,900,000
 
                                 
Basic and diluted net income (loss) per share
 
$
0.11
   
$
0.11
    $ (0.02 )   $ (0.02 )

Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account.
 
Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
 
Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
 
Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 4 - INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).

NOTE 5 - PRIVATE PLACEMENTS

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) to the Sponsor and BlackRock of an aggregate of 15,226,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant resulting in cash proceeds of $15,226,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.

A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

NOTE 6 - RELATED PARTIES

Founder Shares

On March 31, 2021, the Sponsor received 5,750,000 of the Company’s Class B common stock (the “Founder Shares”) for a May 4, 2021 payment of $25,000. Subsequently, on November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 Founder Shares on that date. In connection with the closing of the Initial Public Offering and the sale of the Private Placement Warrants, the Company cancelled 460,000 Founder Shares held by the Sponsor and reissued the shares to parties unaffiliated with the Sponsor. All share amounts retroactively restated to account for the share split.

The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign, or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Promissory Note - Related Party

On March 31, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2022 or (ii) the consummation of the Initial Public Offering. In 2021, the Company borrowed $110,000 on this note, which was repaid in full on December 6, 2021.

General and Administrative Services

Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support for up to 24 months. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Fees related to this arrangement were $30,000 for the three months ended June 30, 2023 and 2022, respectively, and $60,000 for the six months ended June 30, 2023 and 2022, respectively.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2023 and December 31, 2022 there was no amount outstanding under the Working Capital Loans.

Consulting Agreement

A member of the Board of Directors had a written consulting agreement with the Company to provide consulting services related to the Company’s business combination efforts which terminated on December 3, 2022. This agreement was approved by the Board of Directors. Expenses incurred for the three and six months ended June 30, 2023 and 2022 were $0 and $16,668 and $0 and $35,423, respectively.

NOTE 7 - COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriter a 45-day option from the date of Initial Public Offering to purchase up to 3,600,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The over-allotment was exercised in full as part of the Initial Public Offering.

The underwriter received a cash underwriting discount of $0.20 per Unit, or $5,520,000 in the aggregate, payable upon the closing of the Initial Public Offering.

In addition, the underwriter was entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee would have become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement and the trust agreement, but due to proposed SEC regulations imposing potential liability on the underwriter of an initial public offering for a blank check company upon its subsequent initial Business Combination, the underwriter has ended its relationships with most special purpose acquisition companies it helped take public, including the Company, and has waived its deferred underwriting fees.

NOTE 8 - STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock - The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Class A Common Stock - The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were no shares of Class A common stock issued or outstanding (excluding 6,443,098 and 27,600,000, respectively, recorded as temporary equity).

Class B Common Stock - The Company is authorized to issue 12,500,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. On November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 Founder Shares on that date. As of June 30, 2023 and December 31, 2022, there were 6,900,000 shares of Class B common stock issued and outstanding, of which the Sponsor held 6,440,000 shares.

Only holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial Business Combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.

The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.

Warrants - As of June 30, 2023 and December 31, 2022, there were 13,800,000 Public Warrants and 15,226,000 Private Placement Warrants outstanding.

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

in whole and not in part;

at a price of $0.01 per Public Warrant;

upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and

if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00 - Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

at a price of $0.10 per warrant provided that the holder will be able to exercise their warrants on cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;

upon a minimum of 30 days’ prior written notice of redemption;

if, and only if, the last reported sale price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted per stock subdivisions, stock dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and

if, and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of Class A common stock) as the outstanding public warrants, as described above.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants are not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.


NOTE 9 - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION



The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 6,443,098 and 27,600,000 shares, respectively, of Class A common stock outstanding, all of which were subject to possible redemption.



As of June 30, 2023, Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Class A common stock subject to possible redemption at December 31, 2022
 
$
284,449,019
 
Re-measurement of carrying value to redemption value
   
2,353,363
 
Class A common stock subject to possible redemption at March 31, 2023
 

286,802,382
 
Re-measurement of carrying value to redemption value
    2,410,447  
Extension deposit
    480,000
 
Redemption
    (220,995,813 )
Class A common stock subject to possible redemption at June 30, 2023
  $ 68,217,016  

NOTE 10 - FAIR VALUE MEASUREMENTS

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

Description
 
Level
   
June 30,
2023
   
December 31,
2022
 
Assets:
                 
Marketable securities held in the Trust Account
   
1
   
$
68,615,845
   
$
285,581,779
 

Level 1 assets include investments in money market funds or U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

NOTE 11 - SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date these financial statements were issued. Based upon this review the Company did not identify any subsequent events, except as noted below, that would have required adjustment or disclosure in the financial statements.

On July 21, 2023, the PROOF.vc SPV, the Sponsor, and holders of then-outstanding convertible notes of Volato, Inc. (“Volato”) entered into an agreement with Volato whereby Volato issued and sold an aggregate of $10,000,000 of its Series A-1 Preferred Stock to the PROOF.vc SPV and the Sponsor.

On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).

ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS

References in this report (“Quarterly Report”) to “we,” “us” or the “Company” refer to PROOF Acquisition Corp I. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to PROOF Acquisition Sponsor I, LLC, a Delaware limited liability company. The following discussion should be read in conjunction with our financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q/A.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q/A includes forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (“SEC”) filings and elsewhere in this report.

Recent Developments

On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).

Overview

We are a blank check company incorporated on March 16, 2021 as a Delaware corporation and formed for the purpose of effecting a Business Combination. We have not selected any Business Combination target. We intend to effectuate our initial Business Combination using cash from the proceeds of our Initial Public Offering and Private Placement, our capital stock, debt, or a combination of the foregoing.

Results of Operations

We have engaged in limited operations and have not generated any operating revenues to date. All activity for the period from March 16, 2021 (inception) through June 30, 2023 relates to the Company’s formation and the Initial Public Offering, which is described below, and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. We do not expect to generate any operating revenues until the completion of our initial Business Combination. We will generate non-operating income in the form of interest income from the amount deposited in the Trust Account. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. Until the completion of our initial Business Combination, we expect to incur increased expenses as a result of being a public company, including legal, financial reporting, accounting, and auditing compliance expenses, as well as for due diligence and other expenses related to locating an initial Business Combination target and consummating the initial Business Combination.

For the three months ended June 30, 2023, we had net income of $1,270,320 which consisted of $2,482,403 of interest income on investments held in the Trust Account, partially offset by operating costs of $698,927 and income tax expense of $513,156.

For the six months ended June 30, 2023, we had net income of $3,149,581 which consisted of $5,511,344 of interest income on investments held in the Trust Account, partially offset by operating costs of $1,223,029 and income tax expense of $1,138,734.

For the three months ended June 30, 2022, we had a net loss of $156,141 which consisted of formation and operational costs of $499,492 partially offset by interest income on the Trust assets of $373,148 and income tax expense of $29,860.

For the six months ended June 30, 2022, we had net loss of approximately $623,050 which consisted of formation and operational costs of $993,103 partially offset by interest income on the Trust assets of $399,913 and income tax expense of $29,860.

Liquidity and Capital Resources

As of June 30, 2023, we had $68,615,845 in cash currently held in the Trust Account and $2,029,532 in cash that can be used for working capital.

Prior to the consummation of the Initial Public Offering, our liquidity needs were satisfied through the receipt of $25,000 from our Sponsor in exchange for the issuance of the Founder Shares, and the loan proceeds of $110,000 from the Note from our Sponsor. We fully repaid the Note on December 6, 2021. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account.

Based on the foregoing, our management believes that we will have sufficient working capital to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. We will be using these funds to pay existing accounts payable, identify and evaluate prospective initial Business Combination candidates, perform due diligence on prospective Business Combination candidates, pay travel expenditures, select the target business to merge with or acquire, and structure, negotiate, and consummate the Business Combination.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until September 3, 2023 (unless extended to October 3, November 3, or December 3, as applicable) to complete a Business Combination. It is uncertain that the Company will be able to consummate an initial Business Combination by this time. If an initial Business Combination is not consummated by this date and the Company has not exercised its option to extend the deadline in accordance with the terms of its Certificate of Incorporation, there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Contractual Obligations

Registration Rights

The holders of Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans, if any (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), were entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing of any such registration statements.

Administrative Services Agreement

We entered into an agreement to pay an affiliate of our Sponsor a total of $10,000 per month for office space, and secretarial and administrative services provided to members of our management team. Upon completion of the Business Combination or our liquidation, we will cease paying these monthly fees. We incurred $30,000 of such fees for the three months ended June 30, 2023 and 2022, respectively. We incurred $60,000 of such fees for the six months ended June 30, 2023 and 2022, respectively.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:

Class A common Stock Subject to Possible Redemption

We account for Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our outstanding Class A common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, 6,443,098 and 27,600,000 shares, respectively, of Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the balance sheet.

Net Income (Loss) Per Share of Common Stock

The Company has two classes of common stock, Class A and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 29,026,000, of the Company’s Class A common stock in the calculation of diluted net income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and six months ended June 30, 2023 and 2022. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we have determined to rely on the other exemptions from reporting requirements contained in the JOBS Act. As an “emerging growth company” we have chosen to rely on exemptions so that we are not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Recent Accounting Pronouncements

Our management does not believe there are any recently issued, but not yet effective, accounting pronouncements, if currently adopted, that would have a material effect on our financial statements.

ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable for smaller reporting companies.

ITEM 4.
CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective, due solely to the material weakness in our internal control over financial reporting related to the Company’s accounting for agreements and management reporting controls. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Management intends to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we plan to enhance these processes to better evaluate our application of the complex accounting standards that apply to our financial statements, particularly with respect to vendor contracts. As part of this enhanced process, we plan to implement an updated internal control policy providing for increased clarity regarding roles, responsibilities and verification procedures and increased communication among our personnel and third party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1.
LEGAL PROCEEDINGS.

As of June 30, 2023, to the knowledge of our management, there was no material litigation, arbitration, or governmental proceeding pending against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding.

ITEM 1A.
RISK FACTORS.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K for the period ended December 31, 2022, as amended, filed with the SEC on February 27, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report, other than the below, there have been no other material changes to the risk factors disclosed in our Annual Report on Form 10-K for the period ended December 31, 2022, as amended, filed with the SEC on February 27, 2023. However, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

A 1% U.S. federal excise tax may be imposed on us in connection with our redemptions of shares, in connection with a Business Combination or other shareholder vote pursuant to which shareholders would have a right to submit their shares for redemption.

The Inflation Reduction Act (“IRA”) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (“CAMT”) on adjusted financial statement income. The CAMT will be effective for us beginning in 2023.

ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q/A. There has been no material change in the planned use of the proceeds from our Initial Public Offering and private placement as is described in the Company’s final prospectus related to the Initial Public Offering.

ITEM 3.
DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.
MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5.
OTHER INFORMATION.

None.

ITEM 6.
EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q/A.

No.
Description of Exhibit
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*
Filed herewith.
**
Furnished.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


PROOF ACQUISITION CORP I




September 1, 2023
By:
/s/ John C. Backus, Jr.

Name:

John C. Backus, Jr.

Title:

Chief Executive Officer



(Principal Executive Officer)


September 1, 2023
By:
/s/ Steven P. Mullins

Name:

Steven P. Mullins

Title:

Chief Financial Officer



(Principal Financial and Accounting Officer)


33

EX-31.1 2 brhc20058310_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, John C. Backus, Jr., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A for the quarterly period ended June 30, 2023 of PROOF Acquisition Corp I;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 1, 2023


/s/ John C. Backus, Jr

John C. Backus, Jr.

Chief Executive Officer
(Principal Executive Officer)



EX-31.2 3 brhc20058310_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATIONS

I, Steven P. Mullins, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A for the quarterly period ended June 30, 2023 of PROOF Acquisition Corp I;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 1, 2023


/s/ Steven P. Mullins

Steven P. Mullins

Chief Financial Officer
(Principal Financial Officer)



EX-32.1 4 brhc20058310_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q/A of PROOF Acquisition Corp I (the “Company”) for the quarterly period ended June 30, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, John C. Backus, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: September 1, 2023
/s/ John C. Backus, Jr.

John C. Backus, Jr.

Chief Executive Officer
(Principal Executive Officer)

This certification accompanies this Quarterly Report on Form 10-Q/A pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.



EX-32.2 5 brhc20058310_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q/A of PROOF Acquisition Corp I (the “Company”) for the quarterly period ended June 30, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Steven P. Mullins, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: September 1, 2023
/s/ Steven P. Mullins

Steven P. Mullins

Chief Financial Officer
(Principal Financial Officer)

This certification accompanies this Quarterly Report on Form 10-Q/A pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.



EX-101.SCH 6 paci-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - PRIVATE PLACEMENTS link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 070300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details) link:presentationLink link:calculationLink link:definitionLink 090102 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details) link:presentationLink link:calculationLink link:definitionLink 090202 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 090302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details) link:presentationLink link:calculationLink link:definitionLink 090304 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 090306 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090308 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details) link:presentationLink link:calculationLink link:definitionLink 090310 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - INITIAL PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - PRIVATE PLACEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - RELATED PARTIES, Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - RELATED PARTIES, Promissory Note (Details) link:presentationLink link:calculationLink link:definitionLink 090604 - Disclosure - RELATED PARTIES, General and Administrative Services (Details) link:presentationLink link:calculationLink link:definitionLink 090606 - Disclosure - RELATED PARTIES, Related Party Loans (Details) link:presentationLink link:calculationLink link:definitionLink 090608 - Disclosure - RELATED PARTIES, Consulting Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details) link:presentationLink link:calculationLink link:definitionLink 090802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 paci-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 paci-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 paci-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE CONDENSED BALANCE SHEETS [Abstract] Basic net income (loss) per share (in dollars per share) Basic net income (loss) per share (in dollars per share) Cash and Cash Equivalents Cash equivalents Income taxes payable Change in prepaid expenses Prepaid expenses Increase (Decrease) in Prepaid Expense Changes in operating assets and liabilities: Accrued expenses Increase (Decrease) in Accrued Liabilities COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Class B Common Stock [Member] Class B Common Stock [Member] Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Common stock, shares outstanding (in shares) Common stock Common Stock, Value, Issued Total current liabilities Liabilities, Current Current Liabilities: Derivative Financial Instruments Derivatives, Embedded Derivatives [Policy Text Block] Warrants Diluted net income (loss) per share (in dollars per share) Diluted net income (loss) per share (in dollars per share) Effective tax rate Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Error Corrections and Prior Period Adjustments Restatement [Line Items] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Investments held in Trust Account Investments held in Trust Asset, Held-in-Trust, Noncurrent Initial Public Offering [Member] Initial Public Offering [Member] UNAUDITED CONDENSED STATEMENTS OF OPERATIONS [Abstract] Income Statement [Abstract] Accrued interest and penalties Income Taxes Investments held in Trust Account Investment, Policy [Policy Text Block] Total Liabilities Liabilities Total Liabilities, Temporary Equity and Stockholders' (Deficit) Equity Liabilities and Equity LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS, EQUITY (DEFICIT) Liabilities and Equity [Abstract] Related Party, Type [Axis] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Cash flows from financing activities: Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from investing activities: Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net income (loss) Allocation of net income (loss) Net income (Loss) Net income (loss) Other income Nonoperating Income (Expense) Consulting fee Professional Fees Related parties, outstanding amount Operating loss Operating loss Operating Income (Loss) Income (loss) from operations Operating revenues Preferred stock, shares authorized (in shares) Preferred stock, shares issued (in shares) Preferred stock, shares outstanding (in shares) Preferred stock, par value (in dollars per share) Prepaid expenses Prepaid Expense, Current Private Placement [Member] Proceeds from issuance of common stock Proceeds from Issuance of Equity [Abstract] Proceeds from Issuance or Sale of Equity [Abstract] Gross proceeds from initial public offering Proceeds from Issuance Initial Public Offering Gross proceeds to be received from issuance of warrants Proceeds from Issuance of Private Placement Proceeds from sponsor note Loan proceeds Deposit into Trust Account for extension Deposit to Trust Account to exercise three-month extension Extension deposit Net proceeds deposited into trust account Related Party, Type [Domain] Related party transaction amount Related party transaction amount Related Party Transaction [Line Items] RELATED PARTIES Related Party Transactions Disclosure [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Repayment of sponsor note Repayment of related party loan (Accumulated Deficit) Retained earnings Accumulated Deficit Sale of Stock [Domain] Net proceeds from initial public offering and private placement (in dollars per share) Sale of Stock, Price Per Share Effect of Restatement on Each Financial Statement Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Statement of Cash Flows [Abstract] UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS [Abstract] Statement of Changes in Stockholders' Deficit [Abstract] UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) [Abstract] Stockholders' Equity (Deficit): Equity, Attributable to Parent [Abstract] Stockholder's Deficit [Abstract] Stockholders' Equity Note [Abstract] Warrants outstanding (in shares) Class of Warrant or Right, Outstanding STOCKHOLDERS' EQUITY (DEFICIT) Equity [Text Block] Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event Type [Domain] Sale of Stock [Axis] Subsidiary, Sale of Stock [Line Items] Temporary Equity: Total current assets Assets, Current Current assets: Unrecognized tax benefits Weighted average shares outstanding, diluted (in shares) Diluted weighted average shares outstanding (in shares) Weighted average shares outstanding, basic (in shares) Basic weighted average shares outstanding (in shares) Sponsor [Member] Sponsor [Member] Sponsor [Member] Common Stock [Member] Cash Total Assets Assets Interest income - investments held in Trust Account Income earned on Trust assets Warrants and Rights Subject to Mandatory Redemption [Member] Statement [Table] Marketable securities held in the Trust Account ASSETS Assets [Abstract] Statement [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Level 1 [Member] STOCKHOLDERS' EQUITY (DEFICIT) [Abstract] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Common Stock, shares authorized (in shares) Temporary Equity, Shares Authorized Common stock, subject to possible redemption, shares outstanding (in shares) Common stock, subject to possible redemption (in shares) Common Stock, outstanding, subject to possible redemption (in shares) Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Class of Warrant or Right [Line Items] Class of Stock [Domain] WARRANTS [Abstract] Warrants and Rights Note Disclosure [Abstract] Class A Common Stock [Member] Class A Ordinary Shares [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Deferred income taxes Increase (Decrease) in Deferred Income Taxes Formation and operating expenses Formation and operating costs Fee amount Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Net Income (Loss) per Common Share Class of Stock [Axis] Common stock, par value (in dollars per share) Class A Common Stock Subject to Possible Redemption Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block] Offering Costs associated with a Public Offering Deferred Charges, Policy [Policy Text Block] Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis] Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain] Total Stockholders' (Deficit) Equity Total Stockholders' Deficit Ending balance Beginning balance Income tax expense Income Tax Expense (Benefit) Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding Preferred Stock [Abstract] Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Equity Components [Axis] Additional Paid-in Capital [Member] Retained Earnings (Accumulated Deficit) [Member] Equity Component [Domain] Transaction costs Deferred Offering Costs Preferred stock issued Stock Issued During Period, Value, New Issues Non-cash financing activities: Denominator [Abstract] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Income tax payable Class of Stock [Line Items] Schedule of Stock by Class [Table] Commitments and contingencies (Note 5) Adjustments to reconcile net income (loss) to net cash used in operating activities: DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Nature of Operations [Text Block] Accrued expenses Excise tax payable Excise tax Numerator [Abstract] Income (loss) before income tax Loss before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Common stock, redemption price per share (in dollars per share) Temporary Equity, by Class of Stock [Table] Temporary Equity [Line Items] Temporary Equity [Line Items] Common stock, subject to possible redemption, par value (in dollars per share) Common Stock, par value (in dollars per share) Re-measurement of carrying value to redemption value Remeasurement of Class A Common Stock Subject to Possible Redemption Temporary Equity, Carrying Amount, Period Increase (Decrease) Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Recurring [Member] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Cash and Cash Equivalents [Abstract] DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN [Abstract] Ending balance (in shares) Beginning balance (in shares) Shares, Outstanding Class A Common Stock Subject to Possible Redemption Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] COMMITMENTS AND CONTINGENCIES [Abstract] Income Taxes [Abstract] Income Tax Disclosure [Abstract] FAIR VALUE MEASUREMENTS [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent Use of Estimates Assets [Abstract] Assets, Fair Value Disclosure [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION [Abstract] RELATED PARTIES [Abstract] SUBSEQUENT EVENTS [Abstract] Shares cancelled (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Basic and Diluted Net Income (loss) Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Basis of Presentation Share price (in dollars per share) Share price (in dollars per share) Share Price Class A common stock subject to possible redemption; $0.0001 par value; 6,443,098 and 27,600,000 shares at redemption value of $10.59 and $10.31 at June 30, 2023 and December 31, 2022, respectively Class A common stock subject to possible redemption, Ending Balance Class A common stock subject to possible redemption, Beginning Balance Common stock, subject to possible redemption Subsequent Event [Member] Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Concentration of Credit Risk Issuance of Class B common stock to Sponsor (in shares) Stock split Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Number of securities to be called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Share price (in dollars per share) Unit price (in dollars per share) Related Party Transaction [Axis] Related Party Transaction [Domain] Over-Allotment Option [Member] Warrants exercise price (in dollars per share) Net change in cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash at end of period Cash at beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Warrants expiration period RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Error Correction [Text Block] Notes Payable, Related Party, Type [Extensible Enumeration] As Previously Reported [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Minimum [Member] Revision of Prior Period [Axis] Revision of Prior Period [Domain] Adjustment [Member] Cover [Abstract] Document Type Document Quarterly Report Document Transition Report Entity Interactive Data Current Amendment Flag Amendment Description Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Preferred stock shares classified as series A-1. Series A-1 Preferred Stock [Member] Series A-1 Preferred Stock [Member] Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities. Working Capital Deficit Amount Working capital deficit Liquidity And Capital Resources [Abstract] Liquidity and Capital Resources [Abstract] Period of time from closing of Initial Public Offering to complete Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period To Complete Business Combination From Closing Of Initial Public Offering Period to complete business combination from closing of initial public offering Carrying value as of the balance sheet date of outstanding underwriting commissions payable initially due after one year or beyond the operating cycle if longer, excluding current portion. Deferred Underwriting Commissions Deferred underwriting commission Post-transaction ownership percentage of the outstanding voting securities of the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940. Post Transaction Ownership Percentage of Target Business Post-transaction ownership percentage of the target business Period of time to redeem Public Shares if Business Combination is not completed within the Initial Combination Period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period Period to redeem public shares if business combination is not completed within initial combination period Percentage of Public Shares that would not be redeemed if a Business Combination is not completed within the Initial Combination Period. Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period Percentage of Public Shares that can be redeemed without the prior consent of the Company. Percentage of Public Shares that can be Redeemed Without Prior Consent Percentage of public shares that can be redeemed without prior consent Interest received on the Trust Account that can be used to pay dissolution expenses if a Business Combination is not completed with the Combination Period. Interest on Trust Account to be held to Pay Dissolution Expenses Interest on trust account that can be held to pay dissolution expenses Number of operating businesses that must be included in initial Business Combination. Number of Operating Businesses Included in Initial Business Combination Number of operating businesses included in initial business combination Fair market value as a percentage of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. Fair Market Value as Percentage of Net Assets Held in Trust Account Included in Initial Business Combination Fair market value as percentage of net assets held in trust account included in initial business combination The cash inflow associated with the cash withdrawn from trust account with redemptions. Proceeds from Cash Withdrawal from Trust Account with Redemptions Withdrawn from trust account for redemption The period of each additional extension to the period required to complete a Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period of Extension to Period to Complete Business Combination Period of extension to consummate business combination Additional amount of cash outflow for purchase of marketable security. Additional Payments to Acquire Marketable Securities Additional deposit into Trust Account for extension Net tangible assets threshold value for redemption of public shares. Net Tangible Assets Threshold For Redeeming Public Shares Net tangible asset threshold for redeeming Public Shares The extension period available to complete business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Extension Period to Complete Business Combination Business combination extension period Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Organization and Business Operations [Line Items] Per share amount in case of time available to complete a business combination in 21 months. Initial Public Offering Units Sold One [Member] Initial Public Offering Units Sold at $10.20 [Member] Disclosure of information about the Company's organization and business operations. Organization and Business Operations [Table] 'Remeasurement of class a common stock subject to possible redemption. Remeasurement of Class A Common Stock Subject to Possible Redemption Remeasurement of Class A Common Stock to redemption value Number of votes each eligible share holder is entitled to for each common share held. Common Stock Voting Rights Number Of Votes Number of votes per share Class A Ordinary Shares Subject to Possible Redemption [Abstract] Class A Common Stock Subject to Possible Redemption [Abstract] The entire disclosure for temporary equity and common shares subject to possible redemption. Temporary Equity Shares Subject To Possible Redemption [Text Block] CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Person serving on board of directors and person with designation of officer. Director and Officer [Member] Director and Officer [Member] The purchase of shares of the entity by the "initial stockholders" of the entity. Founder Shares [Member] Founder Shares [Member] Period after the initial Business Combination for the common stock price to exceed the threshold price per share, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period after Initial Business Combination Period after initial business combination Period of time after the completion of initial Business Combination in which initial shareholders are not permitted to transfer, assign or sell any of their held Founder Shares, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Holding Period For Transfer Assignment Or Sale Of Founder Shares Holding period for transfer, assignment or sale of Founder Shares Founder Shares [Abstract] Founder Shares [Abstract] Related Party Transaction, Loans [Abstract] Related Party Loans [Abstract] Working capital loans to fund working capital deficiencies or finance transaction costs in connection with a Business Combination. Working Capital Loans [Member] KKR Acquisition Sponsor I LLC (Sponsor), an affiliate of the Sponsor, or certain of the Company's officers and directors. Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] The amount of re-measurement of Class A ordinary shares subject to possible redemption. Remeasurement of Class A Common Stock to redemption value Remeasurement of Class A Common Stock to redemption value The amount of excise tax payable on the redemptions of Class A common stock during the period. Excise Taxon Common Stock Redemptions Excise tax on Class A Common Stock redemptions Units sold in a public offering each consisting of one Class A ordinary share and one-half of one redeemable warrant. Public Shares [Member] Public Shares [Member] Units consist of one Class A ordinary share and one-half of one redeemable warrant. Units Issued During Period, Shares, New Issues Units issued (in shares) The number of securities into which each unit may be converted. For example, but not limited to, each unit may be converted into two shares of common stock. Units, number of securities called by units Number of securities to be called by each unit (in shares) Initial Public Offering of Units [Abstract] Proposed Public Offering [Abstract] The entire disclosure for the initial public offering of the Company's common stock. Initial Public Offering [Text Block] INITIAL PUBLIC OFFERING INITIAL PUBLIC OFFERING [Abstract] The cash inflow associated with the withdrawal for working capital and taxes. Proceeds from Withdrawal for Working Capital and Taxes Withdrawal from Trust Account for working capital and tax Amount of excise tax on redemption of Class A common stock subject to possible redemption in noncash transactions. Excise Tax on Redemption of Class A Common Stock Subject to Possible Redemption Excise tax on redemption of Class A common stock subject to possible redemption The cash outflow for redemption of Class A ordinary shares during the period. Payments for Redemption of Temporary Equity Repayment of Class A common stock subject to possible redemption Redemption The cash inflow from cash withdrawn from Trust Account. Proceeds From Cash Withdrawal From Trust Account Withdrawal from Trust Account for redemptions Ratio applied to the conversion of stock, for example but not limited to, one share converted to two or two shares converted to one. Stock Conversion Ratio Stock conversion basis of Class B to Class A ordinary shares at time of initial business combination Percentage of shares of Class A common stock issuable upon conversion of all shares of Class B common stock on an as-converted basis. Stock Conversion, As-converted Percentage As-converted percentage for Class A ordinary shares after conversion of Class B shares Number of votes each holder is entitled to vote per share. Common Stock, Votes Per Share Number of votes per share Utilities and secretarial and administrative support period, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Utilities and Secretarial and Administrative Support Period Utilities and secretarial and administrative support period General and Administrative Support Agreement [Abstract] General and Administrative Services [Abstract] An agreement whereby, on the effective date of the registration statement on Form S-1 related to the Initial Public Offering through the earlier of consummation of the initial Business Combination and the Company's liquidation, the Company will pay a monthly fee for office space, utilities and secretarial and administrative support. General and Administrative Support Agreement [Member] General and Administrative Services [Member] Consulting Agreement [Abstract] Loan of approximately $110,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (Note). The Note was non-interest bearing and payable upon the completion of the Initial Public Offering. Promissory Note [Member] Promissory Note [Member] Related Party Transaction, Promissory Note [Abstract] Promissory Note [Abstract] Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share. Redeemable Warrants [Member] Redeemable Warrants [Member] Units, each consisting of one Class A ordinary share, $0.0001 par value, and one- half of one redeemable warrant. Units [Member] Units [Member] Warrants and rights that embody an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur. Warrants and Rights Subject to Mandatory Redemption, One [Member] Redemption of Warrants for Cash When Price Equals or Exceeds $18.00 [Member] Warrants issued in connection with the Initial Public Offering. Each one whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. Public Warrant [Member] Public Warrants [Member] Public Warrant [Member] Warrants and rights that embody an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur. Warrants and Rights Subject to Mandatory Redemption, Two [Member] Redemption of Warrants for Cash When Price Equals or Exceeds $10.00 [Member] Threshold number of specified trading days that common stock price must exceed threshold price within a specified consecutive trading period, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Trading Days Threshold trading days Period to provide written notice to redeem warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Notice Period to Redeem Warrants Notice period to redeem warrants Threshold period of specified consecutive trading days that common stock price must exceed threshold price for specified number of trading days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Consecutive Trading Days Threshold consecutive trading days Period of time required to pass after the filing of a registration statement to become effective before warrant holders may be permitted to exercise warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Period for Registration Statement to Become Effective Period for registration statement to become effective Period of time after the completion of initial Business Combination in which initial shareholders are not permitted to transfer, assign or sell any of their held warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Holding Period for Transfer Assignment or Sale of Warrants Limitation period to transfer, assign or sell warrants Period the entity is required to file a registration statement following the closing of a Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Period to File Registration Statement Number of days to file registration statement Period of time in which warrants may be redeemed, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Class of Warrant or Right Redemption Period Redemption period Redemption price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Redemption Price of Warrants or Rights Warrant redemption price (in dollars per share) Period for warrants to exercise after the completion of public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period to Exercise Warrants After Public Offerings Period to exercise warrants after public offerings Period after the completion of a business combination when warrants will become exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period to Exercise Warrants After Business Combination Period warrants to become excisable after business combination Investments held in Trust Account [Abstract] Each whole Private Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share. Private Placement Warrant [Member] Private Placement Warrant [Member] Period of time after the completion of the initial Business Combination in which the Sponsor and the Company's officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Class of Warrant or Right Holding Period Holding period for transfer, assignment or sale of warrants Number of warrants or rights issued during the period. Class of Warrant or Right, Issued Warrants issued (in shares) Private Placement Warrants [Abstract] Private Placement Warrants [Abstract] The entire disclosure of sale of warrants in a private placement offering. Private Placement [Text Block] PRIVATE PLACEMENTS PRIVATE PLACEMENTS [Abstract] Period of time from the date of the final prospectus relating to the Initial Public Offering for underwriters to purchase additional Units to cover over-allotments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Option for Underwriters to Purchase Additional Units, Term Term of option for underwriters to purchase additional Units to cover over-allotments Underwriting discount fee per unit paid to underwriters. Underwriting Discount Fee Underwriting discount (in dollars per share) Aggregate underwriting discount fee paid to the underwriters upon the closing of the Initial Public Offering. Underwriting Discount Underwriting discount Number of additional Units that can be purchased by the underwriters to cover over-allotments. Additional Units that can be Purchased to Cover Over-allotments Additional Units that can be purchased to cover over-allotments (in shares) Per share amount of deferred fee of gross proceeds of an Initial Public Offering paid to the underwriter. Deferred Underwriter Fee Discount Per Share Deferred underwriter fee discount (in dollars per share) Underwriting Agreement [Abstract] Underwriting Agreement [Abstract] Represents the number of demands eligible security holder can make. Number of Demands Eligible Security Holder Can Make Number of demands entitled to holders Registration Rights [Abstract] Carrying value as of the balance sheet date of outstanding underwriting commissions initially due after one year or beyond the operating cycle if longer, excluding current portion. Deferred Underwriting Commissions Non Current Deferred underwriting commission Amount of other costs incurred in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants. Other Offering Costs Other offering costs Other costs Amount of costs incurred and deferred for underwriting fees in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants. Underwriting fees, Deferred Deferred underwriting fees Deferred underwriting fee Amount of costs incurred for underwriting fees in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants. Underwriting fees Underwriting fees Offering Costs associated with a Public Offering [Abstract] EX-101.PRE 10 paci-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2023
Sep. 01, 2023
Entity Listings [Line Items]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (the Amendment”) amends the Quarterly Report on Form 10-Q of PROOF Acquisition Corp I (the “Company,” “we,” “our” or “us”), as filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2023 (the “Original Filing”). This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing but that had previously been restated in Note 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS of the Company’s Annual Report on Form 10-K filed with the SEC on February 27, 2023.  
Document Quarterly Report true  
Current Fiscal Year End Date --12-31  
Document Period End Date Jun. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Document Transition Report false  
Entity File Number 001-41104  
Entity Registrant Name PROOF ACQUISITION CORP I  
Entity Central Index Key 0001853070  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 86-2707040  
Entity Address, Address Line One 11911 Freedom Drive  
Entity Address, Address Line Two Suite 1080  
Entity Address, City or Town Reston  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 20190  
City Area Code 571  
Local Phone Number 310-4949  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Units [Member]    
Entity Listings [Line Items]    
Title of 12(b) Security Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant  
Trading Symbol PACI.U  
Security Exchange Name NYSE  
Class A Common Stock [Member]    
Entity Listings [Line Items]    
Title of 12(b) Security Class A common stock, par value $0.0001 per share (included as part of the Units)  
Trading Symbol PACI  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   6,443,098
Redeemable Warrants [Member]    
Entity Listings [Line Items]    
Title of 12(b) Security Redeemable Warrants (included as part of the Units)  
Trading Symbol PACI.WS  
Security Exchange Name NYSE  
Class B Common Stock [Member]    
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   6,900,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 2,029,532 $ 1,342,435
Prepaid expenses 263,271 467,021
Total current assets 2,292,803 1,809,456
Investments held in Trust 68,615,845 285,581,779
Total Assets 70,908,648 287,391,235
Current Liabilities:    
Accrued expenses 357,328 132,417
Excise tax payable 2,209,958 0
Income tax payable 1,852,353 455,833
Total current liabilities 4,419,639 588,250
Deferred income taxes 59,640 317,426
Total Liabilities 4,479,279 905,676
Commitments and contingencies (Note 5)
Temporary Equity:    
Class A common stock subject to possible redemption; $0.0001 par value; 6,443,098 and 27,600,000 shares at redemption value of $10.59 and $10.31 at June 30, 2023 and December 31, 2022, respectively 68,217,016 284,449,019
Stockholders' Equity (Deficit):    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
(Accumulated Deficit) Retained earnings (1,788,337) 2,035,850
Total Stockholders' (Deficit) Equity (1,787,647) 2,036,540
Total Liabilities, Temporary Equity and Stockholders' (Deficit) Equity 70,908,648 287,391,235
Class A Common Stock [Member]    
Temporary Equity:    
Class A common stock subject to possible redemption; $0.0001 par value; 6,443,098 and 27,600,000 shares at redemption value of $10.59 and $10.31 at June 30, 2023 and December 31, 2022, respectively 68,217,016 284,449,019
Stockholders' Equity (Deficit):    
Common stock 0 0
Class B Common Stock [Member]    
Stockholders' Equity (Deficit):    
Common stock $ 690 $ 690
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Stockholders' Equity (Deficit):    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Class A Common Stock [Member]    
Temporary Equity:    
Common stock, subject to possible redemption, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, subject to possible redemption (in shares) 6,443,098 27,600,000
Common stock, redemption price per share (in dollars per share) $ 10.59 $ 10.31
Stockholders' Equity (Deficit):    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 70,000,000 70,000,000
Common stock, shares issued (in shares) 0 0
Common stock, shares outstanding (in shares) 0 0
Class B Common Stock [Member]    
Stockholders' Equity (Deficit):    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 12,500,000 12,500,000
Common stock, shares issued (in shares) 6,900,000 6,900,000
Common stock, shares outstanding (in shares) 6,900,000 6,900,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income (loss) from operations        
Formation and operating expenses $ 698,927 $ 499,429 $ 1,223,029 $ 993,103
Operating loss (698,927) (499,429) (1,223,029) (993,103)
Interest income - investments held in Trust Account 2,482,403 373,148 5,511,344 399,913
Other income 2,482,403 373,148 5,511,344 399,913
Income (loss) before income tax 1,783,476 (126,281) 4,288,315 (593,189)
Income tax expense (513,156) (29,860) (1,138,734) (29,860)
Net income (loss) 1,270,320 (156,141) 3,149,581 (623,050)
Class A Common Stock [Member]        
Income (loss) from operations        
Net income (loss) $ 915,959 $ (124,913) $ 2,415,156 $ (498,440)
Weighted average shares outstanding, basic (in shares) 17,835,276 27,600,000 22,690,664 27,600,000
Weighted average shares outstanding, diluted (in shares) 17,835,276 27,600,000 22,690,664 27,600,000
Basic net income (loss) per share (in dollars per share) $ 0.05 $ 0 $ 0.11 $ (0.02)
Diluted net income (loss) per share (in dollars per share) $ 0.05 $ 0 $ 0.11 $ (0.02)
Class B Common Stock [Member]        
Income (loss) from operations        
Net income (loss) $ 354,361 $ (31,228) $ 734,425 $ (124,610)
Weighted average shares outstanding, basic (in shares) 6,900,000 6,900,000 6,900,000 6,900,000
Weighted average shares outstanding, diluted (in shares) 6,900,000 6,900,000 6,900,000 6,900,000
Basic net income (loss) per share (in dollars per share) $ 0.05 $ 0 $ 0.11 $ (0.02)
Diluted net income (loss) per share (in dollars per share) $ 0.05 $ 0 $ 0.11 $ (0.02)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock [Member]
Class B Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Total
Class B Common Stock [Member]
Beginning balance at Dec. 31, 2021 $ 690 $ 0 $ (6,245,863) $ (6,245,173)  
Beginning balance (in shares) at Dec. 31, 2021 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (Loss) $ 0 0 (466,910) (466,910)  
Ending balance at Mar. 31, 2022 $ 690 0 (6,712,773) (6,712,083)  
Ending balance (in shares) at Mar. 31, 2022 6,900,000        
Beginning balance at Dec. 31, 2021 $ 690 0 (6,245,863) (6,245,173)  
Beginning balance (in shares) at Dec. 31, 2021 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (Loss)       (623,050) $ (124,610)
Ending balance at Jun. 30, 2022 $ 690 0 (7,010,509) (7,009,819)  
Ending balance (in shares) at Jun. 30, 2022 6,900,000        
Beginning balance at Mar. 31, 2022 $ 690 0 (6,712,773) (6,712,083)  
Beginning balance (in shares) at Mar. 31, 2022 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Remeasurement of Class A Common Stock to redemption value   0 (141,596) (141,596)  
Net income (Loss) $ 0 0 (156,141) (156,141) (31,228)
Ending balance at Jun. 30, 2022 $ 690 0 (7,010,509) (7,009,819)  
Ending balance (in shares) at Jun. 30, 2022 6,900,000        
Beginning balance at Dec. 31, 2022 $ 690 0 2,035,850 2,036,540  
Beginning balance (in shares) at Dec. 31, 2022 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Remeasurement of Class A Common Stock to redemption value   0 (2,353,363) (2,353,363)  
Net income (Loss) $ 0 0 1,879,261 1,879,261  
Ending balance at Mar. 31, 2023 $ 690 0 1,561,748 1,562,438  
Ending balance (in shares) at Mar. 31, 2023 6,900,000        
Beginning balance at Dec. 31, 2022 $ 690 0 2,035,850 2,036,540  
Beginning balance (in shares) at Dec. 31, 2022 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (Loss)       3,149,581 734,425
Ending balance at Jun. 30, 2023 $ 690 0 (1,788,337) (1,787,647)  
Ending balance (in shares) at Jun. 30, 2023 6,900,000        
Beginning balance at Mar. 31, 2023 $ 690 0 1,561,748 1,562,438  
Beginning balance (in shares) at Mar. 31, 2023 6,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Remeasurement of Class A Common Stock to redemption value   0 (2,410,447) (2,410,447)  
Net income (Loss) $ 0 0 1,270,320 1,270,320 $ 354,361
Excise tax on Class A Common Stock redemptions   0 (2,209,958) (2,209,958)  
Ending balance at Jun. 30, 2023 $ 690 $ 0 $ (1,788,337) $ (1,787,647)  
Ending balance (in shares) at Jun. 30, 2023 6,900,000        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:      
Net income (loss) $ 1,270,320 $ 3,149,581 $ (623,050)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Income earned on Trust assets (2,482,403) (5,511,344) (399,913)
Changes in operating assets and liabilities:      
Prepaid expenses   203,750 252,062
Income taxes payable   1,254,447 0
Deferred income taxes   (115,713) 0
Accrued expenses   224,911 55,953
Net cash used in operating activities   (794,368) (714,948)
Cash flows from investing activities:      
Deposit into Trust Account for extension (480,000) (480,000) 0
Withdrawal from Trust Account for redemptions   220,995,813 0
Withdrawal from Trust Account for working capital and tax   1,961,465 0
Net cash provided by investing activities   222,477,278 0
Cash flows from financing activities:      
Repayment of Class A common stock subject to possible redemption   (220,995,813) 0
Net cash used in financing activities   (220,995,813) 0
Net change in cash   687,097 (714,948)
Cash at beginning of period   1,342,435 2,579,658
Cash at end of period $ 2,029,532 2,029,532 1,864,710
Non-cash financing activities:      
Excise tax on redemption of Class A common stock subject to possible redemption   2,209,958 0
Remeasurement of Class A Common Stock Subject to Possible Redemption   $ 4,763,810 $ 141,596
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
6 Months Ended
Jun. 30, 2023
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN [Abstract]  
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
NOTE 1 - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN

PROOF Acquisition Corp I (the “Company”) was incorporated in Delaware on March 16, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (collectively, the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had limited operations and no operating revenues. All activity for the period from March 16, 2021 (inception) through June 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).

The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 30, 2021. On December 3, 2021, the Company consummated the Initial Public Offering of 27,600,000 units (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), generating gross proceeds of $276,000,000, which is described in Note 4.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 15,226,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement transaction to PROOF Acquisition Sponsor I, LLC (the “Sponsor”) and certain funds and accounts managed by subsidiaries of BlackRock, Inc. (“BlackRock”).

Following the closing of the Initial Public Offering on December 3, 2021, an amount of $281,520,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 5) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.

Transaction costs related to the IPO amounted to $15,623,739 consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable (which was originally held in a Trust Account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”)) and $443,739 of other offering costs. These costs were charged to additional paid-in capital upon completion of the Initial Public Offering. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 8).

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management agreed to place an amount equal to $10.20 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants, located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account, plus any pro rata interest then in the Trust Account, net of taxes payable. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination, and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance with ASC 470-20. The common stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The re-measurement will be treated as an adjustment to adjust the temporary equity to the redemption amount. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.

If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The holders of the Founder Shares have agreed (a) to waive their redemption rights with respect to the Founder Shares (and Public Shares with respect to our Sponsor and officers and directors of the Company) held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Completion Window (as defined in the Amended and Restated Certificate of Incorporation of the Company) or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

On May 19, 2023, the Company convened a Special Meeting. The shareholders of the Company approved proposals to amend the Certificate of Incorporation (the “Extension Amendment Proposal”) and to amend the Trust Agreement (the “Trust Agreement Amendment Proposal”) to extend the date by which the Company must consummate a Business Combination from June 3, 2023 to September 3, 2023, or to October 3, November 3, or December 3, 2023, as applicable, if the Company deposits additional $160,000 in the Trust Account for each one-month extension of the end of the Completion Window.


In connection with the approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, shareholders holding 21,156,902 shares of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $220,995,813 was withdrawn from the Trust Account to pay such redeeming holders.

In connection with approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, PACI deposited $480,000 in the Trust Account in connection with the exercise of the first three-month extension of the end of the Completion Window to September 3, 2023.

In connection with the redemption, the Company recorded excise tax of approximately $2.2 million. To the extent the Company issues shares during the year ended December 31, 2023, including in connection with a business combination, it likely will reduce the excise tax liability.

If the Company has not completed a Business Combination within 21 months (or up to 24 months, if applicable) from the closing of the Initial Public Offering, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Completion Window.

The holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Completion Window. However, if the holders of Founder Shares acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Completion Window. The underwriter agreed to waive its rights to the deferred underwriting commission (see Note 8) held in the Trust Account and, as a result, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of a distribution in liquidation, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit of $10.00.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share following the closing of this offering, or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00, due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of June 30, 2023, the Company had approximately $2.0 million in its operating bank account and a working capital deficit of approximately $2.0 million.

The Company’s liquidity needs up to June 30, 2023 had been satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, the loan under the promissory note from the Sponsor of approximately $110,000 (the “Note”) (see Note 7) to the Company, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Note from the Sponsor was repaid in full on December 6, 2021.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until September 3, 2023 (unless extended to October 3, November 3, or December 3, 2023, as applicable) to complete a Business Combination. It is uncertain that the Company will be able to consummate an initial Business Combination by this time. If an initial Business Combination is not consummated by this date and the Company has not exercised its option to extend the deadline in accordance with the terms of its Certificate of Incorporation, there will be a mandatory liquidation and subsequent dissolution of the Company. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.


Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
6 Months Ended
Jun. 30, 2023
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
NOTE 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS


This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing.
The following tables summarize the effect of the previous restatement on each financial statement line item as of the dates, and for the period, indicated:

   
As previously reported
   
Adjustments
   
As restated
 
Statement of changes in stockholders’ deficit for the six months ended June 30, 2022
                 
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Accumulated Deficit - June 30, 2022
   
(7,292,517
)
   
282,008
     
(7,010,509
)
Total Stockholders’ Deficit
   
(7,291,827
)
   
282,008
     
(7,009,819
)
                         
Statement of operations for the three months ended June 30, 2022
                       
Formation and operating cost
   
619,518
     
(120,089
)
   
499,429
 
Operating loss
   
619,518
     
(120,089
)
   
499,429
 
Loss before income tax
   
(246,370
)
   
120,089
     
(126,281
)
Net loss
   
(276,230
)
   
120,089
     
(156,141
)
Class A common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
Class B common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
                         
Statement of operations for the six months ended June 30, 2022
                       
Formation and operating cost
   
1,275,111
     
(282,008
)
   
993,103
 
Operating loss
   
1,275,111
     
(282,008
)
   
993,103
 
Loss before income tax
   
(875,197
)
   
282,008
     
(593,189
)
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Class A common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
Class B common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
                         
Statement of cash flows for the six months ended June 30, 2022
                       
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Change in prepaid expenses
   
534,070
     
(282,008
)
   
252,062
 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Basis of Presentation
 
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.


In the opinion of the Company’s management, the unaudited financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of June 30, 2023 and its results of operations and cash flows for the three and six months ended June 30, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2023 or any future interim period.

Emerging Growth Company
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates
 
The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
 
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Cash and Cash Equivalents
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Cash was $2,029,532 and $1,342,435 as of June 30, 2023 and December 31, 2022, respectively.
 
Investments held in Trust Account
 
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At June 30, 2023 and December 31, 2022, the Company had $68,615,845 and $285,581,779, respectively, in investments held in the Trust Account.
 
Offering Costs associated with a Public Offering
 
The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering.” Offering costs of $15,623,739 consist principally of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable and $443,739 of other offering costs. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 7).

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company’s effective tax rate was 29% and 0% for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was 27% and 0% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21.0% for the three and six months ended June 30, 2023 and 2022, due to changes in the valuation allowance on the deferred tax assets.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

While ASC 740 identifies usage of the effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant unusual or infrequent. Computing the ETR for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants for any other change in fair value of a complex financial instrument), the timing of any potential Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expenses in the current period based on 740-270-25-3 which states, “if an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (or benefit) but is otherwise able to make a reliable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the unusual elements that can impact its annualized book income and its impact on ETR. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2023.


Class A common stock subject to possible redemption
 
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the shares of Class A common stock subject to possible redemption in the amount of $68,217,016 and $284,449,019 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s balance sheets at June 30, 2023 and December 31, 2022. The increases of $2,410,447 and $4,763,810 during the three and six months ended June 30, 2023, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value. The increases of $141,596 and $141,596 during the three and six months ended June 30, 2022, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value.
 
Immediately upon the closing of the Initial Public Offering, the Company recognized the re-measurement from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment.

Net Income (Loss) per Common Share
 
The Company has two classes of common stock, Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of June 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period presented. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):

    For the Three Months     For the Three Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
915,959
   
$
354,361
    $ (124,913 )   $ (31,228 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
17,835,276
     
6,900,000
      27,600,000       6,900,000  
                                 
Basic and diluted net income (loss) per share
 
$
0.05
   
$
0.05
    $   $

    For the Six Months     For the Six Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
2,415,156
   
$
734,425
    $ (498,440 )   $ (124,610 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
22,690,664
     
6,900,000
      27,600,000
      6,900,000
 
                                 
Basic and diluted net income (loss) per share
 
$
0.11
   
$
0.11
    $ (0.02 )   $ (0.02 )

Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account.
 
Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
 
Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
 
Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
INITIAL PUBLIC OFFERING
6 Months Ended
Jun. 30, 2023
INITIAL PUBLIC OFFERING [Abstract]  
INITIAL PUBLIC OFFERING
NOTE 4 - INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
PRIVATE PLACEMENTS
6 Months Ended
Jun. 30, 2023
PRIVATE PLACEMENTS [Abstract]  
PRIVATE PLACEMENTS
NOTE 5 - PRIVATE PLACEMENTS

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) to the Sponsor and BlackRock of an aggregate of 15,226,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant resulting in cash proceeds of $15,226,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.

A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES
6 Months Ended
Jun. 30, 2023
RELATED PARTIES [Abstract]  
RELATED PARTIES
NOTE 6 - RELATED PARTIES

Founder Shares

On March 31, 2021, the Sponsor received 5,750,000 of the Company’s Class B common stock (the “Founder Shares”) for a May 4, 2021 payment of $25,000. Subsequently, on November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 Founder Shares on that date. In connection with the closing of the Initial Public Offering and the sale of the Private Placement Warrants, the Company cancelled 460,000 Founder Shares held by the Sponsor and reissued the shares to parties unaffiliated with the Sponsor. All share amounts retroactively restated to account for the share split.

The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign, or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Promissory Note - Related Party

On March 31, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2022 or (ii) the consummation of the Initial Public Offering. In 2021, the Company borrowed $110,000 on this note, which was repaid in full on December 6, 2021.

General and Administrative Services

Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support for up to 24 months. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Fees related to this arrangement were $30,000 for the three months ended June 30, 2023 and 2022, respectively, and $60,000 for the six months ended June 30, 2023 and 2022, respectively.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2023 and December 31, 2022 there was no amount outstanding under the Working Capital Loans.

Consulting Agreement

A member of the Board of Directors had a written consulting agreement with the Company to provide consulting services related to the Company’s business combination efforts which terminated on December 3, 2022. This agreement was approved by the Board of Directors. Expenses incurred for the three and six months ended June 30, 2023 and 2022 were $0 and $16,668 and $0 and $35,423, respectively.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 7 - COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriter a 45-day option from the date of Initial Public Offering to purchase up to 3,600,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The over-allotment was exercised in full as part of the Initial Public Offering.

The underwriter received a cash underwriting discount of $0.20 per Unit, or $5,520,000 in the aggregate, payable upon the closing of the Initial Public Offering.

In addition, the underwriter was entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee would have become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement and the trust agreement, but due to proposed SEC regulations imposing potential liability on the underwriter of an initial public offering for a blank check company upon its subsequent initial Business Combination, the underwriter has ended its relationships with most special purpose acquisition companies it helped take public, including the Company, and has waived its deferred underwriting fees.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY (DEFICIT)
6 Months Ended
Jun. 30, 2023
STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]  
STOCKHOLDERS' EQUITY (DEFICIT)
NOTE 8 - STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock - The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Class A Common Stock - The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were no shares of Class A common stock issued or outstanding (excluding 6,443,098 and 27,600,000, respectively, recorded as temporary equity).

Class B Common Stock - The Company is authorized to issue 12,500,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. On November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 Founder Shares on that date. As of June 30, 2023 and December 31, 2022, there were 6,900,000 shares of Class B common stock issued and outstanding, of which the Sponsor held 6,440,000 shares.

Only holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial Business Combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.

The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.

Warrants - As of June 30, 2023 and December 31, 2022, there were 13,800,000 Public Warrants and 15,226,000 Private Placement Warrants outstanding.

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

in whole and not in part;

at a price of $0.01 per Public Warrant;

upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and

if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00 - Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

at a price of $0.10 per warrant provided that the holder will be able to exercise their warrants on cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;

upon a minimum of 30 days’ prior written notice of redemption;

if, and only if, the last reported sale price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted per stock subdivisions, stock dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and

if, and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of Class A common stock) as the outstanding public warrants, as described above.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants are not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION
6 Months Ended
Jun. 30, 2023
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION [Abstract]  
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

NOTE 9 - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION



The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 6,443,098 and 27,600,000 shares, respectively, of Class A common stock outstanding, all of which were subject to possible redemption.



As of June 30, 2023, Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Class A common stock subject to possible redemption at December 31, 2022
 
$
284,449,019
 
Re-measurement of carrying value to redemption value
   
2,353,363
 
Class A common stock subject to possible redemption at March 31, 2023
 

286,802,382
 
Re-measurement of carrying value to redemption value
    2,410,447  
Extension deposit
    480,000
 
Redemption
    (220,995,813 )
Class A common stock subject to possible redemption at June 30, 2023
  $ 68,217,016  
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2023
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 10 - FAIR VALUE MEASUREMENTS

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

Description
 
Level
   
June 30,
2023
   
December 31,
2022
 
Assets:
                 
Marketable securities held in the Trust Account
   
1
   
$
68,615,845
   
$
285,581,779
 

Level 1 assets include investments in money market funds or U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS
NOTE 11 - SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date these financial statements were issued. Based upon this review the Company did not identify any subsequent events, except as noted below, that would have required adjustment or disclosure in the financial statements.

On July 21, 2023, the PROOF.vc SPV, the Sponsor, and holders of then-outstanding convertible notes of Volato, Inc. (“Volato”) entered into an agreement with Volato whereby Volato issued and sold an aggregate of $10,000,000 of its Series A-1 Preferred Stock to the PROOF.vc SPV and the Sponsor.

On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Basis of Presentation
Basis of Presentation
 
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.


In the opinion of the Company’s management, the unaudited financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of June 30, 2023 and its results of operations and cash flows for the three and six months ended June 30, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2023 or any future interim period.
Use of Estimates
Use of Estimates
 
The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.
 
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
 
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Cash was $2,029,532 and $1,342,435 as of June 30, 2023 and December 31, 2022, respectively.
Investments held in Trust Account
Investments held in Trust Account
 
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At June 30, 2023 and December 31, 2022, the Company had $68,615,845 and $285,581,779, respectively, in investments held in the Trust Account.
Offering Costs associated with a Public Offering
Offering Costs associated with a Public Offering
 
The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering.” Offering costs of $15,623,739 consist principally of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable and $443,739 of other offering costs. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 7).
Income Taxes
Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company’s effective tax rate was 29% and 0% for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was 27% and 0% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21.0% for the three and six months ended June 30, 2023 and 2022, due to changes in the valuation allowance on the deferred tax assets.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

While ASC 740 identifies usage of the effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant unusual or infrequent. Computing the ETR for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants for any other change in fair value of a complex financial instrument), the timing of any potential Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expenses in the current period based on 740-270-25-3 which states, “if an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (or benefit) but is otherwise able to make a reliable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the unusual elements that can impact its annualized book income and its impact on ETR. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2023.
Class A Common Stock Subject to Possible Redemption

Class A common stock subject to possible redemption
 
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the shares of Class A common stock subject to possible redemption in the amount of $68,217,016 and $284,449,019 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s balance sheets at June 30, 2023 and December 31, 2022. The increases of $2,410,447 and $4,763,810 during the three and six months ended June 30, 2023, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value. The increases of $141,596 and $141,596 during the three and six months ended June 30, 2022, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value.
 
Immediately upon the closing of the Initial Public Offering, the Company recognized the re-measurement from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.
Warrants
Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment.
Net Income (Loss) per Common Share
Net Income (Loss) per Common Share
 
The Company has two classes of common stock, Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The calculation of diluted income (loss) per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of June 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period presented. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):

    For the Three Months     For the Three Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
915,959
   
$
354,361
    $ (124,913 )   $ (31,228 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
17,835,276
     
6,900,000
      27,600,000       6,900,000  
                                 
Basic and diluted net income (loss) per share
 
$
0.05
   
$
0.05
    $   $

    For the Six Months     For the Six Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
2,415,156
   
$
734,425
    $ (498,440 )   $ (124,610 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
22,690,664
     
6,900,000
      27,600,000
      6,900,000
 
                                 
Basic and diluted net income (loss) per share
 
$
0.11
   
$
0.11
    $ (0.02 )   $ (0.02 )
Concentration of Credit Risk
Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account.
Fair Value of Financial Instruments
Fair Value of Financial Instruments

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Recent Accounting Standards
Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
6 Months Ended
Jun. 30, 2023
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract]  
Effect of Restatement on Each Financial Statement
The following tables summarize the effect of the previous restatement on each financial statement line item as of the dates, and for the period, indicated:

   
As previously reported
   
Adjustments
   
As restated
 
Statement of changes in stockholders’ deficit for the six months ended June 30, 2022
                 
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Accumulated Deficit - June 30, 2022
   
(7,292,517
)
   
282,008
     
(7,010,509
)
Total Stockholders’ Deficit
   
(7,291,827
)
   
282,008
     
(7,009,819
)
                         
Statement of operations for the three months ended June 30, 2022
                       
Formation and operating cost
   
619,518
     
(120,089
)
   
499,429
 
Operating loss
   
619,518
     
(120,089
)
   
499,429
 
Loss before income tax
   
(246,370
)
   
120,089
     
(126,281
)
Net loss
   
(276,230
)
   
120,089
     
(156,141
)
Class A common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
Class B common stock - basic and diluted net loss per share
   
(0.01
)
   
0.01
     

 
                         
Statement of operations for the six months ended June 30, 2022
                       
Formation and operating cost
   
1,275,111
     
(282,008
)
   
993,103
 
Operating loss
   
1,275,111
     
(282,008
)
   
993,103
 
Loss before income tax
   
(875,197
)
   
282,008
     
(593,189
)
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Class A common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
Class B common stock - basic and diluted net loss per share
   
(0.03
)
   
0.01
     
(0.02
)
                         
Statement of cash flows for the six months ended June 30, 2022
                       
Net loss
   
(905,058
)
   
282,008
     
(623,050
)
Change in prepaid expenses
   
534,070
     
(282,008
)
   
252,062
 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Basic and Diluted Net Income (loss) Per Common Share The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):

    For the Three Months     For the Three Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
915,959
   
$
354,361
    $ (124,913 )   $ (31,228 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
17,835,276
     
6,900,000
      27,600,000       6,900,000  
                                 
Basic and diluted net income (loss) per share
 
$
0.05
   
$
0.05
    $   $

    For the Six Months     For the Six Months  
   
Ended June 30, 2023
   
Ended June 30, 2022
 
   
Class A
   
Class B
    Class A     Class B  
Basic and diluted net income per share
                       
Numerator:
                       
Allocation of net income (loss)
 
$
2,415,156
   
$
734,425
    $ (498,440 )   $ (124,610 )
Denominator:
                               
Basic and diluted weighted average shares outstanding
   
22,690,664
     
6,900,000
      27,600,000
      6,900,000
 
                                 
Basic and diluted net income (loss) per share
 
$
0.11
   
$
0.11
    $ (0.02 )   $ (0.02 )
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables)
6 Months Ended
Jun. 30, 2023
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION [Abstract]  
Class A Common Stock Subject to Possible Redemption

As of June 30, 2023, Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Class A common stock subject to possible redemption at December 31, 2022
 
$
284,449,019
 
Re-measurement of carrying value to redemption value
   
2,353,363
 
Class A common stock subject to possible redemption at March 31, 2023
 

286,802,382
 
Re-measurement of carrying value to redemption value
    2,410,447  
Extension deposit
    480,000
 
Redemption
    (220,995,813 )
Class A common stock subject to possible redemption at June 30, 2023
  $ 68,217,016  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2023
FAIR VALUE MEASUREMENTS [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

Description
 
Level
   
June 30,
2023
   
December 31,
2022
 
Assets:
                 
Marketable securities held in the Trust Account
   
1
   
$
68,615,845
   
$
285,581,779
 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details)
3 Months Ended 6 Months Ended
May 19, 2023
USD ($)
shares
Dec. 03, 2021
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Business
$ / shares
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
shares
Proceeds from Issuance of Equity [Abstract]            
Operating revenues       $ 0    
Net proceeds deposited into trust account     $ 480,000 480,000 $ 0  
Transaction costs     15,623,739 15,623,739    
Underwriting fees     5,520,000 5,520,000    
Deferred underwriting fees     9,660,000 9,660,000    
Other costs     443,739 443,739    
Deferred underwriting commission           $ 0
Net tangible asset threshold for redeeming Public Shares     5,000,001 $ 5,000,001    
Percentage of public shares that can be redeemed without prior consent       15.00%    
Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period       100.00%    
Additional deposit into Trust Account for extension $ 160,000          
Period of extension to consummate business combination 3 months     1 month    
Withdrawn from trust account for redemption $ 220,995,813          
Excise tax 2,200,000   $ 2,209,958 $ 2,209,958   $ 0
Period to redeem public shares if business combination is not completed within initial combination period       10 days    
Sponsor [Member]            
Proceeds from Issuance of Equity [Abstract]            
Net proceeds deposited into trust account $ 480,000          
Class A Common Stock [Member]            
Proceeds from Issuance of Equity [Abstract]            
Common stock, subject to possible redemption (in shares) | shares 21,156,902   6,443,098 6,443,098   27,600,000
Minimum [Member]            
Proceeds from Issuance of Equity [Abstract]            
Number of operating businesses included in initial business combination | Business       1    
Fair market value as percentage of net assets held in trust account included in initial business combination       80.00%    
Post-transaction ownership percentage of the target business       50.00%    
Maximum [Member]            
Proceeds from Issuance of Equity [Abstract]            
Interest on trust account that can be held to pay dissolution expenses     $ 100,000 $ 100,000    
Private Placement Warrant [Member]            
Proceeds from Issuance of Equity [Abstract]            
Warrants issued (in shares) | shares   15,226,000        
Share price (in dollars per share) | $ / shares   $ 1        
Initial Public Offering [Member] | Public Shares [Member]            
Proceeds from Issuance of Equity [Abstract]            
Units issued (in shares) | shares   27,600,000        
Gross proceeds from initial public offering   $ 276,000,000        
Share price (in dollars per share) | $ / shares   $ 10        
Net proceeds deposited into trust account       $ 281,520,000    
Net proceeds from initial public offering and private placement (in dollars per share) | $ / shares     $ 10 $ 10    
Private Placement [Member] | Private Placement Warrant [Member]            
Proceeds from Issuance of Equity [Abstract]            
Warrants issued (in shares) | shares   15,226,000        
Share price (in dollars per share) | $ / shares   $ 1        
Initial Public Offering Units Sold at $10.20 [Member] | Public Shares [Member]            
Proceeds from Issuance of Equity [Abstract]            
Net proceeds from initial public offering and private placement (in dollars per share) | $ / shares     $ 10.2 $ 10.2    
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details) - USD ($)
6 Months Ended 9 Months Ended
Dec. 06, 2021
Jun. 30, 2023
Dec. 05, 2021
Dec. 31, 2022
Liquidity and Capital Resources [Abstract]        
Cash   $ 2,029,532   $ 1,342,435
Working capital deficit   2,000,000    
Sponsor [Member]        
Liquidity and Capital Resources [Abstract]        
Proceeds from issuance of common stock   25,000    
Sponsor [Member] | Promissory Note [Member]        
Liquidity and Capital Resources [Abstract]        
Loan proceeds   $ 110,000 $ 110,000  
Repayment of related party loan $ 110,000      
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Statement of Changes in Stockholders' Deficit [Abstract]                
Net income (Loss) $ 1,270,320 $ 1,879,261 $ (156,141) $ (466,910) $ 3,149,581 $ (623,050)    
Accumulated Deficit (1,788,337)   (7,010,509)   (1,788,337) (7,010,509) $ 2,035,850  
Total Stockholders' Deficit (1,787,647) 1,562,438 (7,009,819) (6,712,083) (1,787,647) (7,009,819) $ 2,036,540 $ (6,245,173)
Income Statement [Abstract]                
Formation and operating costs 698,927   499,429   1,223,029 993,103    
Operating loss 698,927   499,429   1,223,029 993,103    
Loss before income tax 1,783,476   (126,281)   4,288,315 (593,189)    
Net income (Loss) 1,270,320 1,879,261 (156,141) (466,910) 3,149,581 (623,050)    
Statement of Cash Flows [Abstract]                
Net income (Loss) 1,270,320 $ 1,879,261 (156,141) $ (466,910) 3,149,581 (623,050)    
Change in prepaid expenses         203,750 252,062    
Class A Common Stock [Member]                
Statement of Changes in Stockholders' Deficit [Abstract]                
Net income (Loss) 915,959   (124,913)   2,415,156 (498,440)    
Income Statement [Abstract]                
Net income (Loss) $ 915,959   $ (124,913)   $ 2,415,156 $ (498,440)    
Basic net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)    
Diluted net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)    
Statement of Cash Flows [Abstract]                
Net income (Loss) $ 915,959   $ (124,913)   $ 2,415,156 $ (498,440)    
Class B Common Stock [Member]                
Statement of Changes in Stockholders' Deficit [Abstract]                
Net income (Loss) 354,361   (31,228)   734,425 (124,610)    
Income Statement [Abstract]                
Net income (Loss) $ 354,361   $ (31,228)   $ 734,425 $ (124,610)    
Basic net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)    
Diluted net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)    
Statement of Cash Flows [Abstract]                
Net income (Loss) $ 354,361   $ (31,228)   $ 734,425 $ (124,610)    
As Previously Reported [Member]                
Statement of Changes in Stockholders' Deficit [Abstract]                
Net income (Loss)     (276,230)     (905,058)    
Accumulated Deficit     (7,292,517)     (7,292,517)    
Total Stockholders' Deficit     (7,291,827)     (7,291,827)    
Income Statement [Abstract]                
Formation and operating costs     619,518     1,275,111    
Operating loss     619,518     1,275,111    
Loss before income tax     (246,370)     (875,197)    
Net income (Loss)     (276,230)     (905,058)    
Statement of Cash Flows [Abstract]                
Net income (Loss)     $ (276,230)     (905,058)    
Change in prepaid expenses           $ 534,070    
As Previously Reported [Member] | Class A Common Stock [Member]                
Income Statement [Abstract]                
Basic net income (loss) per share (in dollars per share)     $ (0.01)     $ (0.03)    
Diluted net income (loss) per share (in dollars per share)     (0.01)     (0.03)    
As Previously Reported [Member] | Class B Common Stock [Member]                
Income Statement [Abstract]                
Basic net income (loss) per share (in dollars per share)     (0.01)     (0.03)    
Diluted net income (loss) per share (in dollars per share)     $ (0.01)     $ (0.03)    
Adjustment [Member]                
Statement of Changes in Stockholders' Deficit [Abstract]                
Net income (Loss)     $ 120,089     $ 282,008    
Accumulated Deficit     282,008     282,008    
Total Stockholders' Deficit     282,008     282,008    
Income Statement [Abstract]                
Formation and operating costs     (120,089)     (282,008)    
Operating loss     (120,089)     (282,008)    
Loss before income tax     120,089     282,008    
Net income (Loss)     120,089     282,008    
Statement of Cash Flows [Abstract]                
Net income (Loss)     $ 120,089     282,008    
Change in prepaid expenses           $ (282,008)    
Adjustment [Member] | Class A Common Stock [Member]                
Income Statement [Abstract]                
Basic net income (loss) per share (in dollars per share)     $ 0.01     $ 0.01    
Diluted net income (loss) per share (in dollars per share)     0.01     0.01    
Adjustment [Member] | Class B Common Stock [Member]                
Income Statement [Abstract]                
Basic net income (loss) per share (in dollars per share)     0.01     0.01    
Diluted net income (loss) per share (in dollars per share)     $ 0.01     $ 0.01    
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]    
Cash equivalents $ 0 $ 0
Cash $ 2,029,532 $ 1,342,435
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Investments held in Trust Account [Abstract]    
Investments held in Trust Account $ 68,615,845 $ 285,581,779
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Offering Costs associated with a Public Offering [Abstract]    
Transaction costs $ 15,623,739  
Underwriting fees 5,520,000  
Deferred underwriting fees 9,660,000  
Other offering costs $ 443,739  
Deferred underwriting commission   $ 0
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Income Taxes [Abstract]          
Effective tax rate 29.00% 0.00% 27.00% 0.00%  
Statutory tax rate 21.00% 21.00% 21.00% 21.00%  
Unrecognized tax benefits $ 0   $ 0   $ 0
Accrued interest and penalties $ 0   $ 0   $ 0
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption [Abstract]            
Common stock, subject to possible redemption $ 68,217,016   $ 68,217,016     $ 284,449,019
Remeasurement of Class A Common Stock to redemption value 2,410,447 $ 141,596 4,763,810 $ 141,596    
Class A Common Stock [Member]            
Class A Common Stock Subject to Possible Redemption [Abstract]            
Common stock, subject to possible redemption $ 68,217,016   $ 68,217,016   $ 286,802,382 $ 284,449,019
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Numerator [Abstract]            
Allocation of net income (loss) $ 1,270,320 $ 1,879,261 $ (156,141) $ (466,910) $ 3,149,581 $ (623,050)
Class A Common Stock [Member]            
Numerator [Abstract]            
Allocation of net income (loss) $ 915,959   $ (124,913)   $ 2,415,156 $ (498,440)
Denominator [Abstract]            
Basic weighted average shares outstanding (in shares) 17,835,276   27,600,000   22,690,664 27,600,000
Diluted weighted average shares outstanding (in shares) 17,835,276   27,600,000   22,690,664 27,600,000
Basic net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)
Diluted net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)
Class B Common Stock [Member]            
Numerator [Abstract]            
Allocation of net income (loss) $ 354,361   $ (31,228)   $ 734,425 $ (124,610)
Denominator [Abstract]            
Basic weighted average shares outstanding (in shares) 6,900,000   6,900,000   6,900,000 6,900,000
Diluted weighted average shares outstanding (in shares) 6,900,000   6,900,000   6,900,000 6,900,000
Basic net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)
Diluted net income (loss) per share (in dollars per share) $ 0.05   $ 0   $ 0.11 $ (0.02)
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
INITIAL PUBLIC OFFERING (Details) - Initial Public Offering [Member] - $ / shares
Dec. 03, 2021
Jun. 30, 2023
Public Shares [Member]    
Proposed Public Offering [Abstract]    
Units issued (in shares) 27,600,000  
Unit price (in dollars per share) $ 10  
Public Warrant [Member]    
Proposed Public Offering [Abstract]    
Number of securities to be called by each unit (in shares)   0.5
Warrants exercise price (in dollars per share)   $ 11.5
Class A Common Stock [Member]    
Proposed Public Offering [Abstract]    
Number of securities to be called by each unit (in shares)   1
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
PRIVATE PLACEMENTS (Details) - Private Placement Warrant [Member] - USD ($)
6 Months Ended
Dec. 03, 2021
Jun. 30, 2023
Private Placement Warrants [Abstract]    
Warrants issued (in shares) 15,226,000  
Share price (in dollars per share) $ 1  
Gross proceeds to be received from issuance of warrants $ 15,226,000  
Warrants exercise price (in dollars per share)   $ 11.5
Holding period for transfer, assignment or sale of warrants   30 days
Class A Common Stock [Member]    
Private Placement Warrants [Abstract]    
Number of securities to be called by each warrant (in shares)   1
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES, Founder Shares (Details)
1 Months Ended 6 Months Ended
Dec. 03, 2021
shares
Nov. 30, 2021
shares
May 04, 2021
USD ($)
Mar. 31, 2021
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
shares
Founder Shares [Abstract]            
Stock split   1.2        
Class A Common Stock [Member]            
Founder Shares [Abstract]            
Common stock, shares outstanding (in shares)         0 0
Class B Common Stock [Member]            
Founder Shares [Abstract]            
Issuance of Class B common stock to Sponsor (in shares)   6,900,000        
Common stock, shares outstanding (in shares)         6,900,000 6,900,000
Sponsor [Member]            
Founder Shares [Abstract]            
Proceeds from issuance of common stock | $         $ 25,000  
Sponsor [Member] | Class B Common Stock [Member]            
Founder Shares [Abstract]            
Common stock, shares outstanding (in shares)         6,440,000 6,440,000
Founder Shares [Member] | Sponsor [Member]            
Founder Shares [Abstract]            
Holding period for transfer, assignment or sale of Founder Shares         1 year  
Founder Shares [Member] | Sponsor [Member] | Class A Common Stock [Member]            
Founder Shares [Abstract]            
Threshold trading days         20 days  
Threshold consecutive trading days         30 days  
Founder Shares [Member] | Sponsor [Member] | Class A Common Stock [Member] | Minimum [Member]            
Founder Shares [Abstract]            
Share price (in dollars per share) | $ / shares         $ 12  
Period after initial business combination         150 days  
Founder Shares [Member] | Sponsor [Member] | Class B Common Stock [Member]            
Founder Shares [Abstract]            
Issuance of Class B common stock to Sponsor (in shares)       5,750,000    
Proceeds from issuance of common stock | $     $ 25,000      
Stock split   1.2        
Common stock, shares outstanding (in shares)   6,900,000        
Founder Shares [Member] | Sponsor [Member] | Initial Public Offering [Member]            
Founder Shares [Abstract]            
Shares cancelled (in shares) 460,000          
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES, Promissory Note (Details) - Sponsor [Member] - Promissory Note [Member] - USD ($)
6 Months Ended 9 Months Ended
Dec. 06, 2021
Mar. 31, 2021
Jun. 30, 2023
Dec. 05, 2021
Promissory Note [Abstract]        
Related party transaction amount   $ 300,000    
Proceeds from sponsor note     $ 110,000 $ 110,000
Repayment of sponsor note $ 110,000      
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES, General and Administrative Services (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
General and Administrative Services [Abstract]        
Fee amount $ 698,927 $ 499,429 $ 1,223,029 $ 993,103
Sponsor [Member] | General and Administrative Services [Member]        
General and Administrative Services [Abstract]        
Related party transaction amount     10,000  
Fee amount $ 30,000 $ 30,000 $ 60,000 $ 60,000
Sponsor [Member] | General and Administrative Services [Member] | Maximum [Member]        
General and Administrative Services [Abstract]        
Utilities and secretarial and administrative support period     24 months  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES, Related Party Loans (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related Party Loans [Abstract]        
Notes Payable, Related Party, Type [Extensible Enumeration] Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]   Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]
Deposit to Trust Account to exercise three-month extension $ 480,000 $ 480,000 $ 0  
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Working Capital Loans [Member]        
Related Party Loans [Abstract]        
Related party transaction amount   $ 1,500,000    
Share price (in dollars per share) $ 1 $ 1    
Related parties, outstanding amount $ 0 $ 0   $ 0
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTIES, Consulting Agreement (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Consulting Agreement [Abstract]        
Consulting fee $ 0 $ 0 $ 16,668 $ 35,423
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
Demand
$ / shares
shares
Registration Rights [Abstract]  
Number of demands entitled to holders | Demand 3
Underwriting Agreement [Abstract]  
Term of option for underwriters to purchase additional Units to cover over-allotments 45 days
Additional Units that can be purchased to cover over-allotments (in shares) | shares 3,600,000
Underwriting discount (in dollars per share) | $ / shares $ 0.2
Underwriting discount | $ $ 5,520,000
Deferred underwriter fee discount (in dollars per share) | $ / shares $ 0.35
Deferred underwriting fee | $ $ 9,660,000
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details)
6 Months Ended
Nov. 30, 2021
shares
Jun. 30, 2023
Vote
$ / shares
shares
May 19, 2023
shares
Dec. 31, 2022
$ / shares
shares
Stockholder's Deficit [Abstract]        
Preferred stock, shares authorized (in shares)   1,000,000   1,000,000
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Preferred stock, shares issued (in shares)   0   0
Preferred stock, shares outstanding (in shares)   0   0
Stock split 1.2      
Stock conversion basis of Class B to Class A ordinary shares at time of initial business combination   1    
As-converted percentage for Class A ordinary shares after conversion of Class B shares   20.00%    
Class A Common Stock [Member]        
Stockholder's Deficit [Abstract]        
Common stock, shares authorized (in shares)   70,000,000   70,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Number of votes per share | Vote   1    
Common stock, shares issued (in shares)   0   0
Common stock, shares outstanding (in shares)   0   0
Common stock, subject to possible redemption, shares outstanding (in shares)   6,443,098 21,156,902 27,600,000
Class B Common Stock [Member]        
Stockholder's Deficit [Abstract]        
Common stock, shares authorized (in shares)   12,500,000   12,500,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Number of votes per share | Vote   1    
Issuance of Class B common stock to Sponsor (in shares) 6,900,000      
Common stock, shares issued (in shares)   6,900,000   6,900,000
Common stock, shares outstanding (in shares)   6,900,000   6,900,000
Class B Common Stock [Member] | Sponsor [Member]        
Stockholder's Deficit [Abstract]        
Common stock, shares issued (in shares)   6,440,000   6,440,000
Common stock, shares outstanding (in shares)   6,440,000   6,440,000
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details) - $ / shares
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
WARRANTS [Abstract]    
Period warrants to become excisable after business combination 30 days  
Period to exercise warrants after public offerings 12 months  
Warrants expiration period 5 years  
Number of days to file registration statement 15 days  
Period for registration statement to become effective 60 days  
Limitation period to transfer, assign or sell warrants 30 days  
Public Warrants [Member]    
WARRANTS [Abstract]    
Warrants outstanding (in shares) 13,800,000 13,800,000
Private Placement Warrant [Member]    
WARRANTS [Abstract]    
Warrants outstanding (in shares) 15,226,000 15,226,000
Redemption of Warrants for Cash When Price Equals or Exceeds $18.00 [Member] | Class A Ordinary Shares [Member]    
WARRANTS [Abstract]    
Share price (in dollars per share) $ 18  
Warrant redemption price (in dollars per share) $ 0.01  
Redemption period 30 days  
Threshold trading days 20 days  
Threshold consecutive trading days 30 days  
Redemption of Warrants for Cash When Price Equals or Exceeds $18.00 [Member] | Class A Ordinary Shares [Member] | Minimum [Member]    
WARRANTS [Abstract]    
Notice period to redeem warrants 30 days  
Redemption of Warrants for Cash When Price Equals or Exceeds $10.00 [Member] | Class A Ordinary Shares [Member]    
WARRANTS [Abstract]    
Share price (in dollars per share) $ 10  
Warrant redemption price (in dollars per share) $ 0.1  
Redemption of Warrants for Cash When Price Equals or Exceeds $10.00 [Member] | Class A Ordinary Shares [Member] | Minimum [Member]    
WARRANTS [Abstract]    
Notice period to redeem warrants 30 days  
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Vote
$ / shares
shares
Jun. 30, 2022
USD ($)
May 19, 2023
shares
Dec. 31, 2022
$ / shares
shares
Class A Common Stock Subject to Possible Redemption [Abstract]            
Class A common stock subject to possible redemption, Beginning Balance   $ 284,449,019 $ 284,449,019      
Extension deposit $ 480,000   480,000 $ 0    
Redemption     (220,995,813) $ 0    
Class A common stock subject to possible redemption, Ending Balance $ 68,217,016   $ 68,217,016      
Class A Common Stock [Member]            
Class A Common Stock Subject to Possible Redemption [Abstract]            
Common Stock, shares authorized (in shares) | shares 70,000,000   70,000,000      
Common Stock, par value (in dollars per share) | $ / shares $ 0.0001   $ 0.0001     $ 0.0001
Number of votes per share | Vote     1      
Common Stock, outstanding, subject to possible redemption (in shares) | shares 6,443,098   6,443,098   21,156,902 27,600,000
Class A common stock subject to possible redemption, Beginning Balance $ 286,802,382 284,449,019 $ 284,449,019      
Re-measurement of carrying value to redemption value 2,410,447 2,353,363        
Redemption (220,995,813)          
Class A common stock subject to possible redemption, Ending Balance $ 68,217,016 $ 286,802,382 $ 68,217,016      
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Recurring [Member] | Level 1 [Member]    
Assets [Abstract]    
Marketable securities held in the Trust Account $ 68,615,845 $ 285,581,779
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details)
Jul. 21, 2023
USD ($)
Series A-1 Preferred Stock [Member] | Sponsor [Member] | Subsequent Event [Member]  
Preferred Stock [Abstract]  
Preferred stock issued $ 10,000,000
XML 55 brhc20058310_10qa_htm.xml IDEA: XBRL DOCUMENT 0001853070 2023-01-01 2023-06-30 0001853070 paci:UnitsMember 2023-01-01 2023-06-30 0001853070 us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 paci:RedeemableWarrantsMember 2023-01-01 2023-06-30 0001853070 us-gaap:CommonClassBMember 2023-09-01 0001853070 us-gaap:CommonClassAMember 2023-09-01 0001853070 2022-12-31 0001853070 2023-06-30 0001853070 us-gaap:CommonClassAMember 2022-12-31 0001853070 us-gaap:CommonClassAMember 2023-06-30 0001853070 us-gaap:CommonClassBMember 2023-06-30 0001853070 us-gaap:CommonClassBMember 2022-12-31 0001853070 2022-01-01 2022-06-30 0001853070 2023-04-01 2023-06-30 0001853070 2022-04-01 2022-06-30 0001853070 us-gaap:CommonClassBMember 2023-01-01 2023-06-30 0001853070 us-gaap:CommonClassBMember 2023-04-01 2023-06-30 0001853070 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001853070 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001853070 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001853070 us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001853070 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001853070 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001853070 us-gaap:RetainedEarningsMember 2022-12-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001853070 us-gaap:RetainedEarningsMember 2021-12-31 0001853070 2021-12-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001853070 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001853070 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001853070 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001853070 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001853070 2023-01-01 2023-03-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001853070 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001853070 2022-01-01 2022-03-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001853070 us-gaap:RetainedEarningsMember 2022-03-31 0001853070 us-gaap:RetainedEarningsMember 2023-06-30 0001853070 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001853070 us-gaap:RetainedEarningsMember 2022-06-30 0001853070 us-gaap:RetainedEarningsMember 2023-03-31 0001853070 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001853070 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001853070 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001853070 2022-03-31 0001853070 2022-06-30 0001853070 2023-03-31 0001853070 paci:PublicSharesMember us-gaap:IPOMember 2021-12-03 2021-12-03 0001853070 paci:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2021-12-03 2021-12-03 0001853070 paci:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2021-12-03 0001853070 us-gaap:InvestorMember 2023-05-19 2023-05-19 0001853070 paci:PublicSharesMember us-gaap:IPOMember 2023-01-01 2023-06-30 0001853070 paci:PublicSharesMember us-gaap:IPOMember 2023-06-30 0001853070 paci:PublicSharesMember paci:InitialPublicOfferingUnitsSoldOneMember 2023-06-30 0001853070 srt:MinimumMember 2023-01-01 2023-06-30 0001853070 2023-05-19 2023-05-19 0001853070 us-gaap:CommonClassAMember 2023-05-19 0001853070 2023-05-19 0001853070 srt:MaximumMember 2023-06-30 0001853070 us-gaap:InvestorMember 2023-01-01 2023-06-30 0001853070 paci:PromissoryNoteMember us-gaap:InvestorMember 2023-01-01 2023-06-30 0001853070 paci:PromissoryNoteMember us-gaap:InvestorMember 2021-12-06 2021-12-06 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2022-01-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2022-04-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember 2022-04-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001853070 srt:ScenarioPreviouslyReportedMember us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001853070 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001853070 paci:PublicSharesMember us-gaap:IPOMember 2021-12-03 0001853070 paci:PublicWarrantMember us-gaap:IPOMember 2023-06-30 0001853070 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-06-30 0001853070 paci:PrivatePlacementWarrantMember 2021-12-03 2021-12-03 0001853070 paci:PrivatePlacementWarrantMember 2021-12-03 0001853070 paci:PrivatePlacementWarrantMember us-gaap:CommonClassAMember 2023-06-30 0001853070 paci:PrivatePlacementWarrantMember 2023-06-30 0001853070 paci:PrivatePlacementWarrantMember 2023-01-01 2023-06-30 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-03-16 2021-03-31 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-05-04 2021-05-04 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-11-30 2021-11-30 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-11-30 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:IPOMember 2021-12-03 2021-12-03 0001853070 paci:FounderSharesMember us-gaap:InvestorMember 2023-01-01 2023-06-30 0001853070 srt:MinimumMember paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-06-30 0001853070 paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 srt:MinimumMember paci:FounderSharesMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 paci:PromissoryNoteMember us-gaap:InvestorMember 2021-03-31 2021-03-31 0001853070 paci:PromissoryNoteMember us-gaap:InvestorMember 2021-03-16 2021-12-05 0001853070 paci:GeneralAndAdministrativeSupportAgreementMember us-gaap:InvestorMember 2023-01-01 2023-06-30 0001853070 srt:MaximumMember paci:GeneralAndAdministrativeSupportAgreementMember us-gaap:InvestorMember 2023-01-01 2023-06-30 0001853070 paci:GeneralAndAdministrativeSupportAgreementMember us-gaap:InvestorMember 2022-01-01 2022-06-30 0001853070 paci:GeneralAndAdministrativeSupportAgreementMember us-gaap:InvestorMember 2023-04-01 2023-06-30 0001853070 paci:GeneralAndAdministrativeSupportAgreementMember us-gaap:InvestorMember 2022-04-01 2022-06-30 0001853070 paci:WorkingCapitalLoansMember paci:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2023-01-01 2023-06-30 0001853070 paci:WorkingCapitalLoansMember paci:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2023-06-30 0001853070 paci:WorkingCapitalLoansMember paci:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2022-12-31 0001853070 2021-11-30 2021-11-30 0001853070 us-gaap:CommonClassBMember 2021-11-30 2021-11-30 0001853070 us-gaap:InvestorMember us-gaap:CommonClassBMember 2022-12-31 0001853070 us-gaap:InvestorMember us-gaap:CommonClassBMember 2023-06-30 0001853070 paci:PublicWarrantMember 2022-12-31 0001853070 paci:PublicWarrantMember 2023-06-30 0001853070 paci:PrivatePlacementWarrantMember 2022-12-31 0001853070 paci:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember us-gaap:CommonClassAMember 2023-06-30 0001853070 paci:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember us-gaap:CommonClassAMember 2023-06-30 0001853070 srt:MinimumMember paci:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 srt:MinimumMember paci:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 paci:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001853070 us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001853070 us-gaap:CommonClassAMember 2023-03-31 0001853070 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001853070 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001853070 us-gaap:InvestorMember paci:SeriesA1PreferredStockMember us-gaap:SubsequentEventMember 2023-07-21 2023-07-21 shares iso4217:USD iso4217:USD shares paci:Business pure paci:Demand paci:Vote true This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (the Amendment”) amends the Quarterly Report on Form 10-Q of PROOF Acquisition Corp I (the “Company,” “we,” “our” or “us”), as filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2023 (the “Original Filing”). This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing but that had previously been restated in Note 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS of the Company’s Annual Report on Form 10-K filed with the SEC on February 27, 2023. --12-31 2023 Q2 0001853070 P10D http://proof-paci.com/20230630#SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember http://proof-paci.com/20230630#SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 0.5 10-Q/A true 2023-06-30 false 001-41104 PROOF ACQUISITION CORP I DE 86-2707040 11911 Freedom Drive Suite 1080 Reston VA 20190 571 310-4949 Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant PACI.U NYSE Class A common stock, par value $0.0001 per share (included as part of the Units) PACI NYSE Redeemable Warrants (included as part of the Units) PACI.WS NYSE Yes Yes Non-accelerated Filer true true false true 6443098 6900000 2029532 1342435 263271 467021 2292803 1809456 68615845 285581779 70908648 287391235 357328 132417 2209958 0 1852353 455833 4419639 588250 59640 317426 4479279 905676 0.0001 0.0001 6443098 27600000 10.59 10.31 68217016 284449019 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 70000000 70000000 0 0 0 0 6443098 27600000 0 0 0.0001 0.0001 12500000 12500000 6900000 6900000 6900000 6900000 690 690 -1788337 2035850 -1787647 2036540 70908648 287391235 698927 499429 -698927 -499429 2482403 373148 2482403 373148 1783476 -126281 513156 29860 1270320 -156141 17835276 17835276 27600000 27600000 0.05 0.05 0 0 6900000 6900000 6900000 6900000 0.05 0.05 0 0 1223029 993103 -1223029 -993103 5511344 399913 5511344 399913 4288315 -593189 1138734 29860 3149581 -623050 22690664 22690664 27600000 27600000 0.11 0.11 -0.02 -0.02 6900000 6900000 6900000 6900000 0.11 0.11 -0.02 -0.02 6900000 690 0 2035850 2036540 0 2353363 2353363 0 0 1879261 1879261 6900000 690 0 1561748 1562438 0 2209958 2209958 0 2410447 2410447 0 0 1270320 1270320 6900000 690 0 -1788337 -1787647 6900000 690 0 -6245863 -6245173 0 0 -466910 -466910 6900000 690 0 -6712773 -6712083 0 141596 141596 0 0 -156141 -156141 6900000 690 0 -7010509 -7009819 3149581 -623050 5511344 399913 -203750 -252062 1254447 0 115713 0 224911 55953 -794368 -714948 480000 0 220995813 0 1961465 0 222477278 0 220995813 0 -220995813 0 687097 -714948 1342435 2579658 2029532 1864710 2209958 0 4763810 141596 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 1 - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">PROOF Acquisition Corp I (the “Company”) was incorporated in Delaware on March 16, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (collectively, the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2023, the Company had limited operations and no operating revenues. All activity for the period from March 16, 2021 (inception) through June 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).</span></div> <div><br/> </div> <div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 30, 2021. On December 3, 2021, the Company consummated the Initial Public Offering of 27,600,000 units (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), generating gross proceeds of $276,000,000, which is described in Note 4.</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 15,226,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement transaction to PROOF Acquisition Sponsor I, LLC (the “Sponsor”) and certain funds and accounts managed by subsidiaries of BlackRock, Inc. (“BlackRock”).</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Following the closing of the Initial Public Offering on December 3, 2021, an amount of $281,520,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 5) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Transaction costs related to the IPO amounted to $15,623,739 consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable (which was originally held in a Trust Account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”)) and $443,739 of other offering costs. These costs were charged to additional paid-in capital upon completion of the Initial Public Offering. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 8).</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management agreed to place an amount equal to $10.20 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants, located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account, plus any pro rata interest then in the Trust Account, net of taxes payable. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination, and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares were issued with other freestanding instruments (i.e., public warrants), the initial carrying value of common stock classified as temporary equity was the allocated proceeds determined in accordance with ASC 470-20. The common stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The re-measurement will be treated as an adjustment to adjust the temporary equity to the redemption amount. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.</div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The holders of the Founder Shares have agreed (a) to waive their redemption r<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">ights with respect to the Founder Shares (and Public Shares with respect to our Sponsor and officers and directors of the Company) held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Completion Window (as defined in the Amended and Restated Certificate of Incorporation of the Company)</span> or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders w</span>ith the opportunity to redeem their Public Shares in conjunction with any such amendment.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">On May 19, 2023, the Company convened a Special Meeting. The shareholders of the Company approved proposals to amend the Certificate of Incorporation (the “Extension Amendment Proposal”) and to amend the Trust Agreement (the “Trust Agreement Amendment Proposal”) to extend the date by which the Company must consummate a Business Combination from June 3, 2023 to September 3, 2023<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">, or to October 3, November 3, or December 3, 2023, as applicable, if the Company deposits additional $160,000 in the Trust Account for each one-month extension of the end of the Completion Window</span>.</span></div> <div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with the approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, shareholders holding 21,156,902 shares of Class A Common Stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $220,995,813 was withdrawn from the Trust Account to pay such redeeming holders.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with approval of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, PACI deposited $480,000 in the Trust Account in connection with the exercise of the first three-month extension of the end of the Completion Window to September 3, 2023.</div> <div style="font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with the redemption, the Company recorded excise tax of approximately $2.2 million. To the extent the Company issues shares during the year ended December 31, 2023, including in connection with a business combination, it likely will reduce the excise tax liability.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If the Company has not completed a Business Combination<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">within 21 months (or up to 24 months, if applicable) from the closing of the Initial Public Offering</span>, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:Fact_b0c590383b554e3e885e510593ba5104">ten</span> business days thereafter, re</span>deem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">within the Completion Window</span>.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The holders of the Founders Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Completion Window</span>. However, if the holders of Founder Shares acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Completion Window</span>. The underwriter agreed to waive its rights to the deferred underwriting commission (see Note 8) held in the Trust Account and, as a result, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of a distribution in liquidation, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit of $10.00.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share following the closing of this offering, or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00, due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Liquidity and Capital Resources </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2023, the Company had approximately $2.0 million in its operating bank account and a working capital deficit of approximately $2.0 million.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s liquidity needs up to June 30, 2023 had been satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares, the loan under the promissory note from the Sponsor of approximately $110,000 (the “Note”) (see Note 7) to the Company, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Note from the Sponsor was repaid in full on December 6, 2021.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In c<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">onnection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">September 3, 2023 (unless extended to October 3, November 3, or December 3, 2023, as applicable)</span> to complete a Business Combination. It is uncertain that the Company will be able to consummate an initial Business Combination by this time. If an initial Business Combination is not consummated by this date and the Company has not exercised its option to extend the deadline in accordance with the terms of its Certificate of Incorporation, there will be a mandatory liquidation and subsequent dissolution of the Comp</span>any. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company through one year from the issuance of these financial statements. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Risks and Uncertainties</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div> 0 27600000 276000000 15226000 1 281520000 10.2 15623739 5520000 9660000 443739 0 1 0.80 0.50 10.2 5000001 0.15 1 160000 P1M 21156902 220995813 480000 P3M 2200000 100000 10 10 10 2000000 2000000 25000 110000 110000 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">NOTE 2 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="display:none;"><br/></div> <div style="text-align: left; text-indent: 36pt; margin-bottom: 9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt;">This Amendment includes adjustments that had been made to the Company’s financial statements to account for operating expenses for the quarterly period ended June 30, 2022, specifically expenses for directors and officers liability insurance, that were not included in the Company’s Original Filing.</span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt;">The following tables summarize the effect of the previous restatement on each financial statement line item as of the dates, and for the period, indicated:</span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">As previously reported</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Adjustments</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">As restated</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of changes in stockholders’ deficit for the six months ended June 30, 2022</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Accumulated Deficit - June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,292,517</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,010,509</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Total Stockholders’ Deficit</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,291,827</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,009,819</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of operations for the three months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Formation and operating cost</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">619,518</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">499,429</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Operating loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">619,518</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">499,429</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Loss before income tax</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(246,370</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(126,281</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(276,230</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(156,141</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class A common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">—<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class B common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">—<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of operations for the six months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Formation and operating cost</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1,275,111</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">993,103</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Operating loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1,275,111</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">993,103</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Loss before income tax</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(875,197</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(593,189</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class A common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.03</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.02</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class B common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.03</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.02</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of cash flows for the six months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Change in prepaid expenses</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">534,070</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">252,062</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt;">The following tables summarize the effect of the previous restatement on each financial statement line item as of the dates, and for the period, indicated:</span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">As previously reported</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Adjustments</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">As restated</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of changes in stockholders’ deficit for the six months ended June 30, 2022</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Accumulated Deficit - June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,292,517</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,010,509</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Total Stockholders’ Deficit</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,291,827</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(7,009,819</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of operations for the three months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Formation and operating cost</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">619,518</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">499,429</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Operating loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">619,518</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">499,429</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Loss before income tax</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(246,370</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(126,281</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(276,230</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">120,089</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(156,141</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class A common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">—<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class B common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">—<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of operations for the six months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Formation and operating cost</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1,275,111</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">993,103</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Operating loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1,275,111</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">993,103</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Loss before income tax</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(875,197</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(593,189</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class A common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.03</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.02</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Class B common stock - basic and diluted net loss per share</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.03</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">0.01<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(0.02</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Statement of cash flows for the six months ended June 30, 2022</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Net loss</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(905,058</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(623,050</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Change in prepaid expenses</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">534,070</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">(282,008</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">252,062</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> -905058 282008 -623050 -7292517 282008 -7010509 -7291827 282008 -7009819 619518 -120089 499429 -619518 120089 -499429 -246370 120089 -126281 -276230 120089 -156141 -0.01 -0.01 0.01 0.01 0 0 -0.01 -0.01 0.01 0.01 0 0 1275111 -282008 993103 -1275111 282008 -993103 -875197 282008 -593189 -905058 282008 -623050 -0.03 -0.03 0.01 0.01 -0.02 -0.02 -0.03 -0.03 0.01 0.01 -0.02 -0.02 -905058 282008 -623050 -534070 282008 -252062 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Presentation</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the opinion of the Company’s management, the unaudited financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of June 30, 2023 and its results of operations and cash flows for the three and six months ended June 30, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2023 or any future interim period.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Emerging Growth Company</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Cash and Cash Equivalents</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Cash was $2,029,532 and $1,342,435 as of June 30, 2023 and December 31, 2022, respectively.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At June 30, 2023 and December 31, 2022, the Company had $68,615,845 and $285,581,779, respectively, in investments held in the Trust Account.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Offering Costs associated with a Public Offering</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering.” Offering costs of $15,623,739 consist principally of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable and $443,739 of other offering costs. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 7).</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Income Taxes</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<span style="font-style: italic;">Income Taxes</span>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">. The Company’s effective tax rate was 29% and 0% for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was 27% and 0% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21.0% for the three and six months ended June 30, 2023 and 2022, due to changes in the valuation allowance on the deferred tax assets</span>.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">.</span><br/> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">While ASC 740 identifies usage of the effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant unusual or infrequent. Computing the ETR for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants for any other change in fair value of a complex financial instrument), the timing of any potential Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expenses in the current period based on 740-270-25-3 which states, “if an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (or benefit) but is otherwise able to make a reliable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the unusual elements that can impact its annualized book income and its impact on ETR. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2023.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/></div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Class A common stock subject to possible redemption</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the shares of Class A common stock subject to possible redemption in the amount of $68,217,016 and $284,449,019 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s balance sheets at June 30, 2023 and December 31, 2022. The increases of $2,410,447 and $4,763,810 during the three and six months ended June 30, 2023, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value. The increases of $141,596 and $141,596 during the three and six months ended June 30, 2022, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Immediately upon the closing of the Initial Public Offering, the Company recognized the re-measurement from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> Warrants</span><br/></div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"> <br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Net Income (Loss) per Common Share</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company has two classes of common stock, Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The </span><span style="font-size: 10pt; font-family: 'Times New Roman';">calculation of diluted income (loss) per share of common stock does</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> not </span><span style="font-size: 10pt; font-family: 'Times New Roman';">consider</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the effect of the warrants </span><span style="font-size: 10pt; font-family: 'Times New Roman';">issued</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> in </span><span style="font-size: 10pt; font-family: 'Times New Roman';">connection with </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the </span><span style="font-size: 10pt; font-family: 'Times New Roman';">(i) </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Initial Public Offering</span><span style="font-size: 10pt; font-family: 'Times New Roman';">, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of June 30, 2023, the Company did not have any </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">dilutive </span><span style="font-size: 10pt; font-family: 'Times New Roman';">securities or other contracts that could, potentially, be exercised or converted into common</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> stock </span><span style="font-size: 10pt; font-family: 'Times New Roman';">and then share in the earnings of the Company.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> As a result, diluted net </span><span style="font-size: 10pt; font-family: 'Times New Roman';">income (</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">loss</span><span style="font-size: 10pt; font-family: 'Times New Roman';">)</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> per </span><span style="font-size: 10pt; font-family: 'Times New Roman';">common </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">share is the same as basic net </span><span style="font-size: 10pt; font-family: 'Times New Roman';">income (</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">loss</span><span style="font-size: 10pt; font-family: 'Times New Roman';">)</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> per </span><span style="font-size: 10pt; font-family: 'Times New Roman';">common </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">share for the period </span><span style="font-size: 10pt; font-family: 'Times New Roman';">presented</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value.</span> <span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):</span></div> <div><br/> </div> <div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">915,959</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">354,361</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,913</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(31,228</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">17,835,276</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> </tr> </table> </div> <div><br/></div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">2,415,156</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">734,425</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(498,440</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,610</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">22,690,664<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentration of Credit Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Fair Value of Financial Instruments</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Derivative Financial Instruments</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Recent Accounting Standards</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Presentation</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows.</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In the opinion of the Company’s management, the unaudited financial statements as of June 30, 2023 and for the three and six months ended June 30, 2023 include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the financial position of the Company as of June 30, 2023 and its results of operations and cash flows for the three and six months ended June 30, 2023. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2023 or any future interim period.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Cash and Cash Equivalents</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Cash was $2,029,532 and $1,342,435 as of June 30, 2023 and December 31, 2022, respectively.</div> 0 0 2029532 1342435 <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At June 30, 2023 and December 31, 2022, the Company had $68,615,845 and $285,581,779, respectively, in investments held in the Trust Account.</div> 68615845 285581779 <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Offering Costs associated with a Public Offering</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering.” Offering costs of $15,623,739 consist principally of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees payable and $443,739 of other offering costs. The deferred underwriting commission liability was reduced to $0 in 2022 as the underwriter resigned and withdrew its right to the deferred underwriting fees (see Note 7).</div> 15623739 5520000 9660000 443739 0 <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Income Taxes</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<span style="font-style: italic;">Income Taxes</span>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">. The Company’s effective tax rate was 29% and 0% for the three months ended June 30, 2023 and 2022, respectively. The Company’s effective tax rate was 27% and 0% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21.0% for the three and six months ended June 30, 2023 and 2022, due to changes in the valuation allowance on the deferred tax assets</span>.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months<span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">.</span><br/> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">While ASC 740 identifies usage of the effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant unusual or infrequent. Computing the ETR for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants for any other change in fair value of a complex financial instrument), the timing of any potential Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expenses in the current period based on 740-270-25-3 which states, “if an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (or benefit) but is otherwise able to make a reliable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the unusual elements that can impact its annualized book income and its impact on ETR. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through June 30, 2023.</div> 0.29 0 0.27 0 0.21 0.21 0.21 0.21 0 0 0 0 <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Class A common stock subject to possible redemption</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, the shares of Class A common stock subject to possible redemption in the amount of $68,217,016 and $284,449,019 are presented as temporary equity, outside of the stockholders’ equity (deficit) section of the Company’s balance sheets at June 30, 2023 and December 31, 2022. The increases of $2,410,447 and $4,763,810 during the three and six months ended June 30, 2023, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value. The increases of $141,596 and $141,596 during the three and six months ended June 30, 2022, respectively, in the Class A common stock subject to possible redemption is a remeasurement adjustment to the redemption value<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Immediately upon the closing of the Initial Public Offering, the Company recognized the re-measurement from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.</div> 68217016 284449019 2410447 4763810 141596 141596 <div><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> Warrants</span><br/></div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"> <br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Net Income (Loss) per Common Share</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company has two classes of common stock, Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. The </span><span style="font-size: 10pt; font-family: 'Times New Roman';">calculation of diluted income (loss) per share of common stock does</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> not </span><span style="font-size: 10pt; font-family: 'Times New Roman';">consider</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> the effect of the warrants </span><span style="font-size: 10pt; font-family: 'Times New Roman';">issued</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> in </span><span style="font-size: 10pt; font-family: 'Times New Roman';">connection with </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the </span><span style="font-size: 10pt; font-family: 'Times New Roman';">(i) </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Initial Public Offering</span><span style="font-size: 10pt; font-family: 'Times New Roman';">, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. As of June 30, 2023, the Company did not have any </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">dilutive </span><span style="font-size: 10pt; font-family: 'Times New Roman';">securities or other contracts that could, potentially, be exercised or converted into common</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> stock </span><span style="font-size: 10pt; font-family: 'Times New Roman';">and then share in the earnings of the Company.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> As a result, diluted net </span><span style="font-size: 10pt; font-family: 'Times New Roman';">income (</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">loss</span><span style="font-size: 10pt; font-family: 'Times New Roman';">)</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> per </span><span style="font-size: 10pt; font-family: 'Times New Roman';">common </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">share is the same as basic net </span><span style="font-size: 10pt; font-family: 'Times New Roman';">income (</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">loss</span><span style="font-size: 10pt; font-family: 'Times New Roman';">)</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> per </span><span style="font-size: 10pt; font-family: 'Times New Roman';">common </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">share for the period </span><span style="font-size: 10pt; font-family: 'Times New Roman';">presented</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. Re-measurement associated with the Class A common stock subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value.</span> <span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):</span></div> <div><br/> </div> <div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">915,959</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">354,361</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,913</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(31,228</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">17,835,276</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> </tr> </table> </div> <div><br/></div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">2,415,156</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">734,425</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(498,440</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,610</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">22,690,664<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> </table> <span style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0);">The following table reflects the calculation of basic and diluted net income (loss) per common share for the three and six months ended June 30, 2023 and 2022 (in dollars, except per share amounts):</span> <div><br/> </div> <div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Three Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">915,959</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">354,361</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,913</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(31,228</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">17,835,276</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.05</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">—</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"></td> </tr> </table> </div> <div><br/></div> <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: middle; font-weight: bold; text-align: center; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; white-space: nowrap;" valign="bottom">For the Six Months</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" style="vertical-align: middle; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Ended June 30, 2022</div> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class A<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class A</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">Class B</td> <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0); font-style: normal;">Basic and diluted net income per share</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Numerator:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: middle;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">2,415,156</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">734,425</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(498,440</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(124,610</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td style="vertical-align: middle; width: 52%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Denominator:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted weighted average shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">22,690,664<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">6,900,000<br/> </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">27,600,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,900,000<br/> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 52%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">Basic and diluted net income (loss) per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0);">0.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.02</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> </tr> </table> 915959 354361 -124913 -31228 17835276 17835276 6900000 6900000 27600000 27600000 6900000 6900000 0.05 0.05 0.05 0.05 0 0 0 0 2415156 734425 -498440 -124610 22690664 22690664 6900000 6900000 27600000 27600000 6900000 6900000 0.11 0.11 0.11 0.11 -0.02 -0.02 -0.02 -0.02 <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentration of Credit Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company has not experienced losses on this account.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Fair Value of Financial Instruments</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">●</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Derivative Financial Instruments</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Recent Accounting Standards</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</div> <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 4 - INITIAL PUBLIC OFFERING</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and <span style="-sec-ix-hidden:Fact_5dde2ece6f0843de929866b7b3428a81">one-half</span> of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).</div> 27600000 10 1 1 11.5 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 5 - PRIVATE PLACEMENTS</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) to the Sponsor and BlackRock of an aggregate of 15,226,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant resulting in cash proceeds of $15,226,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.</div> 15226000 1 15226000 1 11.5 P30D <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">NOTE 6 - RELATED PARTIES</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Founder Shares</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal;">On March 31, 2021, the Sponsor received 5,750,000 of the Company’s Class B common stock (the “Founder Shares”) for a May 4, 2021 payment of $25,000. Subsequently, on November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Founder Shares on that date. In connection with the closing of the Initial Public Offering and the sale of the Private Placement Warrants, the Company cancelled 460,000 Founder Shares held by the Sponsor and reissued the shares to parties unaffiliated with the Sponsor. All share amounts retroactively restated to account for the share split.</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal;">The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign, or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Promissory Note - Related Party</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal;">On March 31, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2022 or (ii) the consummation of the Initial Public Offering. In 2021, the Company borrowed $110,000 on this note, which was repaid in full on December 6, 2021.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">General and Administrative Services</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal;">Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support for up to 24 months. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Fees related to this arrangement were $30,000 <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">for the three months ended June 30, 2023 and 2022, respectively,</span> and $60,000 for the six months ended June 30, 2023 and 2022, respectively.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Related Party Loans</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal;">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As of June 30, 2023 and December 31, 2022 there was</span> no amount outstanding under the <span style="-sec-ix-hidden:Fact_3875066b7e0745a3aac9ac6bdaefa624"><span style="-sec-ix-hidden:Fact_3627426a098641faa2f487b6fc9b4d25">Working Capital Loans</span></span>.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Consulting Agreement </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">A member of the Board of Directors had a written consulting agreement with the Company to provide consulting services related to the Company’s business combination efforts which terminated on December 3, 2022. This agreement was approved by the Board of Directors. Expenses incurred for the three and six months ended June 30, 2023 and 2022 were $0 and $16,668 and $0 and $35,423, respectively.</span></div> 5750000 25000 1.2 6900000 460000 P1Y 12 P20D P30D P150D 300000 110000 110000 10000 P24M 30000 30000 60000 60000 1500000 1 0 0 0 16668 0 35423 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 7 - COMMITMENTS AND CONTINGENCIES</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Registration Rights</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div> <div><br/></div> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Underwriting Agreement</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company granted the <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">underwriter</span> a 45-day option from the date of Initial Public Offering to purchase up to 3,600,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The over-allotment was exercised in full as part of the Initial Public Offering.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">underwriter</span> received a cash underwriting discount of $0.20 per Unit, or $5,520,000 in the aggregate, payable upon the closing of the Initial Public Offering. </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">In addition, the underwriter was entitled to a deferred fee of</span> $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee would have become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement and the trust agreement, but due to proposed SEC regulations imposing potential liability on the underwriter of an initial public offering for a blank check company upon its subsequent initial Business Combination, the underwriter has ended its relationships with most special purpose acquisition companies it helped take public, including the Company, and has waived its deferred underwriting fees.<br class="Apple-interchange-newline"/> </div> 3 P45D 3600000 0.2 5520000 0.35 9660000 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 8 - STOCKHOLDERS’ EQUITY (DEFICIT)</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Preferred Stock</span><span style="font-family: 'Times New Roman';"> - The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">As of June 30, 2023 and December 31, 2022,</span> there were no shares of preferred stock issued or outstanding.</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Class A Common Stock</span><span style="font-family: 'Times New Roman';"> - The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">As of June 30, 2023 and December 31, 2022,</span> there were no shares of Class A common stock issued or outstanding (excluding 6,443,098 and 27,600,000, respectively, recorded as temporary equity).</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Class B Common Stock</span><span style="font-family: 'Times New Roman';"> - The Company is authorized to issue 12,500,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. On November 30, 2021, the Company effected a 1.2:1 stock split for each outstanding share of Class B common stock, resulting in the Sponsor holding an aggregate number of 6,900,000 Founder Shares <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">on that date. As of June 30, 2023 and December 31, 2022, there were</span> 6,900,000 shares of Class B common stock issued and outstanding</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">, of which the Sponsor held 6,440,000 shares.</span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Only holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Business Combination,</span> we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering. </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Warrants</span><span style="font-family: 'Times New Roman';"> -</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> As of June 30, 2023 and December 31, 2022,</span> there were 13,800,000 Public Warrants and 15,226,000 Private Placement Warrants outstanding.</div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</div> <div><span style="color: rgb(0, 0, 0);"> </span><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00</span><span style="font-family: 'Times New Roman';"> - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:</span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">in whole and not in part;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">at a price of $0.01 per Public Warrant;</div> </td> </tr> </table> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00</span><span style="font-family: 'Times New Roman';"> - Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">in whole and not in part;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">at a price of $0.10 per warrant provided that the holder will be able to exercise their warrants on cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">upon a minimum of 30 days’ prior written notice of redemption;</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">if, and only if, the last reported sale price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted per stock subdivisions, stock dividends, reorganizations, recapitalizations and the like) on the trading day before the Company sends the notice of redemption to the warrant holders; and</div> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">•</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0);">if, and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of Class A common stock) as the outstanding public warrants, as described above.</div> </td> </tr> </table> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants are not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.</div> 1000000 1000000 0.0001 0.0001 0 0 0 0 70000000 0.0001 1 0 0 0 0 6443098 27600000 12500000 0.0001 1 1.2 6900000 6900000 6900000 6900000 6900000 6440000 6440000 6440000 6440000 1 0.20 13800000 13800000 15226000 15226000 P30D P12M P5Y P15D P60D 18 0.01 P30D P30D 18 P20D P30D 10 0.1 P30D 10 P30D <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-weight: bold;">NOTE 9 - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION</div> <div><span style="font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-size: 10pt;"><br/> </span> </div> <div><span style="font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 70,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 6,443,098 and 27,600,000 shares, respectively, of Class A common stock outstanding, all of which were subject to possible redemption.</span></div> <div><span style="font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/> </span></div> <div><span style="font-size: 10pt;"> </span></div> <div> <span style="font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">As of June 30, 2023, Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Class A common stock subject to possible redemption at December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">284,449,019</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Re-measurement of carrying value to redemption value</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">2,353,363</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Class A common stock subject to possible redemption at March 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);"><br/> </div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">286,802,382</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%;" valign="bottom">Re-measurement of carrying value to redemption value <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">2,410,447</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">Extension deposit<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">480,000<br/> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%;" valign="bottom">Redemption <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(220,995,813</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">Class A common stock subject to possible redemption at June 30, 2023 <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">68,217,016</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> </table> </div> 70000000 0.0001 1 6443098 27600000 <div> <span style="font-size: 10pt;"> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">As of June 30, 2023, Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Class A common stock subject to possible redemption at December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">284,449,019</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Re-measurement of carrying value to redemption value</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">2,353,363</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Class A common stock subject to possible redemption at March 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);"><br/> </div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);">286,802,382</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%;" valign="bottom">Re-measurement of carrying value to redemption value <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">2,410,447</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">Extension deposit<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">480,000<br/> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%;" valign="bottom">Redemption <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(220,995,813</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">Class A common stock subject to possible redemption at June 30, 2023 <br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">68,217,016</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> </table> </div> 284449019 2353363 286802382 2410447 480000 220995813 68217016 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 10 - FAIR VALUE MEASUREMENTS</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">June 30, 2023 and December 31, 2022</span> and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div> <div><span style="font-size: 10pt;"> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-size: 10pt;"> </span><span style="font-size: 10pt;"><br/> </span> </div> <div><span style="font-size: 10pt;"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Level</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"> </td> <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">June 30, </div> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-size: 10pt;">2023<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">December 31,</div> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-size: 10pt;">2022<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-size: 10pt;">Assets:</div> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt;" valign="bottom"> </td> <td colspan="2" style="vertical-align: top; font-size: 10pt;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-size: 10pt;">Marketable securities held in the Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0);"><span style="font-size: 10pt;">68,615,845<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);"><span style="font-size: 10pt;">285,581,779<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-size: 10pt;"> </span> <span style="font-size: 10pt;"> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt;"><br/> </span> </div> <div><span style="font-size: 10pt;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Level 1 assets include investments in money market funds or U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">June 30, 2023 and December 31, 2022</span> and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div> <div><span style="font-size: 10pt;"> </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-size: 10pt;"> </span><span style="font-size: 10pt;"><br/> </span> </div> <div><span style="font-size: 10pt;"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Level</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"> </td> <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">June 30, </div> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-size: 10pt;">2023<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">December 31,</div> <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-size: 10pt;">2022<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-size: 10pt;">Assets:</div> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt;" valign="bottom"> </td> <td colspan="2" style="vertical-align: top; font-size: 10pt;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-size: 10pt;">Marketable securities held in the Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">1</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0);"><span style="font-size: 10pt;">68,615,845<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0);"><span style="font-size: 10pt;">285,581,779<br/> </span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 68615845 285581779 <div style="color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">NOTE 11 - SUBSEQUENT EVENTS</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date these financial statements were issued. Based upon this review the Company did not identify any subsequent events, except as noted below, that would have required adjustment or disclosure in the financial statements.<br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">On July 21, 2023, the PROOF.vc SPV, the Sponsor, and holders of then-outstanding convertible notes of Volato, Inc. (“Volato”) entered into an agreement with Volato whereby Volato issued and sold an aggregate of $10,000,000 of its Series A-1 Preferred Stock to the PROOF.vc SPV and the Sponsor.</span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> <br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On August 1, 2023, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”) with PACI Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Volato, Inc., a Georgia corporation (“Volato”). Pursuant to the terms of the Business Combination Agreement, a business combination between the Company and Volato will be effected through the merger of Merger Sub with and into Volato, with Volato surviving the merger as a wholly-owned subsidiary of Volato Group (the “Business Combination,” and together with the other transactions contemplated by the Business Combination Agreement and the other agreements contemplated thereby, the “Transactions”).</span></div> 10000000 EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +=T(5<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "W="%7:G^8%N\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M:L,P#(=?9?B>R$E@?TSJ2\M.&PQ6V-C-V&IK&L?&UDCZ]DN\-F5L#["CI9\_ M?0*U.@CM([Y$'S"2Q70SNJY/0H<5.Q % 9#T 9U*Y93HI^;.1Z=H>L8]!*6/ M:H]0M[!] M(M5KG'XE*^@4<,4ND]^:]6;[R&3-ZZ;@#P6OMM6]:.Y$PS]FUQ]^5V'GC=W9 M?VQ\$90M_+H+^0502P,$% @ MW0A5YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" "W="%7?PF)#B\) "R,P & 'AL+W=OM5,(H(2F/:(H8 MF5VT^O8G_]B2 ?D9WR*RXAO;2%J94OI3[@S#BY8E2T1B$@@I@>'/$_%)'$LE M*,>O4K1575,&;FZOU6]R\V!FBCGQ:?P]"L7BHM5KH9#, M0&.>_X]6Q;F>UT)!Q@5-RF H01*EQ5_\7%;$1D#/VA+@E '.FP![VQ7<,L#- MC18ERVU=8X$OSQE=(2;/!C6YD==-'@UNHE0VXT0P^#6".'%Y38,,6D4@G(9H MD(I(O*!A6G0/68$7[>%7 U&=,-2N6K0MG9HGR"OM!4+#BHAB1\'=^% M4E9%==9%O7*,@O_)TB/D6FWD6(ZK*8]O#I^0Y1&R;%WXJ^*X55J6-CJ?K@*,Q= MW<1XKG-ECAFD\G2RIZ=KP@,6+>6(UEDSRSPL(HZ4UAT]0C82 M%(D%05\SS 1A\0L:DR5E D'*D.D5%:V,/LB3JM@_?NLYCOWY(\+R"-^M@.@, MC<;W]S>H'_S*(A[E.90&<1;*ZX?_ S%Y3%8> M%FB!0S0E)(5;0DC6C5)6AI2S3S]+/RE.@PBNPP6&_%2$4[B%!C0#>^T@@C M!O=LRHKJHS,XBU!^:9D)5 M"PRHIXAF'(J3UQ",+^D^%[NC@B ';F[CP>2A_S#X,KA[0-#+1N/!M^']X^3V M!QI.)H^#:W0SO.O?^J2M./TTS*,P_^_&?_^A2 S__G4P95.X+ M1TOUS_=ICJTHA9:EN&-$;5M->K[/6,9?(SQO*< M'W'HN.@'P4SB"@*4TM[9S&J=CNUT7%MGTAA8T^199?)LOS8<%='6(S''-MXC''U36II@^V$=+7\P>X=1%TER53 MPK3FS"*697<\V[8\K<$F9@FVFB;89M O#8[)'*9(T)" CL!]6I-FH9( _:^/ MP\GP87A_A_S[\0@-M9Z;F$38:A9AFZ4Y0K10$P.*4Y6L%;321@"6YVI=<"5SCTU#?X&;U MZX'6Y3?;N:)6W[S+;1#2,DI FZ9M&3/C$W04NVPB7; M3#E&XP\KJC5NEIQD$0P,V^KI&[H):G(4-3EFT'GKUY=[,(@?Z$J[6K!#;@SS M+.TR@V\.K.M3D9-C1IVW/JML-6+T":::VAZ]0_.;=B'+'%37J,(GQTP\;XV. M*,Q\8_17M-R:D'6=:?TU0DJ,HR=F/DLK9=X'V<@%'#DG] M-&:'X@_M$PK?'%77IZ(D9T]*$H05SZODQ!NOC6M]FA6W^6P"C1R%1LY>:"2G M,L!^D%7GE&F1=X?.'4T[. A(+-N M[[5FG6U+8N:PNO84 #E[ = @(6PN1^6_0$$LULN=6I]FP:T^FP ?5X&/NQ?X M#)XWUQF*]13M SRSVM9U!G-<79<*>]R]L&>R(-!9#6VX0V9;&YK#ZKI3K..: MR>0QC01'?W\A\BZI?^YZ($0I[38!/.[&,^<#/W0^[%/G)K#(55CDFHGF(1(Q MD0]?;.?#]./ZN9R^,YN5\E[31@0'"Q10&/IY=4IIB5SY&P]RQX\QS/OZ<$J2 M0&J >4WPLWB(E9+. L>S=00C(2$)GD+Q5IC)M2YM]35!7:ZB+M?,2)#DPARR M7I(IC;6U9A88]?WAT:/661.M^Z%?],-)W@^-.>] ?%2Z;X*V7$5;;N^P.>] ]%2:;X+%7,5BKAF= MWI/SS$JZ9-9&2\S0$XXS@GZWCN22LWS(7V; #]7S=\SEB6+]X#M/GQ^UM=4$ MT7F*Z#PS@^U.<3L$9(K3OIK4!,-YBN$\,WSMG^!V"&U+<.:PNOX4Q7E[K5AM MYK>)YKG76.^\^Z2PJ^@*=P[$"F5YIO@+D]QE[>#N_9/X3N4 M='VH1I(V7Z5N?2A:\W:\3[@[29L%<@[]/M%::P+4/ 5JGAG4WI&G=ZR$;"H=)\$VAUK-#J>*_% MLCJW:+/R>^NA5'MUBSZSY+\WM^CNQE<1IH]4%*/_\, MHZM.+[YF^8+E2BA',9E!J'5T"E=GQ0R8GT0\@4 %<; 8 >&PO M=V]R:W-H965T&ULW5G;/(ODB M-YPK]!2%L;P8;93:GDXFTM_PB,D3L>4Q?+,62<04W";W$[E-.%ME3E$XH1C; MDX@%\6AZGGUVFTS/Q4Z%0BL>+$1E]^^!3<+]1Z0>3Z?F6 MW?,%5Y^WMPG<3;^Z&.$4$0^YK](0#/X]\!D/PS02X/A:!!V5OYDZ[E]_B_YK1A[(+)GD,Q'^ M&:S4YF+DCM"*K]DN5)_$XSM>$++2>+X(9?87/1:V>(3\G50B*IP!013$^7_V M5"S$G@,Q.QQHX4!?ZF 4#D9&-$>6T;IFBDW/$_&(DM0:HJ47V=IDWL FB--M M7*@$O@W 3TUGO]]^D MUA._B'F5QZ0=,7_;Q2?(P&-$,34T[K-^]VON@SO)W&G=?0+L2HJTI$BS>$87 MQ5V2\%@A)B57\E3')P]@Z@.D)^E4;IG/+T9P5"1/'OAH^O-/Q,9G.G8#!:MQ M-4JN1E_TZ8S)C8Y@[F5G7NG)?IC"XGJ6 >O[L(^];4<,DYJ&5=K58)DE++,7 MUFW"MRQ8(?X$Y4=RJ8.81[#V(=H&=4@#8=O,M!U,B1Z@50*T>@'>"<5".&_[ MF:(#:;5!4H^ZV&B@;-L1%WNF9>MAVB5,NQ?F^_B!2P555$FTX>$*!3&Z2Z!* MZ+#:+0RV:Q/+-:T&V+8A=2W+)8[CZ>$Z)5SG!:MZV;F:3NN''>QAUS;=!L*V M(74=PR.T*S'=$J'[HMKP(6#+( Q4P/4%PAVR0 P4K$;8*PE[O5MRZ?O)CO>? M1*^UVH;E&+2Y*6TS8E"3./H=(;CJ2+@7XOS)#R1'BCVA+7MFRY!K6Q#6'$7L M>583IL80=T#<:YKDP#GT1708(M%4 0MRMEDM-(8F'$##Z,!9=3[2VVP:92VL MDEP+E[91F,2S#:\)MVUHN2ZUNI:U:EZDOWM=\S4'J&E9^[:^'5"--@+/-G$3 M:-O,((Y).ZHPJ=H9Z>]G^;I^.+">FE9E.AYU6NO9-O2P93M=,*NF1OJ[VDQ$ M45"T"Q:OD"]B%<3W//8!,CJ^$8HC2R_P>@/K:Q322KT?#U0G7[5*8O>6]CL> M;44"HPF:?]T%ZEE;UTEOOWUM81\J6IUQU6U)?[N=A2!\VC) MDU+BCR&:W/)LG@N?M;O4[O^V2XF#B=T\2CJE8)JFATF'EB&55"#]6F&1KN=& MA"N>R%^*I$+'4+,"/U!O].DUJ&X8*EJ=?Z4<2+]T !%?E.[MF3ITE@=F#5KI&WI@.B\*]"POT!D-]-?'K!S^K87=&^_5#R8& MBE9G7XDF:OYX0Z:]PNO5C >*5F=OJ'*# MJJ2AHM795RJ)>H,G9:_N>C7_@:+5GS]7\LGHET^'DK)PWW_$;'O-M#Q@E$.; M[+WU2%\Y?63)?1!+%/(U>.$3![(ZR=_BY#=*;+,7(4NAE(BRRPUGL%&I 7R_ M%C 0%S?INY7R7=KT/U!+ P04 " "W="%7'LIK@1P$ "H% & 'AL M+W=O MV79V4\]ZVSYT^B"#;-0 8B5A[^ZOKP0$+(?PX=(\Q$C<>W2.9%T=:W:B[(E[ M& OP)?!#/C<\(:([T^2.AP/$>S3"H7RSIRQ 0C;9P>01P\A-D@+?M"UK9 :( MA,9BEO1MV&)&8^&3$&\8X'$0(/;U ?OT-#>@\=SQD1P\H3K,Q2Q"![S%XO=H MPV3+S%%<$N"0$QH"AO=SXQ[>+6U;)201?Q!\XF?/0$G94?JD&K^X<\-2C+"/ M':$@D/PXXB7V?84D>7S.0(U\3)5X_OR,_C81+\7L$,=+ZO])7.'-C8D!7+Q' ML2\^TM,[G D:*CR'^CSY#TYI['AJ "?F@@99LF00D##]1%^RB3A+@(-7$NPL MP6Z:T,\2^HG0E%DB:X4$6LP8/0&FHB6:>DCF)LF6:DBHEG$KF'Q+9)Y8+'][ M7*T?M^L5>+A_?_^X7(/MN_7ZTQ;<;!##H?"P( [R;\%/X'M@ N[)7CXSA1Q: M 9A.-LQ#.HS]RC"_QF$/]*TWP+;L?DGZLCI]A1V9#I-T6T\WI>!E>E+ 0?E@&JSW?$(.7ANR-W$ M,3MB8_'#=W!D_5RFMB,P37L_U]ZO0E]LY#[!C&$7<#4+;T"$&#@B/\;@AH3 MI;Z/& <19NEJWY;-1CK$.!E"58KCPNI9E@5GYO%<9VV8IF"0*QBT4Y!^*P&* MA4<9^29?*"5I;RG]%']XQ@M:R=\%__HX3< P%S"\2@#A/*XG/WQ!ZI)V581& M>)03'EU%6)X+7*#0)>&ACO6HEG55A,9ZG+,>5[)>^HAS< ^6- CDB9%L>O#7 M!QSL,/N[C&,E7-L]WA&8IGR2*Y]4UK=/.(@HD\=R5MM**]JD2[4=@6EJI[G: M:?4ZI^O[_-6,=_](CP $!1'EG.Q\+/V&*V=$^8;KRMVT6;FK#=/D0:LXHZW. M!-;MPVRH\VTV&@SZUG1R(:8DT!Z/*JH?//,,^X1(PXNUJ+%"F4C3K12 MW1M.+T65AO5?6Z'"3\#.#07LU%%TA:;K+SP%K#85^HI>L\5@0TM1'Z=+*$P% MK'85%YNLK:6 +[W"V"HU%4TB=0V%KX#5QJ)40S-7 >MM166(SK@P%K#:690R M;F$K8+VOJ S1:1?. C:Q%@_-K44U7NO=_G^8"UBX"UAM+ZZI=IVZC:[0=/V% MWX!M#,=5U:ZAHZB/TW__%I;";F4IVE8[^Z4Y@/:PK-HUB=0U%#;";F,C6E6[ M#%ES0=-2^O6!.ONS*XC*(_D_5[X,OH&$^L!4@GEVC:3N\#X@=B A!S[>RTRK M-Y80++T62QN"1LG-THX*08/DT<-(5@45(-_O*17/#759E5].+OX%4$L#!!0 M ( +=T(5<]1 X\U 4 .<> 8 >&PO=V]R:W-H965T&ULK5G9;N,V%/T5PBV*##")1&JQE#H&'$N#ID 6Q$GGH>B#8C&V,)+HBK23 M_GVIQ=I(,TJK/,22?'BNSN%R+\W9&\E^T"W&#+PG<4JO)EO&=I>:1M=;G 3T M@NQPRK]Y)5D2,'Z;;32ZRW 0%HV26$.Z;FM)$*63^:QX]I#-9V3/XBC%#QF@ M^R0)LG^N<4S>KB9P[8(-7F#WO'C)^I]4L893@E$8D!1E^ MO9HLX*6/S+Q!@?@CPF^T=0UR*2^$_,AO;L*KB9Z_$8[QFN44 ?\XX"6.XYR) MO\??%>FDCIDW;%\?V;\5XKF8EX#B)8F_1R';7DV<"0CQ:["/V2-Y^PU7@JR< M;TUB6OP';R76,)%5C_@9)E):?P7ME1*L!YY$W0%4#U&]@GFA@5 V, MH1',JH$Y-()5-2BD:Z7VPC@O8,%\EI$WD.5HSI9?%.X7K;E?49H/E!7+^+<1 M;\?FSW>+9^_FR?? \O[.\^]6_&KUM'CR;_V[IQ6X_P;N'_S'Q=/-_=T*G(/G ME0?.?OXRTQB/G3-HZRK.=1D'G8AC@%N2LBT%?AKB4-+>4[>W%>TUKKD6CH[" MKY&2\/=]>@$,_2M .C(D[[,_5>NWE/KO:\7Y MJ)2I+=M;K;CG4KD2G%2O!"<7+ &J%-NU8ENI^"9EF(\C!J)R.I[SBP._YWF9 M4;#%<<@?@*>,9P6P6*_)/F4R6VSA[9#I(+/U=J4M(LZ8&M!T>JZ(,,N"T##- MGBD2.M=UX0E/IK4G4_4H8%N<58;(Q$X'BA5Q4K$B3"Y60J<0Z]1BG0\&0'L9 M?L&\#L3'P<""=YE^1W@1.'4, 2+.1(YC0*MG@(3/XE/ M<>4.N+4#[A 'N-CC.B<3[4J"0_Z.?=$2''(=6^]IEL!XGSM3H]_K'_)U-$.] MJ<%TI>H[7,_YLN^E]94N=C6:Z@;JR5E*@.?<&VCV^UH"Y%/"M?J#PI4@@58DB3AF6[%R/H'^/,6)R\X^TOJ@I+OLY7'J&S>J&S^ M6&S=GD%-SZ!Q2\**;ZR>&9/-&Y7-'XNMVS--K0Z59>? U<(0BS)HN9;;7RQ$ M'$\,9CN551:*0&1"2UAT?1FCZ3JF>6JQ: IBJ*Z(OQ>[?AR"X, 'X@8#N@VX MP8#L&66\2.:UXM?\5X-H#Z;9)4!WY.)$N>WX=,^,R>:-RN:/Q=;]4;79RJ 1MC(5 M1WOF&Y9IV+V)O93@S@V(4'_7+L'QS9N)^IM6&1\O=FQX(J6@9A^#U/N8\4J3 M*E [[_'\**;2Y5"@-Q3H#P!V[6DV$TA9$H]:EE2A!A@T$.@-!?H#@%V#FIH> MJ6OZ,4N2*M0'V1>)9;K@BXQ(R+X2E"+[HJ;:1^IJ?]R2I KVD2GB3]F"*3(B MT101)3-%:QW<)3C;%">F%!0_[9:G-_73^E1V49Q%]IY?P\LEE#SWX*5?GKDV M].41\&V0;:*4@AB_\E#ZQ92/ZJP\52UO&-D5QX8OA#&2%)=;'(0XRP'\^U=" MV/$F#U"?;<__!5!+ P04 " "W="%7O9WBM"$( "N1 & 'AL+W=O M0["7\;/8SB5<2<9=;(]T9$ M4?21[[C!8'J*Y ;N*4+SV?2?Z=L:\\/ED@ ??/[AV'QZ3](/1 M]'CE/+ Y2VY75Q%_-]JR+%V?!;$;!BAB]R>#4_S!5K,&&>(OESW'.]E3+P?7W/2P?:>:G-]9GZ^)FCBYM-/MX>O&;-4?G%_R+R]D? M'R\_F=;U_&=D_7E[?O,/>F=:]OGL_.8(#='MW$3O?CPZ'B6\:^D-1HN\&V>; M;I"&;LQ"W^?S;)Z$BR_HW\_,OV/1?VCF.7&,SI#P6\%-9O*;G"Z7;CJ='0]= M.>YRZ 9HYJSRAH9K=(VEV\$9\TVYE#MC.'9/QJ _\9>W"#=,1\97M.L&#( M2?AP%^\1Q;\@HA LF@8;3CWC3'>]IZD^48Y'3[M6K&,J"+..&.I$U<8Z+0.M M!B V*D!;.M9T>_\0KYP%.QGP_3MFT1,;3'_Z >O*KQ(EZ59)VE/)=WQJQH\. MO]51)U4W_%I9U?1?15EI/[J/SJ"+GY\GL,O26+8KYU?EV[R3?T[W7H>8B?D,].M!3M#&B>,AI;&8T^,E;.D%9)C8YGB+03?7<12#(+DLP&(BM94-G:O\9D#>%2B;"!NR0" M@GE?-*C%0F8SRI"G6(9 NL@%8G@Z0^W'MRG9-!LB[T7M2 M@Z8#0-EL*+:R08N, ):&G&)WKM4?STE;5HC:OD+JD(8HIPE9#W/D ]Y7T"+( MQO(HN]6K:Q>W'A3P)(-A.4 MS0)ELZ'8RI.@R&!@>0KCFOG<\NN(OP0)"N_S"M!IN8B1A"AB2^:OLMKDD^.M MF7 .0.8#9KB>'ZGMM'7($*M8F^C5C;8CT(8:0MD<11H"R_,0W3SM>MZAMHFV MIQT$D"'6=*Y*5;N.0%L$I)B0<8.W6Z04L#RGL(^W.^EREM=3#365ZI F;U>( M%'J[APCI21'2$VFT^%IO-V=O/\CEW>B[AX.R6:!L-A1;V:!%>$[DX7EK\E)L MQWIP*B@,UT/=6F6X#B$*U<;5:-@2 W5-K8;-\N'N*^=.E;UOF5V2P11+6P]\ M&Y8(4-R;6P*2S0)ELZ'8RC8M(GQ"W]#7)9"Q\@R4S01ELT#9;"BV\B0HL@)$ MGA4 ]77E]^H]!]JS"@+(D%"-TOHC.%V1-M0@R@8IL@H$H'9/VHOWI+UZ+X#@ ML3$A>M7;[0JTY6/;5[LB>B>O*>%3H9)=:OBDO8@O@*3Q@*&.JUH*@42EXZJ6 MAPB"21$$$Z@ZOEC7KH5\>3=Z[_2@I7Q0-AN*K6S0(HPFKRSGB]VV+O5\TAY9 M"R -'K$0*/*(#U'1)T7\30!K^F)INQ;UY3WIO41 R_J@;#846_D!V"(+0-^R ML$]!"_N@;"8HFP7*9D.QE2=!D3F@ (5].4=OVX(6]D'9+%K/4%"L3K1QU?<3 M VJJD039SIID7N@KZGK"[T/VJ6N3]OK^@+($!OC,:5&Y=AJ0!JZ:E1U.LA# M_CM/^4/5]<7*=G[('_8I?]C'_&&?\S]$!$^+")Z^LJXOMF.7NCYMC\ %$''< M(P8*XA[Y5LXB_*6!57RQMUZJ^O">]EPAH51^4S89B*]NTR O0MZSJ4]"J M/BB;"KZM+VN3]NS#P(()H9"237[T!5H"_I%-97N9$3+JA1Y!=I2UW]9N'RG M2IP7Q">@<(X6$S062@89DL]H^_, LB0$&7"@X2JO%V1-M0@RG\]660"U%[/ M W3QC'-&N4F0I=JCDW>C] MMZ6@<30HFPW%MC'H:.>7&])?\N N+G>"8^2Q>TZOO#>X]-'FQS$V;Y)PE?V8 MPUV8)*&?73XRA_M1*8!_?Q^&R?]#;'^B9/H_4$L#!!0 ( +=T(5<+ MNF6[%08 )T> 8 >&PO=V]R:W-H965T&ULK5EK;]LV M%/TKA#<,';#4(O6R,L> 8Z5HAS4-XF3]3$MTK%82/9*.DW\_4E(D6Z(8&U,_ M-'K<>Z1S='EY:$[WE/WD&T($>,G2G%^--D)L+\=C'FU(AOE'NB6YO+.F+,-" MGK*G,=\R@N,B*4O'R+*\<8:3?#2;%M?NV&Q*=R)--D)=&,^F6_Q$ED0\;N^8/!O7*'&2D9PG- >,K*]&_%>BH?J9*/#Q^ M0_]4D)=D5IB3!4V_)['87(TF(Q"3-=ZEXI[N/Y.*D*OP(IKRXG^PKV*M$8AV M7-"L2I9OD"5Y^1>_5$(<)$@'.[E$?+ MA_G#S=>;VP?P[1-8S)>?P:>_OWU?@@OPN S!AU]_GXZ%?+0"&$?58Z[+QZ"> MQ]C@*\W%AH.;/":Q)G]ASO<,^6-)N>:-WGA?(R/@7[O\(["M/P"RD*U[G_^7 M'IZ>C@QL[/HKV@6>W8.WP'P#UG(,<[!F- .R+3 LDORI'%>)2 B_U'VU$M;1 MPZJ><\FW.")7(]E4.&'/9#3[[1?H67_J)!L2+!P([$A.IY;3,:'/;F6_3?*( M9@1\2"GGVH(O(;P"0G77YQE$OF4C:SI^/E2E&V=#)W G\#@N[,9=>,BVW ;O MB(M;)JENJXN1*J8=)[&\?7HEN4-6 MTI!@X4!@1^I[M?J>L9*^E (3S'*IIYSG'IC\&@!S3@37R5C"N8=5@)P)%T':<5EUI NT@"*"MKRN_9N:;6\X&YT^$MVJDX 5P'H,TP:LD[:\7 M?\AZ&1(L' CL2-5)K>K$6"]WC&QQ$@/R(HT=)]H2,2*K^X%C M>Y.V#KI :5&<28\2C2N%Y]G2)'\F_!0S 0?UI8.BA4.A'6O:6%-H]J8AV5*> M*.LF[5KI)N00H[M<@#5ESK&(UAA49' M-ON>B$W,\!ZG9=5T2PG-/JP MILMN&7U.8MEI5Z_:!J/585#W6:$=5PAR?!_YG5[;#>U3HK&,<')6EUTG.99+ MO!.Z[*!.VO!7M6@&= T6J5S7@#F0GBV32S@N:/03 M\-WJ!XF$6C3+ALP3:5T/^I)6[D%M+.SZTXO>OG2RET6-ET5F+]MQ.;JRT\E@ MQCU7!J3QMGTR:&+[9&CL+3+;VT*&8BFL-%"":#D/:G!1U[AZ$]\*VBL839S1 MV*'&XB*SQ2U:#A9@19Z2/%??7 X3Z7(3JOMM]]J,=C;]KE^%MH,>V\>_,;;(:/)J_D1.M6;F=N=7/60AN>9 3S'2/M*7=12K0L)%HV$MV]271O MEFA0OUNA'0YFQ_?L"6ROBC2!T(%NX+5T&A_LVV6$/17[GQP4UK[T@2DW;K]B)ELT!RE92TCKHR^_&ROW0LL30;?%[N"*"D&S MXG!#<$R8"I#WUY2*MQ/U@'I'>O8?4$L#!!0 ( +=T(5=YC^$VO1@ A/ M 8 >&PO=V]R:W-H965T&ULS5Q;;QLYEGZO7T%X,@,; MD&U)OB3I3@(HSF6\Z,2&G70#N]@'JHJ2V*Z+NEAE1?/K]UQ(%BF5%&>V&YB' M[EBJ(GEXKM\Y/-2K554_F(52C?A6Y*5Y?;!HFN5/IZGA92EP=O7M%WM_6;5U7;Y+I4M[4P;5'(>OU6 MY=7J]<'HP'UQI^>+!K\X??-J*>?J7C5?E[YD6E4/^.$Z>WTP1()4KM(&9Y#PSZ.Z4GF.$P$9?]@Y M#_R2.##\V\W^@?8.>YE*HZZJ_#>=-8O7!R\.1*9FLLV;NVKU3V7W\^AY?3UC1580<#!84N^5_YS?(A&/!BN&/ V X8$]V\$%'Y3C;RS:NZ M6HD:WX;9\ _:*HT&XG2)0KEO:GBJ85SSYMW[^ZN[Z]LOUS>?QW-R^OZ/O[L7D\SOQ\>;Z\T=Q=?/YZOW=YU>G#="! MLYVF=LVWO.9XQYJ7XE-5-@LCWI>9RN+QIT"_W\38;>+M>.^$_]66)^)L.!#C MX?ALSWQGGBEG--_97\84\3^3J6EJT+G_[>,/+W_>OSS:X4]F*5/U^@ ,S:CZ M41V\^O^?GFRWLQ$L?B3^#L[=T-C)RD?[3: M:++LJZI>BFMQV"R4^,??7HS'PY^OJF(IRS5]&OU\)%;2"%VF\&)5RT9E\$&\ M4[E8RLY!8]'[P2CX1^ JRQ8F,C!R)M1LA@ZF MG N9%*J>JWH@4KG4CA<@N]I#7#5&)%6Q527_'REFP70K_#%HH*]N+>4$8?@&\CY M/:I\/1 !=]ZZJ:ZZJ1RKXKUK(\JJ$3G0@%QK*B'%4M:-3END29<9N*AZ#M\#=R!P ?,Z&0MSC%'-0=]IS: MM^$9\A6"2KK@/0;SF';Z.U!%9.>B$SSS((GS7MTM"T9>6^@:EK]:C*EJ8$\BA Z6;=:9FJ=05*5U?% MAH**0U!FM<1IC^#5NFKGBY@@F#N'S1G<>T :2GGT_&=6:%8AI K?T"6H)"CM MLIWF.H4=SF!Y(/+0*LVU?7[+SV_LZ93OGC_9].[FZ%I_(08O[=CH OJ4GJ&,^#+CHX(Q"BDS7P#'4;/"DZ^-J M50))X%2,SK1$KS>+F.(LI5NE,PZ8,/FU I.LNI4_HJ_7,EK8S<'O=D[YMJU- M*\O&V3.POS".@/U\P*5Z@\=4-2NERF@/N'%>F[47Y,41#KV_=33X/H@7GU(S@YT/]@$M .N8_'=NQ'6'T91?E>D[0\8[]6S14J M%5.&(TG'!""STLB4W3)$J$:!U5,LF*Z?P%'O,WDVZ;[?F L?JNEZD 0D?PE6 MCD-NK>8:(2,M!7&HX:5L,$@V'?@.LX_X>^FC$!1IE((Y$"LQ3&/!(<^ M5X_60PP=(KHI [_!7\8NP0=ZWOE. D&@X^>#R^%P,!P.P?^B^W%:_Q4_!0)D MY0'6F*6-X\3U.@.1@&Z8!9!.P"YO,P9U^)QF $P4@1AK4"KD8KA'B!(8=&YSR"-(D7ZSKWGQ0^@",%?KE"9\ M-CH9#A,(3V+G4-PCC:#'2_\XL"84T39 OU_"+D"/KP?BEU^N(CKMHXXHL*Q4 MU8V$M69MF3%JDFE:M;C%0I8 T,A,O8_0##3? CT/=X"FV<%ZG?+?=^;V 5Q- MM7)>Z&EB0;/8-@! JK) TEA'7HP&%V-6[,-GH^')>(@@CA3RJ(O8)20!H6XY MN2;V;]9?J\R[R'$N:%M:AV36,UT&6GG!UDXR\W;RI<;X/F'>LA-BEB]4WO^2 M"^&Z? 20PC-]/;D_$7-P&'5)RT,>T-9 LS)LO7:>0@%Z!KHQ P*?!B:AR^3> MUF;&A_+H<'1YU,D YZ?IG"%,4N+QZ.7YD "_11&1,O4/"Q JQ2?81(,44FP9 MO;@0F5P;Q!\Y.ORJ)C5GM%@>\R*ZF]@E'LT"[ =B5D8 2N4S4;4-A[("$K(U MK%(_X%Z!HQWTLN'%4@<)HVJ\&E: 9#DB 5UW+=CY6!X_W\\28D6F$ V0O./Y M!Q;>XE>,4#%B_P39PU$/V-T!XX AA]H.R#"8\^O7MC;4C_NX9N+=+P)S/SUXFZ %A66NASRZ\A<$GX"T@1M0V>#I3 MJ'+/7@XN+_T+8 >JQO"V]2:DL6LY!28?LC-'\ZAJ#2D?I(IK;P)RPP!(A:X@ MR@.C2LSQ[RF!IQW.$ N M'F$1U2V.@"I&'ZO5*2RT>Q.4]D-/CL_)P[@/AAH M^)R,F$@6:Y3EZ$HAA(60-K=Y>L;:A!F=U-FQ+GU9HEV2'$+9?S>1<(Q,(D;" M)(4V5*#-M9SJ'*T*.0EOMJF5Y1#Y".YR3#R N?P4L"6(P'J.FHL[1N9FM5I1 M2E)C/=4I2/_R),=# RPE)_W=:8$LRM@YQXVS6EP,K0?6M9JD M@GF3T(&8-DWANUD+],19:8&Z[X>'9:Q]2;?9KGIU:750_ZKJA INQOG]F=2U M<\N/,F_!*?[1PB)H+0UX?PG4O!C^/62VG6!W0 R#+7F[(W&HOB$>M7X]Z7=! MG>4PPFGDM\ G5:4MR=AJ #AO7*#JH>"HI^10E?FZ3RR17]>\RR5XC^,F&;A/'788T3\75I MI?54U!]X*4HHR:8)L 4HTROL!KH4INHT=.<2G"@A,9ON:Y];RJO4E/,UG[!'&6G2"N[-%4RR4H$!83,.0A_%"JX,@) M3B#!A]W.( K$RRE-\ K9QP(KK1):Y3+=VIUX87*+M):X1[6[;N00]'1-*F]8 M*!2X+:;K6W;7= Z/I9IPEZ02_VK!=:XPN2#V SAZB.AG:F6^'_&CTK9ILTFF M"_V%!(G&.LED]0BKJR."SC:69U9 ?<+@8C\0*2"DPQ^1Z)P?A#_+WH \2)9Y M:\C6_10^JNP>1<$>EPC#L$-$;@,ETUW0N0OC4\-@^LE&UP_PQJG_J3E> M;Y/[*W'^8G@\&A[?OWPY"/6$/#YG##/ $?Y$!.P!/SQB3H9N+-.9W%'@^@D-(6OUP1M*5D L4>;"@A')PR[ M GVHUTX"*YOMHB$R@ K.\'Q@U]L:0R)Y/CP>#]FG1HO&I]JQ]$#_\,@2WX&E MIIR?.7YMZ85S:W3.V"G0YDFV23B^.HD%L1((KS'!8-WU%FLV]C3]@1^"DL-]5'SC>XX]J05D<,:G8PIPO> M-4P[+_6_OK]=710JP\X"S-U)!P!WIF#O7,K.?F\Y%'7ZU960-S:$_&;$W[>0 MDRS,BHTH,L700O$2$3[Q>OL4V%4BR13=ELB:W;8Z\MW!U#' %@.A)62R:&I% M6LTI%F_+$1UL[J/K265K5*]3Q[ -]CW7J!(V M68<%9I)HA B(!4,^MK''5;'?P!I*X#RY",7[B\V;(J:-]%.9D[9RUR1#<7K> M:6P4F+'7 ,E\4+8"3X8:FAFB-+,3INU"@K&I.K2-+L8!UUV)/^9+OU3Q)V+!&OR$T0#J!ZH$W. 33F/UGX@_1BS\&'K;'!F8B6M@H$98E#,O^/72R YG, MT(0CU)=5J0VZ'@_!(#Q&1'SHRX?["I/7LP'(905V5 _V6DE8Q])FO\(D3U 8 M4N=0M*PGY&.J*0'/7G)^4%DLI[J\R(28_/>VC+)16./;&N&83G7#FK(I7WZ% M!?)N)^5.@#$"==4M-F[0C \5U^-<^M]S@GG)^H5D MQ2[<]4YF(FOYH+;N^KF2777YT)GQIO8IX,0?IF G)47:[4R7#DBS\YVEZ/!E?X0X\$ &@TVM"?01 MMF;-)-K!]$RGDV%A@JK\P-^2P-T<3'9N63>Z^'MO46+@]9HU47,9R:@.V4:E MHHUBX(8+6$A0>^LI#B4!]Y747&73=52'$5R(Z2NM;/D54--M6PQ'50#3G;.2 M!*Q!$X',!#]P/V#5$6TW=,154BZ(%;OJ'$^ORDZ/W+F&-6@^ ; 5#E_@V&A3\LSWS8L**ZV==!@]6P?6G<+?V MY-?UMNU2'_)7W-=NV]IA@7NU;,(VK#,QL'IV \9IO^\Z&.GA1N?6&?M2#PFW M@F &>;0AU-ZU43P;V;Z2WH-@C,8$#*H2\F6\WY0H+PDK:YNI]ZOK=;_7V(2X M^\3K\YOO2VP0*R/^BPYA/!J,+BX'+X=C%QA@V2O,A,6$X#\UDC)N5G6J#;3,0ST 9!R]?7@Q>0,S$\AKWB\A5 MV16-8J&@!Y5KIJ4+>W;3)WTL_\O83?WG5JT4-O>\V*-,.R*(X[GGG*X)^,&Z MK'+BQU2NSYAZN1+GD['3PRI2C4X5,BFDK9'?/*C^I@NN@ST;GXQ% 8"$#[!L M%0Z)C7M+J(3K08D%]/B"NYD07U]PQMP=;/>&IK[N]P'BU5P_<$T;D!*W+%G" MW$X2W]:TE1QA*A/&J&S?F0]V0(U$P=<>L"MX-C''7P] 6]M.-69U!35DN^UINS=2/=-TGE.U,#: M J9&V0H(UQ7W=._LRTVGBEK:N,4I4M&9BYZ!#E/TSZ4N#,0[<%E ?YW133F^ MSH67. %'8DD"&<3W78!63)(,-V_$RU#4(I_ID\#-9AB;GFR&5MP&-K>U!ITS M7=2QK35X4R>LD,CNADB@_%TQ>K=C9@8A+$2#B [*1DA[:Z[PN=0QUSCWX.B D2)N[;/EL9[8< MO]Z=W7Z"C+>B"J,5M2W;4XVA[!ALV4N7/U3AG06 U!(L/57H,Q*WH4A0L;OQ M5Q0Y1<=O=>!NK&.Q4NRZ:V>NP$X3'[,&L'!ZNF](UDZ1V;X!@WHAERV:FN,+T^ZF[R%S8:)Q6:X*J8]04.M+!\Y%?0--HA9AO 2YD-CH%T,5>LE6U9Q&^E/JWHH5 M;Z9P''?3A;0,JK[?4B=S!=?_C"IA@ MB"C\>'0Q< )Z!W@+X$UK$^:OI=4T/D*;4A=I M*=ZCQ^FV-W%.N+(72EK%]>./M-,KWJF_S[J)\?C<>;L8X#L/QZ4F% MD:2G,'(D[OC7$D"OXEU]ZMJ5(11"2 5DVX "*T1(TM]JTD!PVA6 ;WZ]?G<\ M>@EFB[$%KU? Q+@;E"M?XJ28M*)6 .YEX6,SH&9M8U?8_?&H03LAH6CSS(89 MT'VL73ZZB\ONU'Y3NV9>/R@GIY20*PW&%2F[WV[@<^WPUPAL:$F=Y5&)U5T: ML;OVY]8RT_G:M_UPJ\$F7,6_C0K(\G> ;6#O>P)1*L$E[!581GR^%<,PGPHJ MS?#>.JL%I:1&&8?'6R_>]<:!5T)::<=;H@O47>SJZ&X-P(KVV)/RW*I<@0N=LR [YVO?7AQJH4?; G.^+*="3"O7&2#X4 MC4]3.]?1V=9WJXS^D#?XJ0[TR\D3$R[@BO/>W5IFYV(6]>-+M;W@0VU!$* , MM0S9Z_;<36CE\&.[#),\NUP'GJPY!&.!S<8WB.&%I4Q-&Z=N8,=1ML*J[5O2 MC<7)$4[?T!=X@#8,8]SE&[S03\L3[S.U\;Q#!:05'<[M:.+;W6TI'Z7._9T9 M^E$$3&V635_JCH;;(!!E@_*^*2$#<%EQH&Y>RQS7 /KD3@O7/MINVOV_YW%" M]:M_2(.I20?=P%HUD9?9ZSBH*^!/=AQ]OT]U&OPZ&?WB _X&FV%+YQ\J\]_Z MGWF;\*^;=:_S;\1]DOB;/ ;U0R&#D^>7QPPT'8?FFI)OW4VK9JF*NC/!7A? M5>,+\'Q6 7*Q'W !_^-W;_X/4$L#!!0 ( +=T(5?;!\YLM00 #L, 8 M >&PO=V]R:W-H965T&ULK5=M3^,X$/Z>7S'J2BM6RM+$ M?8>V4H&BY<2;:-G3Z70?W&3:^$CBKNU0N%]_XR0-+5>Z:(\/D'@R\\S,,^.Q MVU])]: C1 -/29SJ02TR9GE4K^L@PH3K0[G$E+[,I4JXH:5:U/52(0]SHR2N M,\]KUQ,NTMJPG\MNU; O,Q.+%&\5Z"Q)N'H^P5BN!C6_MA;WBE;U"B44":9:R!04S@>UD7]TTK3ZN<)W@2N]\0XVDYF4#W9Q$0YJ MG@T(8PR,1>#T>,13C&,+1&'\*#%KE4MKN/F^1C_/ M,&"E @K#:AV9<\U=R:@A.I+@2*L5)OV[(M06H!Z6; MD\(->\--&ZYD:B(-XS3$<-N^3B%7<;-UW"=L+^!O67H(#<\%YK'&'KQ&Q4,C MQVM\) _PYVBFC:+.^FL7)87'YFZ/=K<=Z24/<%"C[:11/6)M^/F3W_:.]^33 MK/)I[D/_N+KN=;,[B>N;Z1@8?(5?(W4:"0TCVO@A_1D0:1!G(6K@X=^T'ZQ, M@XFX@8B',$-,:3^$"$:2%.%4)DN>/G_^U&5^YU@[ 1ISB1J0+P">:=IJ<6;&%^Y%Q95#%ST Z0H: MH&!V@_7[<=:;T=*8H0G2+I%:H$%)9Y1W2 MRZ[$X$:)!>46PSD!I8M#X@W)94QCUF9B^"RF&(IA*_[!' /GE[7.6BS!HD\$HV"($NR MV$8#9Z6'KZ^@#CHNZS&WY7]QO!Z M;M>W&%MEWKL-GK MN4W6 -=MNHV/I7-N0<=ME79]$+X5@ M'9(UMM5:;==O6K73F!/XB*)-*,>B Z@2=!*+($\H%'%FJY26>+;]0$=\O@NZ[1)I;(YOCB]7L/UO<;K NW5 M?:M$76O2VVJ^EC7)Z_O.O?)_2]18,VH7K +\]1+]!W![GG!-XXW&Y+M+]%X> M\D%EYQ3-NB478744.*U&T_5H)VQ4AK7HK[ M2EK=C$?%A?!%O;A67W%%QP2=.#@G4^^P0Q=155Q5BX61R_QZ.).&+IOY:T2W M>U16@;[/I33KA750_5X8_@M02P,$% @ MW0A5Q_Y"IIY&0 I4P !@ M !X;"]W;W)KV+<[B[I>O7KYTJ8+O51V4*YT ;_,RVJI:OA:W;ZTJTJK MC#8M\Y?CX?#PY5*98N?=&WKVJ7KWIFSJW!3Z4Q7;9KE4U>.9SLO[MSNC'??@ ML[E=U/C@Y;LW*W6KKW7]9?6I@F\O_2F96>K"FK*(*SU_NW,Z>G4VQ?6TX%]& MW]O@NTQA,4_'.GSW6>XT$ QN]RYHZ_$C>&G]WI MEX0[X#)35I^7^6\FJQ=O=XYWXDS/59/7G\O[?VK!YP#/2\OUY[,-V) MT\;6Y5(V P1+4_"_ZD'H$&PX'F[9,)8-8X*;+R(H?U*U>O>F*N_C"E?#:?B! M4*7= )PID"G7=06_&MA7O[O^\O[]Z>?_BC]>QM=7/W^XNKPZ/_UP$Y^>GW_\ M\N'FZL//\:>/OUZ=7UU,M9Q_&[\NB7MCXHLATUMW_ M$N#TP(X=L&?C)P_\I2D&\628Q./A>/+$>1./_(3.F_QMY./_/IW9N@(9^I\^ M.O UT_YK4*]>V95*]=L=4!RKJSN]\^[''T:'P]=/(#'U2$R?.OUO*'N=#S3NHB!9"M5P3I3T E5!JLUJ$F]H.]-4>-YJ\K M(:M?Z(O^M5S7MK@.!+@3=&UW@/P7BZU)5)5;S[XP_'X_'P]<^G MIY_HX^CU7@PF#S;6L&(9 &D*-H5D4XI>L/ J4X"\-&1Z;%R7,=J0>#3<_P_: M=%K5)LUU?(Q ?-:W3JN-7Q>;E<&DM& M<1?7">37%^<.\$%\KJL:#'('5D!F7I9U4=8ZSHQ-\](VP*&HP!5(+*!?WF1, MK%Z>/,4))%S M+0$E2\LK(5KRZ6I@>Q)O&HJVZBB1GH@Z%63"W:5)X'U^%^< M;^$ @%%6R/1!?$I@P,?\,<%=CW%6QH"B0R8&S(0=GA(17NA(8>-"I]I:<$AT MFXI11G,-1%J%\@M M0"L2FOP:0*@6##_!#/XR8HQ2!#I5-E%/ >?9P?Q%4M? MN3*%G(5?SUD9D&NCH]<6K'H!;A!)3:A\3T,4W0HF47N3&#-F%6VO%Y76],2: MAWC)EEBC):9-D=\4DDIE7\'GT 5)?+\P*>A8!9 7(!]PFXI96H1G(* 5ZEZA M:A"E9(.4.A+?!.0V2#]G M1[3;<,L;Q&0G8ER0-Q#T@)\@,W MP=5X5^WU&*[3E+@^.IE,$MRIEDRPCN'J M+']4#4)@EJMHRH>\S'8""C]F8*7 %#C4N0&' MI6-+,%]WZ"1+XGH?2&0$ZC+]AJ< 0X')57D'FHHF$A3J%A]# MY*(@8%PTZ$K4(]^,/ *_RDS]&O%&#GEXV%S#Q) MZU=@EAKO__1#S68)J%"( V3I9C>VIK ]=F6%"VJD3;&_70K01B LM@$O[M-@ MAB=">,#NFPK0+LD^#3H^80'FD_8 G,B"+AI\Y'8\.')8:E4(R/<+T ?ER4A7 M6]MP?.@H+X88KP:[/P>F%K4SH'1Z1F$[ND@Q5_AI72B3,)1@-U!$V[P:,4IE MB!KN6A,%#Z[BGVNSU#U:\-W]2%ICR<,LTCK((U:IRC02F/%-DNT5KT4BC42T2(S!:L MU^*X1@O]GU2,6AP-@=_-,2 MJ,PA8$&>;5E6VL7L*)T0;!&9[Q"&;EX;U50[ 61SGS7P5:P\(<6!GA+RH#OV M3!O$YY@86DH&[0)D89^ -\6=EKS0F2' PH#Y *"6 MF/ZA;A%9,4N2[ CPS#% )^L/R3^0QK(/AI2'TC7= D+^)W*09"8+7#]YU.[R MK4GB>H8T%N3O8<.+<3(-EN&([$D3CMEXG@1YV%S!KSC0*GRDH?:)B M C"_T00$Q5H0N+,%0)>GR_D@_@U%K<>:1Z:'3[BNRRM5Z>?3G].I]EC:C#$J M)ZT@4N @,V:+V[4=PO@O0KA)?H(L6H>LTFD)=N(/-H4M-4'O-J"4PN;WV(S' M2I4,86%P9RJGLB#WE#I7.1L,T0,Y(,B.>CS.SY!OB\<#UZ!=R8=R4I?.M48V M.+V8SU-B^3W-%09TZM:=8EL^<=3JUW6=#R0^ MR+/^U >H>'EZ?1:?7I_'D^EP?S3G9[ZX?U.N )"#TWC?588N7#P$R"I(>JLQB ]25]K?C$N]:B! ^8(7E: _])\ $@J0>=#<6 ?=( MM5S20(R".T$P6"(-00[9D;!H1>Z)3JSI1"X*H,P<34%%A-5R:\2W#GI==%N( M@)/B"L-&)-3XY!\$R/ ?:Y7AIRK"L+XO=O@SUQYM7/N],G211=LN[;F$8\F@ M8H:&KJFQ&N;78&UU--C O*\FWF.5&!@)@]F 6V='T%)*;0VY3@Y$_(F7) 1# MTJ'U2H7!AO!_J;Z6E5-M//W5QG M&'])61,9C?MR=6_[131(C;)24U$SX@9&F\/598TG>KB;(H@_\/@9!'US0^E$ M3BD$6#"RF^+:,>1R&,*1]SJ_\SHV< I-T4=:F1FRV44X$A#"+UB>9?IA@(S9 M-0&MZAJV8%W6=ULV$\'.:7A&> (&TNHA3''Z.A0W6(@VA M-4C")=V+*9HG Z]OB93(%M\C6Z*GG6G.''/S36,-$&CERG/PDX4EBD.'%56O MO:11!X5$- Y$M"OI_FZ+%K5J*&+"TJHETQN!=U2Y%%US)3ANYZNR@;:X8@/= M"/#?:^IV/+6]P 30URL<1+XC+%#%+51_(B%<4W#L8VI*GI&6ZEYQ&89_M8US M(Q'6]<#9D9!S!LZA*3(X+'NX?9GJX- M6;-!\9,VZ+>%@3#"J8^WFUADDXY7W?$/JBBP[N!= !=?*X"7 UM5M"U'K(5; M*LT8L0QDS&F/1,94-"DR5NCH[">&>&JB6;./7WD1TC?IF@L0D6R M,,!QFPK^:YDI]4C+RR M./&A[ :P*5.M05+6$2]5>>HF6%I7%*@],CCJ8?",ZD&P M"X1Q?WP$_QWL3Z0 1Y;8^I#-D*PA!6KB8U.XIJHO%RKLN!'GR-]C_0QG$02< M72QA0$*Y%XM0>"L&<.*/8GKVJ'&"(TS(P7LL:;J;J :,?@:CT%P'I3]BU]HY M4;?W2]4"\"UB/D"QJ%\;Y(QVH1Q;I%HK:M%MZN-3)I$_TEB_QV8(-1B$X&0_Y4#MTR; MW3:&G^@"+$@E.).=GQX/R33"%='&%4OLL5"0']YAU\I8*DB[6BO%;+,N,-HH M*YV[4CV%=7B^7A*G.OCN^JF&[G,2G[FFR:(0.,HR@Y$):7<%M5#LGE1E[JJ= MTJ/''D&+=W @A4JXKTS9.J6: U8_^G'G6_>VS+7T9DU_$4\NW^LK!L*-9846 M"'R3H!^AC$2^-=8=0>UB=[QMX\T3H5 M5&J:/3NH!67"UIJV$:(V3J:C(2!S)'6CY.APDAR/AE'@[)\[UM93%"38_XH- MXV2MDY+YN4,_&]JN=V7J$#^NP$U'R<&)\,U]>19NG?+$^/\:-TAHKY9+G:&O M O/B+1*VA"4"Q*]7F(V"GUHKHG;]8YA/T57[(2R<<,@YY((9@(Y)C%@[_ H M#BD]2/>WTS?H%.(Y$*PJJI+[0/>OT)#],'LP.+_".I'"JCVF?)GS*1#LF6P? MEZB5P6+#KE"7QA/JMFZ^1VE80TU;#'19"[D9VF,=(4=RL?Q6[^VC?9R280?$ M2KX?F&N,-YW;#)^W'M0&(4A!M2UKI;Y T;)1^/ MF?J(H T#DO@G8S%N:HQ=()=^#28*2#(NQ%))S"W[?,V<)M?AV?'H ,[2- AC M[B3G^*?.:)HDW P+VZ'T&RGD"HYMK_E^H=D#MBAS;PE2.TUC(%A:ZTN4;&>D MW*.YQ,Z3U Y-X4>,PS"F=Q^5M/N H0/)5;OAW: Q0>DM$\YQ6>:5VN(S4:R- M=+9BC-.9#U19B?H\0WE?2"@77Z.L)E+ODV33!5Q/P"2C2"T?G)9W1F%D5 ?T M?JZI6P!4=[,<"8?@!=8A=7!N&_W@>I;SMQ.ZOE$( M5)[8&'-L9L3W)5.7W5%H1))^P]?:G+,UFW/59D+2]:2BQX)F(H$/6'U1$'#5 M]UK:QVNW'13H16)!E]&>/@4BH,ZJL;0&/_&5@GY[NG=-IWM STK+!-! MDC&COE/G8!MR*/##D>OLWFS6"C*3-T&"%H#,L*[1ESC(M27- M6(]V.S7,B .OT+UOS,40 ='@!TUO?.?&601Z:R7+$"&E58<_"KJDC(:/$F2>>T:&0D:C'_1)*P;1"E2 O M"U2&V M7+/?>Q5=R@TW=(.\#=KW,+K8O*[GV3AR$9M84<\Q9U7/U@D1BHT',?K 59*R M>A6!(RE33\@-LD4OHA-PWB<')_!IC^$6\.QI/DY/1!&00OD 2-AX? MQWO13[HHJ3*/)V_"X@QI[ SIIMV,(!<]GAPDXZ/#Z# Y&?)TP/@H.92/_N'3 MN*Y;4H!^.!@>R#\ -+G+\>OVD^?6-4C!&J_@4?3_@%.8\!XDHX-#^'PT@3Q^ MC)CN3D^.(0L>,J^0<8>CX;^'69 ['IX,D\/#Z;^?6:.1_(-0 ]/&#+]\.B_! M@Q1U._M\#M8%TIK/QGZ++WMC9?(!@?%O+5NWK).&1W-HPV=7>+:;=:& FJ8R M53LNI8(W2?!J4S<\K$M!9D+1(M>YL/.-ED/RU$OI0?^DJ;^ %[96(?-(+Y$>_POE\BV)+T*2'K9 M=G5,^V*2B0YD3PV:(P6FDHO8#XZ$#Q%![X$?A,=&"&,@NJ)5. M+F$?@HDJ;%PMX+NJTL6C2QH 0^HT_B%Y@RD@JN2!?1H9I-MH+F?-M_F3XEM* M(&MZ=KO0/$15TOPIM9>Y>@+G_=Z4-<7"AM\5B/@/.@BV4E6G?B:^,RF#(D$. M3N\K_0J!5AZ/0CI(LP A '>["4 YPS?VI<5 Z,DID^XI;KX#B>:'#E]%/_YP M'9-\L#<0/3R. !V]LC5KLMY^S 3)U M]NGPUS3-T*7,I$.9/J;[IAN(4IW3#']1.E7+,#FC%PUX+ ="M=*_=<9#/*YU M"3*5X97EBKN4]T7X'DGB*>8GHM"L5&PR^,53-RE5ZW11&)P:0FU@X,*W"\*. MN>-UYV4!T>H,3Z\XX0PQI_?6+;JGSEL5R8:F8Q^)-2$T%DL:!Z1!_UK?@D+] M(9$VQH[^]:X<:>%3ASY;@V!$/"R#/ Y@""\+[!KF7<&5\OXHDK_2U,#:>E5; MC@NL 4'(^,;RNF.'B%)U[ =F$)3)MKB0L*J@F;O2J.VO>)$ R8PP3DB0P(0+ M>(JX+]%6[\B%K\CKW8.;UNCSXSP[IXN+&GUXBU+)Z9ZW9QR%E&E]VD9[5R;4,^HUT^$6)M?#(Y?;]X';V/U3(RO50QIPJ\' M.=M7/=S@O%T$88:@WR%?S 1UO2MC(R=QV?-F\P-I[KR.UFUVFMXW ?R<%=O. M8M]]]5KG$*/?\0\HU/L48((KKW.9O',5"ALTT (A2%L*R!N_8G)&8\EL(]G4 MA8Z#H<\: ]]PAOS:OX7X?G/JT75&#=$%KF25W\;NN_-MD'?'QMZ&?SI*'P?E/Y %KU?5M3\ M5Z3\4_\WN$[Y3T^UR_D/>+U7^#HIR)N>P];AX.A@A]O)[DM=KN@/4C MK=*/ID"T\%P*:<9!86UU$88F+;!DIJLJE%3)E2Z9I5!O0E-I9)D'E2*,HV@8 MEHS+8#+RN96>C%1M!9>XTF#JLF3Z989";<=!+]@G;OFFL"X13D85V^ =VH=J MI2D*6Y:,ER@-5Q(TYN-@VKN8#5R_;_C!<6L.UN F62OUZ((D&P>1$X0"4^L8 M&+V><(Y"."*2\6?'&;1;.N#A>L]^Z6>G6=;,X%R)GSRSQ3@X#R##G-7"WJKM M-]S-<^KX4B6,?\*VZ>V?!I#6QJIR!R8%)9?-FSWOSN$ QN84?U:-)')?NH]Q9355..#M)ELE],KV"U7E MXC99?AV%ELA=2YCNB&8-4?P&T1"NE;2%@87,,/L?'Y*H5EF\5S:+CQ)^KV47 M^E$'XBCN'^'KMY/V/5__?9/"K^G:6$U_Q^_7AFXX!Z]S.L=;CB_.55DQ^0)&B0SBL\XPBCI1%,$#@0PP"PPJS5,$EL.E 8$Y0:/N&5E7 M-^9N JLJ;ZBULF1/ORSH/D3M&JB>*V7W@=N@O6$G?P%02P,$% @ MW0A M5[!3'N,!! 40D !D !X;"]W;W)K&ULC5;? M;]LV$'[W7W%0AZ(%/$N6XS1(; .VYV(9EM:(L^9AV ,MG20V%*F25)S\]SM2 MBNJLMM<76R3O/G[WFY.=T@^F0+3P5 IIID%A;749AB8IL&1FH"J4=)(I73)+ M2YV'IM+(4J]4BC".HO.P9%P&LXG?6^O91-56<(EK#:8N2Z:?%RC4;AH,@Y>- M6YX7UFV$LTG%G4+_R8B5,P+K>"I[ YRQ#3<=]?[A49<7D M,R1*^FJVF/K]2O-'6H!A N&=VWG[YB*.HZMU>[ 6Y#:J:>OWAU?OP2JGV=M4 M!*4T,)G"@H0>;E7RX+@PJMP\UY@[=5H/Q_TX/N]'400_@,(]TYI):X!98(Y- MXG5^&0Y(O$)]7(4:C"&W. =P"0DS!:FK!#$U#4)W[:"W8DEQ HD;P"?4"3=L M2VX@ ZM:)P6U#E"2?%,P[5DM!3,&YN3$LJ3^1*5.%O^7^' P;IA[M3XUS^U7 M:F@.E:5?J3^XJP>$4BGMVUP;OHY\IE7I=TYX:\?(8VGJ@JB.:!])!RA0I,YC M3N9.$Y_>/$E4[3A=9Z]R)55H0"KK[*T$$A,&BYI2#LD+)+3EDGD+7$:VB,M& MU.W>DG#/V!+;1LZ5(A8(M0F\8+62V;E-:88EGMN[9UP<8% MQ/3>[46DD?]6<^WO]9G#JHJD?28(MGOO$_S_PM%RH7EF"T'N&< =:>R7R)YC M724-/URYRS)*&VV\0$H<$JO9(WC)7--/WD7$F$ 5#L>T# M)2?/R6A*/9J9X$+8.(!W9=0[0)Z6"_-F3'X7;QX;-TSG7!H0F)%J-/@P#D W M [Q96%7YH;E5ED:P_RSHS8/:"=!YII1]6;@+NE?4[%]02P,$% @ MW0A M5X]E+ #C" ZQ4 !D !X;"]W;W)K&ULC5C; M;MLZ%GWW5Q ^P4$"J([M7-IIDP!.FLYD<$X;-.T4@\$\T!)M\U0B59**X_GZ M67N34FPG3OMBZT+N^UI[4V=+Z[[[A5)!/%2E\>?]10CUV\-#GR]4)?W ULK@ MS7\R>GMY M3.MYP;^T6OJU:T&>3*W]3CEYU^QC&O' MK_LB;WRP5=H,"RIMXK]\2'%8V_!FN&/#.&T8L]U1$5OY7@9Y<>;L4CA:#6ET MP:[R;ABG#27E+CB\U=@7+CY?_S'YW$X^?[FYOCL[#!!*KP[S). R"ACO M$' J_K0F++RX-H4J-O7X18'_;,Q ' TS,1Z.CUZ0=]1Y>,3R MCG[-0_&?R=0'AVKX[W/.1EG'S\LBA+SUM1\0\,K=J_[%[[^-3H?O7K#T MN+/T^"7IOY*+EP5\_/3E6IR*5V+;YP^V07:7)72>W$I MC=P<"9"(D;%B)XVB J.4*4 ^D:&]\0CH' MXJZ9>O6CP>-RE0G(_VCO536%N%0>R>YDE5"S&; .NZ48#<9O1[UHCZ]+'5BE MDO 9S.2#-(4V<^')+-+YG",9 N$!;EJHS4:$%K;D_1*T,I\[-9=!"=.P;9!V MFOUM&..V%7A+8F00!=8/Q(V!/F,2/RUU6+"2O+2>A,>8]VZ,#EJ6XK:9ECH7 MG^"DB[H+7NYEJ=K\W#I]3Z;GSQJZ4&4A MIBLVH'6:%#JEO6]4TAS7!HOLN:!QV1@YF^E22\I"YU 2,!"3LDPAEQ7T!0]Y MP=G(S.6*XAUX*T3*/*0\M2(TJ,G2,1W$R@%O3<9#VH1O\H!87L>36P4)?\0DE7 M:KR ()OG#=7!6[$_.4#.E5CAK9"SH*(OJ+*Z5)QUB)7BLD'"%0H0^9EJ(V._ M0KCW+P]ZOD,!A^79Q9G8?S@0.IJ(4@X(96T=.H#!JY7HQ]OO2"UG\A9X$L926-7@ABO$NE[4.LM3_DRFX3F%B MD&;]P=::KI)+_5TE;D# QT/*",.LD"O?HW+2AE\=#5^MO2(3M2W8'V5RQD80 MI:(PC$Z&O#L%?U?TH')_=;H(E90]8E3/W1Z"+MKI2;4]DD MO]J(/N0+:>:*A%O(0;Q0>R4*@0M-1M0S'42>\<0R$N76@CD"_HZDI6+OH:S) M/WKM:-Z@DN@4X:EV+2HA9"/!%-9<^@42I5">FO':F58[C'DNK :@$%L!X]:M M0+<(!9J)*AF4MP#YZF>](]$#B+$QK @W]:-(0R():VMQ7>\7C]I[I+UM&)FH M&^<;&3'P-#45JF!J'?7;IF:8K!,SJA]E42,SD7:XR1Q%AHYA MH9$@1F-;VHB0Q83RV-\'"7[@?@* [8(F:S6*3'/4G-J2=O3T 8IK+N^ MU,A!#D)2Y'<",&[8!O2]F5*PY -^>RZ!C3&B*;Z.L,V]?(EBI,+EZ+1],2P0 MTN2-4#2#"TS0JIN@.2!4BSS.U"KUVFP+UG]8(LI88.M^I1(Q1J4;%(90\G3 M(LW5\/FI5B8SPKJZYR&&.MZ.F:>PBKF,9V#5^=]X"A%A."&T\_)ES>3FSV)' M=6/LEL0T[F\*ZW+;I C^1#2WEAXG_+'2.(+-4\[960% %\6Z;44$DXSF&QZ8 M".^N@T>A/?$@[XL\MS?*3H;M":Y'6S;, 8KO%4^)OVP1&8(.G$X5@E/939=[ MHS0QM@L25KKE'$)T4T'@"#I'J-(PL/OD(JYY5.\(#_]J;A'M6+,(2\75[G>B M,J/)&,#/XJF ZFNJ%*I-T6:X6#"AH J6F(N",K%/D16@U G,VQJ?/TKI_'@\C+4D&+CFB:76-_BV\6_TH:=,/&U+(U\K#9R_ 5'?SF<< M6YEF@C88O:,8"P*']NL&TGA0DTFJ/7D^X^H U5 K3);4A3!=NG04>>R$/ _H MAU_IB*FA#GOT8&]TFIV>ON&7>T/ZZ^T=G63'XZ/-QCEX[D//X=H'.#X-T&=& M9DX3XK>X[FGW)7,2/^ ]+H^?03% SC5JH50S;!T.7I_TXZC?W@1;\^>\J0W! M5GRY4!(\0 OP?F8!\71#"KKONQ?_!U!+ P04 " "W="%710&S_Z,$ !% M"P &0 'AL+W=O&*VT>;0[@V',AE1T%N7/E91C:.(>"VZXN0>%.JDW!'2Y-%MK2 $^\ M4R'#?J]W'A9X"\!*]MZ9I1)I/4C+6Z3 M4= C0B A=H3 \>\)IB E 2&-WPUFL E)CNWG-?HWGSOF$G$+4RU_B<3EH^ B M8 FDO)+N0:]^0)//&>'%6EK_RU:U[0 CQI5UNFB<<5T(5?_SYT:'EL-%;X]# MOW'H>]YU(,_R*W=\/#1ZQ0Q9(QH]^%2]-Y(3BHJR< 9W!?JY\?3^[NYV>7]GR]O9]YO9]/9F,0P=AB##,&[@KFNX_AZX__0 WNDFWU./=_I_\F5_3R+K#';*/[M2 MKY$'NY'I]%S:DL6>7 M!<\,U'F@"2):D2G$*XW =/ 5_JZ52%/PMR%+2 !D=JN$$TA_7D52Q.P>#0RE M9>!W)?P3^4UU4:+D6XI UWN<,PMQ91 !ZX#?"=RT')7_).IP,=^*_K95M)(O MC*>$U-(* VS+.I7<6C;IM,O[N;NC#S%*B\@N80O^2 U!CRY'M?#^+K!6R .> M8UDEE*C-M7&41O&J#IV-J>_:MAS[M.BBK(PGB2#_(^^R)IQS%#\&X_"SR3Y^ MN.CW>U>ER+*7XXC'C_[%R=7./E@)EY/ )5;P7:]8A_6D%L Z",K95I'%$C9- M@0J6$ES3C9Q=5Q;O!107,XF$JC&H=YM8'IX: (A\9U?Y6^5^VPGMCGVHT&!P MT(PR2V\C'V(RKHC/!SBJT[^U5"$7#37&$XC%D,(!3&H@C"WS&J MF7%\QJERWY225;$'#TF&Y';+#*Z"NM\Z@J2.=9Q^6;] MKM_;FRMN7QU&3M,3^"Q2H MBUV3SF;MYL9<5*/1EOS M>L"\XR83>#E+2-&UU_UR%M2MM5XX7?I!*=(.QR[_F..<"X8,<#_5VJT7%& S M.8__!5!+ P04 " "W="%7?$/EY?$, >*0 &0 'AL+W=O-!GH\'H> >]XRCP,=$[_BZ! MV7_/Q\9J\)7_;9+=D3[93!KCYY5I>"[>]"! C-#WHG?VRT_#YX/3'8R?1,9/ M=E'_#DOMIO?'Q]M+]I(=L)3P+S^]' U?G*[KY1J"16@M"G9C57X'VVYG@KU5 M59&0>-,#5A321DB-!"VAGCK.&: MW?,2-L&:GP>'L&G(&J'=SD-V3IO!&41T!L;K(GLG#Y M[ 'QV5;Q+[Y#_.&H_VR+^!<_1OR+[Q3_8\W^4/=>4B<_R&L3D<1D C@/9#@; M'HY>#?T)IBFEC>0RR$K&@MYD/76DM['6AX1C -AQH:SII)M&U08(S4 HO,TA MI4RG6DPY,%S/B3>@]KS_F]?A>S4'#-3LQNL2R7#+"EC_)(/"X<#H O_IXZ;% M3()F.BR)LH"#3TY2XZ'6RF4V:VU ^MILSK)D,WXO:(G&1(;F(%,H)WU,HT"G MD!HN%!!MM(3C82DNN9@;@!B@#C89RYKC\D>$ @]>\!/B#_BQJJI0'TP#B[, MX+QI*5A.>S#%EV4&B=HB+3,?5]):YUC&%-* ! M\>=<(D2-EZSDBT-V50-#=>U50-Z/A&0MK>3E1LG[%'$/QA$(!J&H@&N9 _M+ M/.=>: NT@>_-&K.D;@NU$1+F6XXGG]>E1&71CDPUP8*XWRF@3WK#R#N *#G M"(0B1YH^*O K"$SJ*[Y")0*EF"55X.X<*B'GS[PH)-(%/>P&360I0\W:Y0$D MHSM, 2*?:]@MX#R,1L*A EDOA*C@E[\!(8AV,M&->07!94WR'.]>>7ME MS-E'P 3M0K4 FY;<>P/Q7RKTGET*I%C WZ@_%W0/F!,>@ST[%G0[LNUY!#:, MA=?-\,<<>"M@$#M_'@W^EGG=00<2U:@L.$S+>Y>!SL&I MLHEU\B/(/Z4(<;7- 9MR;C;*M@$,MT7(KN!8!:?6I;/$I=E>#5V>%WR#N3;S M!#CHC]MU3AHZ^WV,UG+NT^0RGJ ?(UQTC^"%T+%YV]084Y 'C0V6MUQ#0L"E MH&"XQ[/-6>@+UYHC8!P\)?-Z,\;-%8?P@Z2*$2N^"9U#LBBHNN $*IC/X$^&N,-C,W=&EP8T*P74$YAL5MGU M9X U([ND6.^ZB(?$ZA[?!U5 8;*$LR9X<]VSMW@4LK8WWH?2D56N[YMH5:TB M[ YLWL&Y^-9 $F83A*LEI++',)=:/MPPBE\40H*4:AL[%$0?7/G+^,YI8X:E'2/GN@P$+;4;/@, MGGH4687"QQ6+'?O-477@>^B\*"H5]UIP WD O0)B0VE+)IQ(9,V!@9T!>\\' M*ZQ,5%FJ!:73S5"'CH 84@AHAM!.,?3ZVR'B:4B0?0\2D&LKAM-ARS$_;\ M]F0,@-)?EMV#?+) '](BUBP8FQ:5&@LW*A?'"O4BTXYX \JXIBFV63ADV(CB M&*FEI.J=>BEG$FR'VJ" >@A\;.K!G%Q46@]3^!P9*<2$&LJ0TW 6-QJG/OAN?#DV? EI>&^X'RS0!?VN?T(9TV?$ :BX#MMHE:JOE<9 MN)P^Y7'TZ :/79+M>D(ICB]09.6:/U_P MAH&WFV0M-(Z,,#]83[JM&2E!H0C'@X/""^6U#2=+16Y%0\L #"Z63FE.'46; M]&,]S_#"5>+0T6C1*.I7#0?)HVQ;(8I:8-=4=:R4Q0$L%/:FG2Q@&9(,17'" M0U>%O,?47!@$ :6GO)9_\0 *.6\D-,C^CHFE2BGOH/VGS@=L/!I0&P(VS2A= M^33&457^ 2H[Z$DX\_LV!);J@G66I5/%@KLA9#OUC!&/3+M>-I@K2XQBU8HA MS%,BI!L861H8K!,8@R<&1K8>&&PU,!8_(B*& Q(DZ #R+=JY: %Z*FS;*FM29;J7+EC68%T*M:'$VB#$9%)$9&D10=5#27UN M4FP2TJ-G^N("WS&T!8;KR58:-I(QY15?1CAMKOI'4K7J2M,U@"-U/WDYUBIOC!_R]#=* MF!;;G;HC-)?K0_4V;65$F%RG:X%#=AY?,97+?J=_=R/0Q&]7RGP<>-/LQ<_2 M-G"]YOJ=R/.#1K&M\?:E3MCO9Y)?9%V +*N#G3!R] W?!.+39/3RUI.XU: S M:'9R?+O57V_&-J@Z)%NDCTD6^TLBO#;I_@"Q, MP>ZGR#ZO7,>\\B7-*Q@9])8U9*Y5R@F:ML/WL2!T5>5#;QECM!"$V0?X"9[Q M\)1U=7S\$&4M0@@",M0&F'.U)QPDI\ZO?7YP9] LY?'C_^[8*YF_!BPK924Q M[ITVL/@XW/3UTU'RS1H!$7Z9AQTU,.0^7XMWX\=_Y^Z;MW:Y^W+P=ZZG$FJ< M4DQ@Z^#PQ;.>RZ?APJJ&OH ;*VM513]G@H.Q<0$\GRAEPP4>$#^)//L_4$L# M!!0 ( +=T(5<5N#2"\@, ,D) 9 >&PO=V]R:W-H965TL%N9.;C_C+IYSBY=*H=TW;!O; M;N)#6FLCBYTS*2AXV?RRQUT>#AQZT2L.\PG,/M M?+&XFGR=P=WLT^SZ=GDUOQF$AHBM>YCN2"8-2?P*21>N96ER#;,RP^RE?TB" M]ZKC9]63^"3@E[IL01(%$$=Q<@(OV6::/H5OU]+"$-7^"*:SCZ:SBGTGW6F)TF.AW S7\Z@#Q_@ M+0E=Y@A3652L?'K_KA>W+SYJF JF->&DLBBHAJD:0 M85&Y*E>V"C68G!E@"LF1^D>&9 %&P@J!&I/= +DFHQ\)R=XHJD)69IZN5_]0 M\[".UE2F::T4EJES7M=6 ^ #EM05#\4#U\!JDTO%_VUHN=8UPD441)'[@,Z9 MU4\P1P/<1[-2QXP,SCQ8VQRLFF+T S<"D@U9(-R;E-IL[D[44-.E( M.1A&<)?>6XCI]OZ0:._,BWL=2G _B-I][PX_%,@T74*:D<8&G#*EGBQQ'@/=.O\1Q%/3[YT&OG<"O;PWBY:T^@VXOH)*AK';A6/L-#\9K M@6KC7B)LJZA+TTS:_>[^/67&%FY M8;V2AD:_>\SI70N5-:#_UY**=;>P!/NWM]%_4$L#!!0 ( +=T(5<@P>VE M4P, !(' 9 >&PO=V]R:W-H965TX."C]9$I$"S\K(H5"'91B'SQOW?%=: MMQ&M%C7;X1;M8WVG:17U*#FO4!JN)&@LEN$ZOKR:.'MO\)7CP9S,P2E)E7IR MBX_Y,APY0B@PLPZ!T;#':Q3" 1&-'QUFV(=TCJ?S9_3W7CMI29G!:R6^\=R6 MRW >0HX%:X2]5X._<&AMQ],0LL98577.Q*#BLAW9SRX/)P[S MT2L.2>>0>-YM(,_RAEFV6FAU .VL"2X=(>RM9K^](PGY]!_YVS. WWY^V$#\0C^A->2 M\% B%$I0B7*Y \M2@> 526N R[;X?16E5-E@R?Q:5363Q[=OYDE\\S2VZK((E9)XI.IU@:%H9$XR-3P.MT.*Y=-S/.$R]*?2I1D: M@PZC;@C*-%GI:#KP658DGOHVK[A@-*I&.Q>KR,&BIB:$/CVGAU@ ]Q)[ MN<.7[G]TTJO!9W>CDL# @MR'0TOJ+_J MM@.W"ZMJW_529:F'^FE)CQ9J9T#_"T5IZ18N0/\,KOX%4$L#!!0 ( +=T M(5>\.%UKD@0 )4* 9 >&PO=V]R:W-H965T[#S7V0[76L0Y:,),?DW]]* M32( MUH);OLBM$_3&HY(M<([VOIQI6O5:E)07* U7$C1FY]%D<#H]X8%C;3;> MP442*_7H%E?I>=1WA%!@8AT"H[\E7J 0#HAH/#684>O2&6Z^K]$_^=@IEI@9 MO%#B;Y[:_#PZB2#%C%7"WJKZ"S;Q?'!XB1+&/Z$.NL,_(T@J8U71&!.#@LOP MSYZ;/&P8G/1_8C!L#(:>=W#D67YDEHU'6M6@G3:AN1I9@W68O:2"F 6+X$XACN%;2Y@8N98KIMGV/ MZ+2U< /: MT>MH;DI.3 2R8J9C&EB8P-/E4H+0GI:8#)%"A!TC _/ 9LSBRH)*FT M)@.66=0D0YH(P62"$$Z0E.!(K%6UR/UV(Z T0<8E:7(FP%B2%L[/7HT:@1M3 M8=J%*4U7"E5)PVIS;FCFEVZL[0;GE*<@E06>DCG/5N"$/]#O #XG6%I@QFD3 M:.Q.GTZ(HE:52"%G2R0/3Q7W :7_T:PY3J T>3&)4*9RW*3W_QKY+MQ(^%J) M%0P'H5<[7G=V>W/SJ;M,8#Y[")(YA624[OBTYDJDJ VHS.W) SHI"5.F7"X@ M47*)VO)8H"?NM1Z48%9UX$HF7=A__^YD..R?!:%?#,Y^!^*#+@XNK2(OP!8: M/4LZ3FS>0$"=DU*\6B]#WCTI0Z2"'1DN7-%4MO?;H-_I]_W/\>#4%W/4G%A- M#@8PH^,3?3?,K4H>@0"_CSZTT4L"?,8FU8)2#5LI:UMR*PR85H9ZVQBW'U,% M_#D^68>VMT_EY99.PQ75%QC)Z/SI4#N4I? :A$355.1!UYQ:L% ISSA),ZT* ML/1Q\:SI/]!HC]M+T3>I0.900JP-5RV8&>: MLRW'K[=-%V:5-A6C-FFJ1^DOUJWY1OJ=JWBMD6QHQ&AK1+D5@PM\W81<"%T3DV:9#HI2^!.6AN[MC+;C$M#:&?X.RX8I M[NQM4+[;\-Q6][7/46_CJN#SY"Y$SD$E;;@UM-+VSC4)5XT7]7!ANV;49A2H MP(Q,^]T_/D2@PR4H+*PJ_<4C5I:N,?XUIWLC:J= ^YFB(ZY9. ?M373\/U!+ M P04 " "W="%7@B4\]8H7 " 2@ &0 'AL+W=OOF%)\4E(51)$424F^54FRG*-3L>.U[)/=VMJ' M(3 DQP8!!@.(4G[]]F5F,"!!6K%3M;4/B4EP+CW=/5]?H9?KHOQJ%DI5XF&9 MY>;5P:*J5L]/3DRR4$MI>L5*Y?#+K"B7LH*OY?S$K$HE4YJTS$Z&_?[D9"EU M?O#Z)3W[4+Y^6=15IG/UH12F7BYE^7BELF+]ZF!PX!Y\U/-%A0].7K]7[[_)"ZOKW_[_/[3[?M?Q(???KV] MOKVY$X9KACFXEX5^35PHB;/%5I>_X)D.SI M'CJZKX9[%_Q7G??$:3\6P_[P=,]ZIYX/I[3>Z8_SX;\OIZ8J09W^IXL/O,VH M>QN\8\_-2B;JU0%<(J/*>W7P^N>?!I/^BSV'&/E#C/:M_OI*&FU$,1,?<.V\ MDJCX741^QS+BTT+!'4J*Y4KFCSJ?BSJ7=:HKE8J9SF6>:)D) X,57-K*B(6\ M5V*J5"[@I"M9PCB=TPIE"J,5*'JUH.]U7N%ZJU+#(JM,&3%7N2IEECWB[VI5 M\=P**/BY#-%XN5:D3*0Y__NE\..R_^.7R\@-]'+PX$H!:,+&"$N,%[P[ M_D]\@@OA88?_Z;ZQT2 #**$H7>$Y=$!GS,'F.< M]2C20L 1W6$$G,R*PW,BP@T=*XS(5:*, 9M"NTF!.IHI8-(JU%\@JB%@51B- M3V,@Q0" $\U@ZDH^08R'3J19B!F8+=,3MZQ]Q4KG=BW\>LV7 :4V.'MA )=S ML&3(:CK*MVZ(I%T!R91',L$G*VEZM2B5HB=&/X@E ZA" *5)D9\4LDJF7\!J MT :Q6"]T G>L!,IST _830K6%BLS4- 2[UXN*U"E>(N5,ZG+AF1W[FT^;G!D MY]$T'+N3X_1KP_%N'D1;//"K]PB?NI=^(C\#2H%AJ(*.&YKN5@HP@RZ$.ZO; M#*["5 GUL )'0S72F]4@C1E<4V#3HY(E[H2L?@.++J>J%*<#NQUR&G@VJU$& M_K8 _;I(>WO,PMB;A?%>//]LB.8;4^DEPF:71?AK*Q"S&4PZ+E>@XIJ !"^N MKAX99S[?,=24ZH]: P^_<9.0O4OY%1CL-T<)2@-^Y,IB\T)6D9S-@/]6,(@N M( JY1-M"Z@#C5<53,RVG.FMPN8%2' CD(C#ASKOF\"XIT+)](<+K#?-VD8/: M N!J1%K3_6O&D25DT8MW\BM^;4[N>=;FCWI09:)!1D;/Q,25/!(M(4N9R"4L/U-7J:*6(A$>'V95$J=]M0.S5H)[+Y'FEH6Z2H(J\'#IOY M^\Y;I1HX4X8K .'*J#G(,T,Y%:AP_/(,D:PM2 + M3 <_ 68LT!VL2Y 3>A:,G(3ZJB&$H#QRE*0Z)2PFSX1(VQB^T]9L NVPQV=> MPX1GP[@_O(C'IT,:^FP0GXZ&\>AT'*P6[5^-7 ?$?# )V>,^*9]Y*9_M%,-0Z" *PQ: S_"B/#@>3(PL,44.R MU\;+I(JMMK5T;' ^!DQY]/I%;EN+WAPU$'S*I2R_XN9UGEIHXF$X8O0*KP1&I%4L:,$&EDK(H*$8Y6JF/7$[ZC_'?8NTAUR MPG%M64D"K"?RGWWF9EF:G(%- [A"2 8^E#)EL;A9NRD4WTGA-ON)LFB3,G!% M"T#2/]E8--P$,-BBT@9MWQ(S+FLC *2%R9W*C$(>3GFUMG)6"OPT,M$2+-&V M3?X%HC+K$X#Q5,Z=Q2$6_55@AH+5BQD:$S32S4&T:<5L.9 TQZBOR#OYW>:U M%4 K)F^YZHT+S-ZQ,TEI0);9O.+[9>MT'M:H#6XH[Z7.Z 98W@=A&IC2*GH" M+L>MT&$A 8\GY_%D,([/1V/&Y^'Y.!Z?#^*SLXLV[L9"=_-JB_Y]"'WN$?I\ M+YS^AC8?CWU=&+(\I@ 7!CEJT>E#/W?8L-H0^*)>^1R&=1B9 M-2#IMY=W5^+R[EJM.,7+GX%,8R"3SZ[0CJ2FI MTVC$N^(E07"&#R%Q?%VZ%TN:Y(T+"A[)I8"1=<).S;,^:B"J-L$L90+L$K 7 MJ"\XC0AT.4LU+=6:(V-,(;O4RNZSB$,#KM5[3 .='>U3ZPNOUA??\!+@5'!= MY$-W"8GE"*8RE6J$4H+4"5YFP-L@"S9"&#$ MJIK@72/>M=?IQG#L@A$[K"1*##Y04,.+?Q A_7]L9 ;V901@?(?3]Y>V/=O: M]EMIB#R-=FW:L0E')*8Q0V@,ZJHH'YLQP.OAH+=U\JZ<2 =R,S$VF&(C9QS6 MHC6Q*564.AE9:W.])B,9-JC^U$)\6"4%B&+/I$GS"IOFQ=\1,C"'9>6_E%^* MTD$+KOL%;*I)=<*&)UP>C*RIIU\H.U $NL743M%K^(+08+ MEZ 9QQ2T6Q9#NP>YM*X=1N(^[RK^J-'$%KF+Z,'S/&)7:I')LH]2' MVEIAH@Q&PIQ[">X&/-\\FDV4$= WN=N92M%'93DBSVA>)M>F6T6# #LM,(-: M5!$GL)I,0%54N**GN\X#'PV7GX)C/-,4!V84^P&"$FY;]P?=4G="6'*MLGM_ MQWKN0I.'EI1ZBF)V7J!UFN&719$Q3DH,(C!'0T3+JH(I-9S39]NVTPFMU7"- M< 4,-N1#Y/*7R.BOBK(9/I''T2D_QWPYWR(%X0=HPEO:%P-]SP8>WS IME-\ MCG2)WLA4;:!(9+=JQ7,"#0-%9555 0JVM9TO[=!1"UK M\BI!+!CH()B =989:7:I,FG/N%NNT@2WQ:6L:$>@?ZTH2;IO>HZ1N\]Z.8I\ M1=QV'U' 8?) M,_ 6;$:*R)89Q9A.Q^$.WVN6"H$MGM9)^6G8T\:0#0P2>S'H]X4&-\9='X^; M<$(CYQMY.TTYDQRS5]X$(/]7=0GTLO,O\R;E7!;WVE""3UMD(#"G.39ZH-1; MGNI[G<*RD.:#LHCY&^=UP:I(EV8H9=*F4ID6UTY^+SY M]-'?[U#6!'X)Z:^U13AB!?X0L +K>S T\<6*3>S;$9R!C2Y+B2>9V7P\>X:[ MAF,Z%,M,#ZW"(E8,D1]'<6@ K"8V%%YA\(0)L>L@2^!SPBYQ;/.._K(X]4'E M) MGL%_X^-3F\8E)#;>9=.D:\B!BN18<^8$\]L[!8B[+D'&*: M!X+N(V&5PJ,8T(D_6N@Y$F :< >2X!H3XVXGJB2@G4$O-%-! IG$M;%.)%>D M:78R953 MECX@(M5$)XW<;592"<6F_.WUZ)=U,&GS"*_I#9^CH^80OE-@6)U MK]@1"J7%=J/C2&PVV0/7!#]PO6%_-#K(!2"I<(ZWC5'H3C97VAW372@&=403 MTC=LM?%.BZWMN:N7X^4%(X_PERSBKBM<^RP^^F)(N1,SR]A6>5SX&ZBDAZE& M^S92]. [%/5\L5$BW!,I#?I-OTQ_?_X<4VCBDHKX6.ZOBN2KN&LP_H,KJ7P$ MGXPK5)WM,D_;)>%=#.T26!)?N"G]+BUUL7)E,$,>?\^"._HBYK7F)RH'K"NM M=,@BC<[[/%(N(?92$K*($!L\)05S#@7;BM)>.U*4^2 XOIJ M23K5.N\A.^HNC/?/2=%GBFK@(7$4C]M[@!9,:3()068;JX5ED;G<-;JKF$TH MPW,'"Y)31XT$">-HHMBU3FR[!]>@R(DQ188.8K#9EB7CS8^Z4KNP8U$B=F(" MJ'K$5!R58L"4)>LPG,G9/#.5THJONJ,+J6-1:UK'5G7 />X-: M'SJ[@3HSR!5UA;_O-.Q6%A0$->S?QVY;!.RJ_'$$O9 E>TG?N#_1COM#9MR' M4)C6!%KC_F#BTIJC>#2Z@ <7&^GJ#AG&FPSH$A /%8=64$>8;>YHT/!,:^7# MJ4C\9/<;+A.6DI6)\&C#>#3HPV'.;(8M/IN#?A2X)4]MP.A(\1+MWX-A M'%:V@D??(>.[F)KQKN@0GH]SE:-!/+ZP#1=U(-[1CYT5;'(2T<&MEUR%E@ EJ0&/'M\*U* M*S#N#[;;H54%:I55V&4M2ZIY>)?\>WC('@-;,%B_Q(R6Q!H,!J>ILRG@ENKT M&(?(E<:TR*'EKGJHB.VN"G)$ 6--30KHDO,MY'I[!SKN=4F"%M[!7F?A=QNY M=/H93YNZVWGP81$@DK5_C#''@;5 Q]Q9[?!Y8\!-X*OEE 0TQB9B**RPVWA< MPBN"P2+U;]B6G\89=P$R]V-YAZ3Q0F+Q1AMT,&MM%J@DOP8-/*28-Q8H;7!B MY_GB!K5XPK/SP1C6 MV_I[V8DG^J=(Z+AI-A8-.]^_%"+ZIS'M4>NHBA!.;6+41N7.W]M# M$XI!FT .#F1:G6$;=/%A,Y3D#"@!!.I'T ];V<+/X:\4K\')O,#0;>I$HQ]==#NGL2Y8[&RF M0W"-NPU"@\57;2QV6P>U?4I;+:AC&A0$\V<2'-%JK6R3Q,;N["[VQ'M5;02S M*])9WHS.X8-@=G8IGT:-N%M3K2N\IO=+5'H,@BXQT0?!UY0JEZV%3:@Z@7\2 MN?Z%3]O9GE1G=1!B!R0SK1M\I<1@A"&*P[6-3L&6-E/Z-;6-H+EU1GTL>:B/ M=KD:@D'J4,,0RN\1!L._F4S8P>#4*)MAVP"YO7O8T+DC_-J, EI9Z(@=TM#M MV6I)(P:B)0I:.[!KWD$5O2UBHB;K'#>Y0/0!I\T)R);"%! RBP0K;9OJ"^M" M?,UZQ =2LL2JD]G "3J,M$Y.[ 4=*AFINNC64 HR)%X),M\@G"?-=#E;BW5- M4-,3']LNXD9[0_0#GK!ZL'TT9-T]/QHMMI7X+7]XK\O))6RZ0Y+WG.'[9*8K M:FV#HO)#+B)629+B.3A]&I5A:?EJLO1\^BMW>$3 M[6!?P^IZ&-UL;]?Q;!@Y3]:BJ)>80]6K34:$:N-)C-YS]J@HGT=@X8K$,W*+ M;=&SZ *\BHOQ!7PZ'8_BT\E /!.'@^$HOAB<@@["%PA.A\-S<12]47E!M15< M>9L6!Z3" >DV;D80HY^?CN/AV22:Q!=][B\9GL43^]$_W'_6320%ZON]_MC^ M T23'1^^:#YY:=V!%FS("AY%_P\DA8F <3P83^#SV>DH'@WQI(>CB_-X-.JS MK%!PDT'_[Q$6Q-23BWX\F8S^?F$-!O8?I!J$-F3Z^=,^1ZIY[W"P]XW U]<% M6"&T$(ZGUX!0$#)^U.9KIPOU_T4"&8VI?#6-C:\452TPN3Q M;0[F@_SMZ\(J!>6?QB1C2G1^1\\AYURQV%5J] N\"T@>@S;N-'N]Y^8]S<'^ M-RS?HIGYM\M;-&*Y;<32*?L?7E6\;8J8<"@*&FVVD5VLQ-47J3C.!48%K@W7 M[8W,;%W=-G1A+5EJZB, Q]))!R[0F'27(#(^=*V]91K/UI M;/[+*_^63>@M8,#4\^\/8;@,#J-94.<(V<]C\+S*L$Z[@.^R3!:/+O2#$U)A M_4\;_>D<7' LG;.+RKM1&]J&(^!7$G-* U3T;+Y0W+-84$LZ=5-P"@[6^Z,N M*@H<=,+E4WX#W9[6EF:H?(^OB-F^J""3@E[DX:_@E69B$/+!UL:0 O!-M@DH MIOA>L:VHT?'L*J?M55P[$S+-]R$_CW[^Z6)R=O$BLCO'H9)L+XWE/?RE?=C# MA@U'&^<,D4>[M_(=3UYL[#YL[6ZWM"4,;)S99/'&JG!V=I_ %QX:VK4G'[W.ELD4R,++?Z"FG?:G#EM<:9+Z+[&#*I4 M9?3B4UZXJY9B)$MO9W$7&OBU1>F2/=RSYBKUH%,I;EFLN"B_SL.7[V+/,=\ MB+!2,F2@*]XT!E8J6>0:F^3P-C!QX2M988.(DW7K#2M[JU-3H/#PYO:9K MT):W7D6+MVXZ%B/Y)H1@L:3N6WHAJ5)SN%!_VK $'6WJK400RI 7/L[JPAHD M(^+>,)1Q0$.X68!K&*0&6V)#.[[;!NPO%55!=V[5)%4#-" *^;RL3=B$%##1 MIJZ[B=EKWYH73@?[WQ=M$J9_P;C]V)*MS)!BI;/M$MWI5-)K^S8#]BF1'H<# M^'V')O/+@3G7#;FH:6_K']@1,:.7GM')2+'F$T[LJ*-CHI3[YRE=:O/(._+, M-J_,38?-PKO.Y0#$>BS6= -Q@6&);<[8KQ64VNFE%&U]02SQE"DG/XF701,4 M:]VE>J8AM',C7=I4NJX(49L=!$'RV^VT 1OUG:\V[*1CJ8^ MVX[#F:[4]);DS2+P?NSQ6^P3S%!7E]4F'[NO'@S

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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 131 193 1 false 29 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://proof-paci.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONDENSED BALANCE SHEETS Sheet http://proof-paci.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://proof-paci.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 040000 - Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS Sheet http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows UNAUDITED CONDENSED STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 060100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Sheet http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Notes 7 false false R8.htm 060200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Sheet http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatements RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Notes 8 false false R9.htm 060300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 060400 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://proof-paci.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 10 false false R11.htm 060500 - Disclosure - PRIVATE PLACEMENTS Sheet http://proof-paci.com/role/PrivatePlacements PRIVATE PLACEMENTS Notes 11 false false R12.htm 060600 - Disclosure - RELATED PARTIES Sheet http://proof-paci.com/role/RelatedParties RELATED PARTIES Notes 12 false false R13.htm 060700 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://proof-paci.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 060800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://proof-paci.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) Notes 14 false false R15.htm 060900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Sheet http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemption CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Notes 15 false false R16.htm 061000 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://proof-paci.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 061100 - Disclosure - SUBSEQUENT EVENTS Sheet http://proof-paci.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 070300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 080200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) Sheet http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) Tables http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatements 19 false false R20.htm 080300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://proof-paci.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 080900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables) Sheet http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionTables CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables) Tables http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemption 21 false false R22.htm 081000 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://proof-paci.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://proof-paci.com/role/FairValueMeasurements 22 false false R23.htm 090100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details) Sheet http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details) Details http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern 23 false false R24.htm 090102 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details) Sheet http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details) Details 24 false false R25.htm 090202 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details) Sheet http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details) Details 25 false false R26.htm 090300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) Details 26 false false R27.htm 090302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesInvestmentsHeldInTrustAccountDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details) Details 27 false false R28.htm 090304 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details) Details 28 false false R29.htm 090306 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) Details 29 false false R30.htm 090308 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details) Details 30 false false R31.htm 090310 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details) Sheet http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details) Details 31 false false R32.htm 090400 - Disclosure - INITIAL PUBLIC OFFERING (Details) Sheet http://proof-paci.com/role/InitialPublicOfferingDetails INITIAL PUBLIC OFFERING (Details) Details http://proof-paci.com/role/InitialPublicOffering 32 false false R33.htm 090500 - Disclosure - PRIVATE PLACEMENTS (Details) Sheet http://proof-paci.com/role/PrivatePlacementsDetails PRIVATE PLACEMENTS (Details) Details http://proof-paci.com/role/PrivatePlacements 33 false false R34.htm 090600 - Disclosure - RELATED PARTIES, Founder Shares (Details) Sheet http://proof-paci.com/role/RelatedPartiesFounderSharesDetails RELATED PARTIES, Founder Shares (Details) Details 34 false false R35.htm 090602 - Disclosure - RELATED PARTIES, Promissory Note (Details) Sheet http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails RELATED PARTIES, Promissory Note (Details) Details 35 false false R36.htm 090604 - Disclosure - RELATED PARTIES, General and Administrative Services (Details) Sheet http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails RELATED PARTIES, General and Administrative Services (Details) Details 36 false false R37.htm 090606 - Disclosure - RELATED PARTIES, Related Party Loans (Details) Sheet http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails RELATED PARTIES, Related Party Loans (Details) Details 37 false false R38.htm 090608 - Disclosure - RELATED PARTIES, Consulting Agreement (Details) Sheet http://proof-paci.com/role/RelatedPartiesConsultingAgreementDetails RELATED PARTIES, Consulting Agreement (Details) Details 38 false false R39.htm 090700 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://proof-paci.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://proof-paci.com/role/CommitmentsAndContingencies 39 false false R40.htm 090800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details) Sheet http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details) Details http://proof-paci.com/role/StockholdersEquityDeficit 40 false false R41.htm 090802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details) Sheet http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details) Details http://proof-paci.com/role/StockholdersEquityDeficit 41 false false R42.htm 090900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) Sheet http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) Details http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionTables 42 false false R43.htm 091000 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://proof-paci.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://proof-paci.com/role/FairValueMeasurementsTables 43 false false R44.htm 091100 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://proof-paci.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://proof-paci.com/role/SubsequentEvents 44 false false All Reports Book All Reports brhc20058310_10qa.htm brhc20058310_ex31-1.htm brhc20058310_ex31-2.htm brhc20058310_ex32-1.htm brhc20058310_ex32-2.htm paci-20230630.xsd paci-20230630_cal.xml paci-20230630_def.xml paci-20230630_lab.xml paci-20230630_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc20058310_10qa.htm": { "axisCustom": 0, "axisStandard": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 450, "http://xbrl.sec.gov/dei/2023": 39 }, "contextCount": 131, "dts": { "calculationLink": { "local": [ "paci-20230630_cal.xml" ] }, "definitionLink": { "local": [ "paci-20230630_def.xml" ] }, "inline": { "local": [ "brhc20058310_10qa.htm" ] }, "labelLink": { "local": [ "paci-20230630_lab.xml" ] }, "presentationLink": { "local": [ "paci-20230630_pre.xml" ] }, "schema": { "local": [ "paci-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 327, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 4, "http://proof-paci.com/20230630": 2, "http://xbrl.sec.gov/dei/2023": 6, "total": 12 }, "keyCustom": 54, "keyStandard": 139, "memberCustom": 14, "memberStandard": 15, "nsprefix": "paci", "nsuri": "http://proof-paci.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://proof-paci.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060400 - Disclosure - INITIAL PUBLIC OFFERING", "menuCat": "Notes", "order": "10", "role": "http://proof-paci.com/role/InitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060500 - Disclosure - PRIVATE PLACEMENTS", "menuCat": "Notes", "order": "11", "role": "http://proof-paci.com/role/PrivatePlacements", "shortName": "PRIVATE PLACEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060600 - Disclosure - RELATED PARTIES", "menuCat": "Notes", "order": "12", "role": "http://proof-paci.com/role/RelatedParties", "shortName": "RELATED PARTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060700 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "13", "role": "http://proof-paci.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT)", "menuCat": "Notes", "order": "14", "role": "http://proof-paci.com/role/StockholdersEquityDeficit", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:TemporaryEquitySharesSubjectToPossibleRedemptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION", "menuCat": "Notes", "order": "15", "role": "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemption", "shortName": "CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:TemporaryEquitySharesSubjectToPossibleRedemptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061000 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "16", "role": "http://proof-paci.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061100 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "17", "role": "http://proof-paci.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "070300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "18", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)", "menuCat": "Tables", "order": "19", "role": "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables", "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010000 - Statement - CONDENSED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://proof-paci.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "20", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables)", "menuCat": "Tables", "order": "21", "role": "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionTables", "shortName": "CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081000 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "22", "role": "http://proof-paci.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details)", "menuCat": "Details", "order": "23", "role": "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "shortName": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090102 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details)", "menuCat": "Details", "order": "24", "role": "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "shortName": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN, Liquidity and Capital Resources (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "-5", "lang": null, "name": "paci:WorkingCapitalDeficitAmount", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090202 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details)", "menuCat": "Details", "order": "25", "role": "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS, Statement of Changes in financial statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20220401to20220630_RestatementAxis_ScenarioPreviouslyReportedMember", "decimals": "0", "lang": null, "name": "us-gaap:OperatingExpenses", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details)", "menuCat": "Details", "order": "26", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details)", "menuCat": "Details", "order": "27", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesInvestmentsHeldInTrustAccountDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments held in Trust Account (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R28": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090304 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details)", "menuCat": "Details", "order": "28", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Offering Costs associated with a Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20221231", "decimals": "0", "lang": null, "name": "paci:DeferredUnderwritingCommissionsNonCurrent", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090306 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details)", "menuCat": "Details", "order": "29", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "U003", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630_StatementClassOfStockAxis_CommonClassAMember", "decimals": "2", "lang": null, "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090308 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details)", "menuCat": "Details", "order": "30", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "lang": null, "name": "paci:RemeasurementOfClassACommonStockSubjectToPossibleRedemption", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090310 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details)", "menuCat": "Details", "order": "31", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20211203to20211203_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_IPOMember", "decimals": "0", "first": true, "lang": null, "name": "paci:UnitsIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090400 - Disclosure - INITIAL PUBLIC OFFERING (Details)", "menuCat": "Details", "order": "32", "role": "http://proof-paci.com/role/InitialPublicOfferingDetails", "shortName": "INITIAL PUBLIC OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630_ClassOfWarrantOrRightAxis_PublicWarrantMember_SubsidiarySaleOfStockAxis_IPOMember", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20211203to20211203_ClassOfWarrantOrRightAxis_PrivatePlacementWarrantMember", "decimals": "0", "first": true, "lang": null, "name": "paci:ClassOfWarrantOrRightIssued", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090500 - Disclosure - PRIVATE PLACEMENTS (Details)", "menuCat": "Details", "order": "33", "role": "http://proof-paci.com/role/PrivatePlacementsDetails", "shortName": "PRIVATE PLACEMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20211203to20211203_ClassOfWarrantOrRightAxis_PrivatePlacementWarrantMember", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20211130to20211130", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "U005", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090600 - Disclosure - RELATED PARTIES, Founder Shares (Details)", "menuCat": "Details", "order": "34", "role": "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "shortName": "RELATED PARTIES, Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630_RelatedPartyTransactionAxis_FounderSharesMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember", "decimals": null, "lang": "en-US", "name": "paci:HoldingPeriodForTransferAssignmentOrSaleOfFounderShares", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20210331to20210331_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090602 - Disclosure - RELATED PARTIES, Promissory Note (Details)", "menuCat": "Details", "order": "35", "role": "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "shortName": "RELATED PARTIES, Promissory Note (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20210331to20210331_RelatedPartyTransactionAxis_PromissoryNoteMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingExpenses", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090604 - Disclosure - RELATED PARTIES, General and Administrative Services (Details)", "menuCat": "Details", "order": "36", "role": "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "shortName": "RELATED PARTIES, General and Administrative Services (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630_RelatedPartyTransactionAxis_GeneralAndAdministrativeSupportAgreementMember_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember", "decimals": "0", "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireMarketableSecurities", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090606 - Disclosure - RELATED PARTIES, Related Party Loans (Details)", "menuCat": "Details", "order": "37", "role": "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails", "shortName": "RELATED PARTIES, Related Party Loans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630_RelatedPartyTransactionAxis_WorkingCapitalLoansMember_RelatedPartyTransactionsByRelatedPartyAxis_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember", "decimals": "0", "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090608 - Disclosure - RELATED PARTIES, Consulting Agreement (Details)", "menuCat": "Details", "order": "38", "role": "http://proof-paci.com/role/RelatedPartiesConsultingAgreementDetails", "shortName": "RELATED PARTIES, Consulting Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "INF", "first": true, "lang": null, "name": "paci:NumberOfDemandsEligibleSecurityHolderCanMake", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090700 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "menuCat": "Details", "order": "39", "role": "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "INF", "first": true, "lang": null, "name": "paci:NumberOfDemandsEligibleSecurityHolderCanMake", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingExpenses", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations", "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "lang": null, "name": "us-gaap:NonoperatingIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090800 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details)", "menuCat": "Details", "order": "40", "role": "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT), Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": "INF", "lang": null, "name": "paci:StockConversionRatio", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:PeriodToExerciseWarrantsAfterBusinessCombination", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090802 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details)", "menuCat": "Details", "order": "41", "role": "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails", "shortName": "STOCKHOLDERS' EQUITY (DEFICIT), Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "paci:PeriodToExerciseWarrantsAfterBusinessCombination", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20221231", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090900 - Disclosure - CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)", "menuCat": "Details", "order": "42", "role": "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "shortName": "CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630_StatementClassOfStockAxis_CommonClassAMember", "decimals": "INF", "lang": null, "name": "paci:CommonStockVotingRightsNumberOfVotes", "reportCount": 1, "unique": true, "unitRef": "U007", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091000 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "menuCat": "Details", "order": "43", "role": "http://proof-paci.com/role/FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230721to20230721_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_SeriesA1PreferredStockMember_SubsequentEventTypeAxis_SubsequentEventMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091100 - Disclosure - SUBSEQUENT EVENTS (Details)", "menuCat": "Details", "order": "44", "role": "http://proof-paci.com/role/SubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230721to20230721_RelatedPartyTransactionsByRelatedPartyAxis_InvestorMember_StatementClassOfStockAxis_SeriesA1PreferredStockMember_SubsequentEventTypeAxis_SubsequentEventMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)", "menuCat": "Statements", "order": "5", "role": "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_CommonStockMember", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230401to20230630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "040000 - Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows", "shortName": "UNAUDITED CONDENSED STATEMENT OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060100 - Disclosure - DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN", "menuCat": "Notes", "order": "7", "role": "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern", "shortName": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ErrorCorrectionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060200 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS", "menuCat": "Notes", "order": "8", "role": "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatements", "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ErrorCorrectionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060300 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://proof-paci.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20058310_10qa.htm", "contextRef": "c20230101to20230630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 29, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "paci_AdditionalPaymentsToAcquireMarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional amount of cash outflow for purchase of marketable security.", "label": "Additional Payments to Acquire Marketable Securities", "terseLabel": "Additional deposit into Trust Account for extension" } } }, "localname": "AdditionalPaymentsToAcquireMarketableSecurities", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "paci_AdditionalUnitsThatCanBePurchasedToCoverOverAllotments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional Units that can be purchased by the underwriters to cover over-allotments.", "label": "Additional Units that can be Purchased to Cover Over-allotments", "terseLabel": "Additional Units that can be purchased to cover over-allotments (in shares)" } } }, "localname": "AdditionalUnitsThatCanBePurchasedToCoverOverAllotments", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "sharesItemType" }, "paci_ClassAOrdinarySharesSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Ordinary Shares Subject to Possible Redemption [Abstract]", "terseLabel": "Class A Common Stock Subject to Possible Redemption [Abstract]" } } }, "localname": "ClassAOrdinarySharesSubjectToPossibleRedemptionAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "paci_ClassOfWarrantOrRightHoldingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time after the completion of the initial Business Combination in which the Sponsor and the Company's officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class of Warrant or Right Holding Period", "terseLabel": "Holding period for transfer, assignment or sale of warrants" } } }, "localname": "ClassOfWarrantOrRightHoldingPeriod", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "durationItemType" }, "paci_ClassOfWarrantOrRightIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights issued during the period.", "label": "Class of Warrant or Right, Issued", "terseLabel": "Warrants issued (in shares)" } } }, "localname": "ClassOfWarrantOrRightIssued", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "sharesItemType" }, "paci_ClassOfWarrantOrRightRedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time in which warrants may be redeemed, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class of Warrant or Right Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "ClassOfWarrantOrRightRedemptionPeriod", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Redemption Price of Warrants or Rights", "terseLabel": "Warrant redemption price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "paci_CommonStockVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of votes each holder is entitled to vote per share.", "label": "Common Stock, Votes Per Share", "terseLabel": "Number of votes per share" } } }, "localname": "CommonStockVotesPerShare", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "integerItemType" }, "paci_CommonStockVotingRightsNumberOfVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of votes each eligible share holder is entitled to for each common share held.", "label": "Common Stock Voting Rights Number Of Votes", "terseLabel": "Number of votes per share" } } }, "localname": "CommonStockVotingRightsNumberOfVotes", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "integerItemType" }, "paci_ConsultingAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consulting Agreement [Abstract]" } } }, "localname": "ConsultingAgreementAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesConsultingAgreementDetails" ], "xbrltype": "stringItemType" }, "paci_DeferredUnderwriterFeeDiscountPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount of deferred fee of gross proceeds of an Initial Public Offering paid to the underwriter.", "label": "Deferred Underwriter Fee Discount Per Share", "terseLabel": "Deferred underwriter fee discount (in dollars per share)" } } }, "localname": "DeferredUnderwriterFeeDiscountPerShare", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "perShareItemType" }, "paci_DeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of outstanding underwriting commissions payable initially due after one year or beyond the operating cycle if longer, excluding current portion.", "label": "Deferred Underwriting Commissions", "verboseLabel": "Deferred underwriting commission" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "paci_DeferredUnderwritingCommissionsNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of outstanding underwriting commissions initially due after one year or beyond the operating cycle if longer, excluding current portion.", "label": "Deferred Underwriting Commissions Non Current", "terseLabel": "Deferred underwriting commission" } } }, "localname": "DeferredUnderwritingCommissionsNonCurrent", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "paci_DirectorAndOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Person serving on board of directors and person with designation of officer.", "label": "Director and Officer [Member]", "terseLabel": "Director and Officer [Member]" } } }, "localname": "DirectorAndOfficerMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "domainItemType" }, "paci_ExciseTaxOnRedemptionOfClassACommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excise tax on redemption of Class A common stock subject to possible redemption in noncash transactions.", "label": "Excise Tax on Redemption of Class A Common Stock Subject to Possible Redemption", "terseLabel": "Excise tax on redemption of Class A common stock subject to possible redemption" } } }, "localname": "ExciseTaxOnRedemptionOfClassACommonStockSubjectToPossibleRedemption", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "paci_ExciseTaxonCommonStockRedemptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of excise tax payable on the redemptions of Class A common stock during the period.", "label": "Excise Taxon Common Stock Redemptions", "negatedLabel": "Excise tax on Class A Common Stock redemptions" } } }, "localname": "ExciseTaxonCommonStockRedemptions", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "paci_ExtensionPeriodToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The extension period available to complete business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Extension Period to Complete Business Combination", "terseLabel": "Business combination extension period" } } }, "localname": "ExtensionPeriodToCompleteBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "durationItemType" }, "paci_FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair market value as a percentage of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination.", "label": "Fair Market Value as Percentage of Net Assets Held in Trust Account Included in Initial Business Combination", "terseLabel": "Fair market value as percentage of net assets held in trust account included in initial business combination" } } }, "localname": "FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "percentItemType" }, "paci_FounderSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Abstract]", "terseLabel": "Founder Shares [Abstract]" } } }, "localname": "FounderSharesAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "stringItemType" }, "paci_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The purchase of shares of the entity by the \"initial stockholders\" of the entity.", "label": "Founder Shares [Member]", "terseLabel": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "domainItemType" }, "paci_GeneralAndAdministrativeSupportAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative Support Agreement [Abstract]", "terseLabel": "General and Administrative Services [Abstract]" } } }, "localname": "GeneralAndAdministrativeSupportAgreementAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails" ], "xbrltype": "stringItemType" }, "paci_GeneralAndAdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An agreement whereby, on the effective date of the registration statement on Form S-1 related to the Initial Public Offering through the earlier of consummation of the initial Business Combination and the Company's liquidation, the Company will pay a monthly fee for office space, utilities and secretarial and administrative support.", "label": "General and Administrative Support Agreement [Member]", "terseLabel": "General and Administrative Services [Member]" } } }, "localname": "GeneralAndAdministrativeSupportAgreementMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails" ], "xbrltype": "domainItemType" }, "paci_HoldingPeriodForTransferAssignmentOrSaleOfFounderShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time after the completion of initial Business Combination in which initial shareholders are not permitted to transfer, assign or sell any of their held Founder Shares, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Holding Period For Transfer Assignment Or Sale Of Founder Shares", "terseLabel": "Holding period for transfer, assignment or sale of Founder Shares" } } }, "localname": "HoldingPeriodForTransferAssignmentOrSaleOfFounderShares", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "durationItemType" }, "paci_HoldingPeriodForTransferAssignmentOrSaleOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time after the completion of initial Business Combination in which initial shareholders are not permitted to transfer, assign or sell any of their held warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Holding Period for Transfer Assignment or Sale of Warrants", "terseLabel": "Limitation period to transfer, assign or sell warrants" } } }, "localname": "HoldingPeriodForTransferAssignmentOrSaleOfWarrants", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INITIAL PUBLIC OFFERING [Abstract]" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://proof-paci.com/20230630", "xbrltype": "stringItemType" }, "paci_InitialPublicOfferingOfUnitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering of Units [Abstract]", "terseLabel": "Proposed Public Offering [Abstract]" } } }, "localname": "InitialPublicOfferingOfUnitsAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "paci_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the initial public offering of the Company's common stock.", "label": "Initial Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "paci_InitialPublicOfferingUnitsSoldOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount in case of time available to complete a business combination in 21 months.", "label": "Initial Public Offering Units Sold One [Member]", "terseLabel": "Initial Public Offering Units Sold at $10.20 [Member]" } } }, "localname": "InitialPublicOfferingUnitsSoldOneMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "domainItemType" }, "paci_InterestOnTrustAccountToBeHeldToPayDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest received on the Trust Account that can be used to pay dissolution expenses if a Business Combination is not completed with the Combination Period.", "label": "Interest on Trust Account to be held to Pay Dissolution Expenses", "terseLabel": "Interest on trust account that can be held to pay dissolution expenses" } } }, "localname": "InterestOnTrustAccountToBeHeldToPayDissolutionExpenses", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "paci_InvestmentsHeldInTrustAccountAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments held in Trust Account [Abstract]" } } }, "localname": "InvestmentsHeldInTrustAccountAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesInvestmentsHeldInTrustAccountDetails" ], "xbrltype": "stringItemType" }, "paci_LiquidityAndCapitalResourcesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Capital Resources [Abstract]", "terseLabel": "Liquidity and Capital Resources [Abstract]" } } }, "localname": "LiquidityAndCapitalResourcesAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails" ], "xbrltype": "stringItemType" }, "paci_NetTangibleAssetsThresholdForRedeemingPublicShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net tangible assets threshold value for redemption of public shares.", "label": "Net Tangible Assets Threshold For Redeeming Public Shares", "terseLabel": "Net tangible asset threshold for redeeming Public Shares" } } }, "localname": "NetTangibleAssetsThresholdForRedeemingPublicShares", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "paci_NoticePeriodToRedeemWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period to provide written notice to redeem warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Notice Period to Redeem Warrants", "terseLabel": "Notice period to redeem warrants" } } }, "localname": "NoticePeriodToRedeemWarrants", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_NumberOfDemandsEligibleSecurityHolderCanMake": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of demands eligible security holder can make.", "label": "Number of Demands Eligible Security Holder Can Make", "terseLabel": "Number of demands entitled to holders" } } }, "localname": "NumberOfDemandsEligibleSecurityHolderCanMake", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "integerItemType" }, "paci_NumberOfOperatingBusinessesIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operating businesses that must be included in initial Business Combination.", "label": "Number of Operating Businesses Included in Initial Business Combination", "terseLabel": "Number of operating businesses included in initial business combination" } } }, "localname": "NumberOfOperatingBusinessesIncludedInInitialBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "integerItemType" }, "paci_OfferingCostsAssociatedWithAPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offering Costs associated with a Public Offering [Abstract]" } } }, "localname": "OfferingCostsAssociatedWithAPublicOfferingAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "paci_OptionForUnderwritersToPurchaseAdditionalUnitsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time from the date of the final prospectus relating to the Initial Public Offering for underwriters to purchase additional Units to cover over-allotments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Option for Underwriters to Purchase Additional Units, Term", "terseLabel": "Term of option for underwriters to purchase additional Units to cover over-allotments" } } }, "localname": "OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "durationItemType" }, "paci_OrganizationAndBusinessOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Organization and Business Operations [Line Items]" } } }, "localname": "OrganizationAndBusinessOperationsLineItems", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "stringItemType" }, "paci_OrganizationAndBusinessOperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the Company's organization and business operations.", "label": "Organization and Business Operations [Table]" } } }, "localname": "OrganizationAndBusinessOperationsTable", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "stringItemType" }, "paci_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other costs incurred in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants.", "label": "Other Offering Costs", "terseLabel": "Other costs", "verboseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "paci_PaymentsForRedemptionOfTemporaryEquity": { "auth_ref": [], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for redemption of Class A ordinary shares during the period.", "label": "Payments for Redemption of Temporary Equity", "negatedLabel": "Repayment of Class A common stock subject to possible redemption", "negatedTerseLabel": "Redemption" } } }, "localname": "PaymentsForRedemptionOfTemporaryEquity", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "paci_PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Public Shares that can be redeemed without the prior consent of the Company.", "label": "Percentage of Public Shares that can be Redeemed Without Prior Consent", "terseLabel": "Percentage of public shares that can be redeemed without prior consent" } } }, "localname": "PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "percentItemType" }, "paci_PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Public Shares that would not be redeemed if a Business Combination is not completed within the Initial Combination Period.", "label": "Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period", "terseLabel": "Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period" } } }, "localname": "PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "percentItemType" }, "paci_PeriodAfterInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period after the initial Business Combination for the common stock price to exceed the threshold price per share, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period after Initial Business Combination", "terseLabel": "Period after initial business combination" } } }, "localname": "PeriodAfterInitialBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodForRegistrationStatementToBecomeEffective": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time required to pass after the filing of a registration statement to become effective before warrant holders may be permitted to exercise warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Period for Registration Statement to Become Effective", "terseLabel": "Period for registration statement to become effective" } } }, "localname": "PeriodForRegistrationStatementToBecomeEffective", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodOfExtensionToPeriodToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of each additional extension to the period required to complete a Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period of Extension to Period to Complete Business Combination", "terseLabel": "Period of extension to consummate business combination" } } }, "localname": "PeriodOfExtensionToPeriodToCompleteBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodToCompleteBusinessCombinationFromClosingOfInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time from closing of Initial Public Offering to complete Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period To Complete Business Combination From Closing Of Initial Public Offering", "terseLabel": "Period to complete business combination from closing of initial public offering" } } }, "localname": "PeriodToCompleteBusinessCombinationFromClosingOfInitialPublicOffering", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodToExerciseWarrantsAfterBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period after the completion of a business combination when warrants will become exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period to Exercise Warrants After Business Combination", "terseLabel": "Period warrants to become excisable after business combination" } } }, "localname": "PeriodToExerciseWarrantsAfterBusinessCombination", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodToExerciseWarrantsAfterPublicOfferings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period for warrants to exercise after the completion of public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period to Exercise Warrants After Public Offerings", "terseLabel": "Period to exercise warrants after public offerings" } } }, "localname": "PeriodToExerciseWarrantsAfterPublicOfferings", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the entity is required to file a registration statement following the closing of a Business Combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Period to File Registration Statement", "terseLabel": "Number of days to file registration statement" } } }, "localname": "PeriodToFileRegistrationStatement", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time to redeem Public Shares if Business Combination is not completed within the Initial Combination Period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period", "terseLabel": "Period to redeem public shares if business combination is not completed within initial combination period" } } }, "localname": "PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "durationItemType" }, "paci_PostTransactionOwnershipPercentageOfTargetBusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post-transaction ownership percentage of the outstanding voting securities of the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940.", "label": "Post Transaction Ownership Percentage of Target Business", "terseLabel": "Post-transaction ownership percentage of the target business" } } }, "localname": "PostTransactionOwnershipPercentageOfTargetBusiness", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "percentItemType" }, "paci_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of sale of warrants in a private placement offering.", "label": "Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENTS" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/PrivatePlacements" ], "xbrltype": "textBlockItemType" }, "paci_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each whole Private Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share.", "label": "Private Placement Warrant [Member]", "verboseLabel": "Private Placement Warrant [Member]" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "paci_PrivatePlacementWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Abstract]", "terseLabel": "Private Placement Warrants [Abstract]" } } }, "localname": "PrivatePlacementWarrantsAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "stringItemType" }, "paci_PrivatePlacementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PRIVATE PLACEMENTS [Abstract]" } } }, "localname": "PrivatePlacementsAbstract", "nsuri": "http://proof-paci.com/20230630", "xbrltype": "stringItemType" }, "paci_ProceedsFromCashWithdrawalFromTrustAccount": { "auth_ref": [], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from cash withdrawn from Trust Account.", "label": "Proceeds From Cash Withdrawal From Trust Account", "terseLabel": "Withdrawal from Trust Account for redemptions" } } }, "localname": "ProceedsFromCashWithdrawalFromTrustAccount", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "paci_ProceedsFromCashWithdrawalFromTrustAccountWithRedemptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the cash withdrawn from trust account with redemptions.", "label": "Proceeds from Cash Withdrawal from Trust Account with Redemptions", "terseLabel": "Withdrawn from trust account for redemption" } } }, "localname": "ProceedsFromCashWithdrawalFromTrustAccountWithRedemptions", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "paci_ProceedsFromWithdrawalForTaxes": { "auth_ref": [], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the withdrawal for working capital and taxes.", "label": "Proceeds from Withdrawal for Working Capital and Taxes", "terseLabel": "Withdrawal from Trust Account for working capital and tax" } } }, "localname": "ProceedsFromWithdrawalForTaxes", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "paci_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan of approximately $110,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (Note). The Note was non-interest bearing and payable upon the completion of the Initial Public Offering.", "label": "Promissory Note [Member]", "terseLabel": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails" ], "xbrltype": "domainItemType" }, "paci_PublicSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units sold in a public offering each consisting of one Class A ordinary share and one-half of one redeemable warrant.", "label": "Public Shares [Member]", "terseLabel": "Public Shares [Member]" } } }, "localname": "PublicSharesMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "paci_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued in connection with the Initial Public Offering. Each one whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50.", "label": "Public Warrant [Member]", "terseLabel": "Public Warrant [Member]", "verboseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "paci_ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of re-measurement of Class A ordinary shares subject to possible redemption.", "label": "Remeasurement of Class A Common Stock to redemption value", "negatedLabel": "Remeasurement of Class A Common Stock to redemption value" } } }, "localname": "ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "paci_RedeemableWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share.", "label": "Redeemable Warrants [Member]", "terseLabel": "Redeemable Warrants [Member]" } } }, "localname": "RedeemableWarrantsMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "paci_RegistrationRightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Registration Rights [Abstract]" } } }, "localname": "RegistrationRightsAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "paci_RelatedPartyTransactionLoansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Loans [Abstract]", "terseLabel": "Related Party Loans [Abstract]" } } }, "localname": "RelatedPartyTransactionLoansAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "stringItemType" }, "paci_RelatedPartyTransactionPromissoryNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Promissory Note [Abstract]", "terseLabel": "Promissory Note [Abstract]" } } }, "localname": "RelatedPartyTransactionPromissoryNoteAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails" ], "xbrltype": "stringItemType" }, "paci_RemeasurementOfClassACommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "'Remeasurement of class a common stock subject to possible redemption.", "label": "Remeasurement of Class A Common Stock Subject to Possible Redemption", "verboseLabel": "Remeasurement of Class A Common Stock to redemption value" } } }, "localname": "RemeasurementOfClassACommonStockSubjectToPossibleRedemption", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "paci_SeriesA1PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock shares classified as series A-1.", "label": "Series A-1 Preferred Stock [Member]", "terseLabel": "Series A-1 Preferred Stock [Member]" } } }, "localname": "SeriesA1PreferredStockMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "paci_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KKR Acquisition Sponsor I LLC (Sponsor), an affiliate of the Sponsor, or certain of the Company's officers and directors.", "label": "Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]", "terseLabel": "Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]" } } }, "localname": "SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "domainItemType" }, "paci_StockConversionAsConvertedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shares of Class A common stock issuable upon conversion of all shares of Class B common stock on an as-converted basis.", "label": "Stock Conversion, As-converted Percentage", "terseLabel": "As-converted percentage for Class A ordinary shares after conversion of Class B shares" } } }, "localname": "StockConversionAsConvertedPercentage", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "percentItemType" }, "paci_StockConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stock Conversion Ratio", "terseLabel": "Stock conversion basis of Class B to Class A ordinary shares at time of initial business combination" } } }, "localname": "StockConversionRatio", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "pureItemType" }, "paci_TemporaryEquitySharesSubjectToPossibleRedemptionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for temporary equity and common shares subject to possible redemption.", "label": "Temporary Equity Shares Subject To Possible Redemption [Text Block]", "terseLabel": "CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION" } } }, "localname": "TemporaryEquitySharesSubjectToPossibleRedemptionTextBlock", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemption" ], "xbrltype": "textBlockItemType" }, "paci_ThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days that common stock price must exceed threshold price for specified number of trading days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days" } } }, "localname": "ThresholdConsecutiveTradingDays", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_ThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price must exceed threshold price within a specified consecutive trading period, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Threshold Trading Days", "terseLabel": "Threshold trading days" } } }, "localname": "ThresholdTradingDays", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "paci_UnderwritingAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriting Agreement [Abstract]", "terseLabel": "Underwriting Agreement [Abstract]" } } }, "localname": "UnderwritingAgreementAbstract", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "paci_UnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate underwriting discount fee paid to the underwriters upon the closing of the Initial Public Offering.", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "paci_UnderwritingDiscountFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting discount fee per unit paid to underwriters.", "label": "Underwriting Discount Fee", "verboseLabel": "Underwriting discount (in dollars per share)" } } }, "localname": "UnderwritingDiscountFee", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "perShareItemType" }, "paci_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs incurred for underwriting fees in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants.", "label": "Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "paci_UnderwritingFeesDeferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of costs incurred and deferred for underwriting fees in connection with the offering of Units in Initial Public Offering and Private Placement of Warrants.", "label": "Underwriting fees, Deferred", "terseLabel": "Deferred underwriting fees", "verboseLabel": "Deferred underwriting fee" } } }, "localname": "UnderwritingFeesDeferred", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "paci_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units consist of one Class A ordinary share and one-half of one redeemable warrant.", "label": "Units Issued During Period, Shares, New Issues", "terseLabel": "Units issued (in shares)" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "paci_UnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units, each consisting of one Class A ordinary share, $0.0001 par value, and one- half of one redeemable warrant.", "label": "Units [Member]", "terseLabel": "Units [Member]" } } }, "localname": "UnitsMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "paci_UnitsNumberOfSecuritiesCalledByUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of securities into which each unit may be converted. For example, but not limited to, each unit may be converted into two shares of common stock.", "label": "Units, number of securities called by units", "verboseLabel": "Number of securities to be called by each unit (in shares)" } } }, "localname": "UnitsNumberOfSecuritiesCalledByUnits", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "paci_UtilitiesAndSecretarialAndAdministrativeSupportPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Utilities and secretarial and administrative support period, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Utilities and Secretarial and Administrative Support Period", "terseLabel": "Utilities and secretarial and administrative support period" } } }, "localname": "UtilitiesAndSecretarialAndAdministrativeSupportPeriod", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails" ], "xbrltype": "durationItemType" }, "paci_WarrantsAndRightsSubjectToMandatoryRedemptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights that embody an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur.", "label": "Warrants and Rights Subject to Mandatory Redemption, One [Member]", "terseLabel": "Redemption of Warrants for Cash When Price Equals or Exceeds $18.00 [Member]" } } }, "localname": "WarrantsAndRightsSubjectToMandatoryRedemptionOneMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "paci_WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights that embody an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur.", "label": "Warrants and Rights Subject to Mandatory Redemption, Two [Member]", "terseLabel": "Redemption of Warrants for Cash When Price Equals or Exceeds $10.00 [Member]" } } }, "localname": "WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "paci_WorkingCapitalDeficitAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of working capital (deficit) i.e., calculated based on current assets less current liabilities.", "label": "Working Capital Deficit Amount", "terseLabel": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficitAmount", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails" ], "xbrltype": "monetaryItemType" }, "paci_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loans to fund working capital deficiencies or finance transaction costs in connection with a Business Combination.", "label": "Working Capital Loans [Member]" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://proof-paci.com/20230630", "presentation": [ "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r172", "r173", "r174", "r175", "r212", "r281", "r310", "r348", "r349", "r410", "r413", "r414", "r415", "r416", "r424", "r425", "r430", "r433", "r437", "r439", "r482", "r494", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r172", "r173", "r174", "r175", "r212", "r281", "r310", "r348", "r349", "r410", "r413", "r414", "r415", "r416", "r424", "r425", "r430", "r433", "r437", "r439", "r482", "r494", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r172", "r173", "r174", "r175", "r204", "r212", "r213", "r214", "r215", "r280", "r281", "r310", "r348", "r349", "r410", "r413", "r414", "r415", "r416", "r424", "r425", "r430", "r433", "r437", "r439", "r442", "r478", "r482", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r172", "r173", "r174", "r175", "r204", "r212", "r213", "r214", "r215", "r280", "r281", "r310", "r348", "r349", "r410", "r413", "r414", "r415", "r416", "r424", "r425", "r430", "r433", "r437", "r439", "r442", "r478", "r482", "r495", "r496", "r497", "r498", "r499" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r93", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r130", "r131", "r132", "r133", "r134", "r143", "r165", "r166", "r232", "r246", "r247", "r248", "r249", "r265", "r266", "r267", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r93", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r130", "r131", "r132", "r133", "r134", "r143", "r165", "r166", "r232", "r246", "r247", "r248", "r249", "r265", "r266", "r267", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "label": "Adjustment [Member]" } } }, "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r93", "r119", "r121", "r122", "r123", "r124", "r125", "r133", "r143", "r232", "r246", "r247", "r248", "r265", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r459", "r460", "r461", "r462", "r470", "r475", "r476", "r484", "r487", "r488" ], "lang": { "en-us": { "role": { "label": "As Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r53", "r76" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Income tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r216", "r217", "r218", "r335", "r467", "r468", "r469", "r483", "r505" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r75", "r99", "r116", "r147", "r154", "r158", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r235", "r237", "r257", "r297", "r371", "r438", "r450", "r480", "r481", "r492" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r96", "r104", "r116", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r235", "r237", "r257", "r438", "r480", "r481", "r492" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets [Abstract]" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r464" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Asset, Held-in-Trust, Noncurrent", "terseLabel": "Investments held in Trust", "verboseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesInvestmentsHeldInTrustAccountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r82", "r299", "r346", "r366", "r438", "r450", "r463" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r23", "r65", "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r5", "r65" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r463", "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r91", "r100", "r101", "r102", "r116", "r137", "r138", "r140", "r142", "r145", "r146", "r163", "r176", "r178", "r179", "r180", "r183", "r184", "r187", "r188", "r191", "r194", "r201", "r257", "r327", "r328", "r329", "r330", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r347", "r358", "r380", "r402", "r417", "r418", "r419", "r420", "r421", "r458", "r465", "r471" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/DocumentAndEntityInformation", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails", "http://proof-paci.com/role/SubsequentEventsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r100", "r101", "r102", "r145", "r187", "r188", "r189", "r191", "r194", "r199", "r201", "r327", "r328", "r329", "r330", "r433", "r458", "r465" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrants exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of securities to be called by each warrant (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r19", "r51", "r298", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 5)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r70", "r170", "r171", "r423", "r479" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Class A Common Stock [Member]", "verboseLabel": "Class A Ordinary Shares [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/DocumentAndEntityInformation", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Class B Common Stock [Member]", "terseLabel": "Class B Common Stock [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/DocumentAndEntityInformation", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r467", "r468", "r483", "r502", "r505" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r56", "r358" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r56", "r358", "r377", "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r56", "r301", "r438" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r52", "r86" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Offering Costs associated with a Public Offering" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r477" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "verboseLabel": "Transaction costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesOfferingCostsAssociatedWithPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesEmbeddedDerivatives": { "auth_ref": [ "r0", "r2", "r3", "r4" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.", "label": "Derivatives, Embedded Derivatives [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesEmbeddedDerivatives", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r11", "r45", "r46", "r47", "r48", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Warrants" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r112", "r124", "r125", "r127", "r128", "r130", "r135", "r137", "r140", "r141", "r142", "r143", "r248", "r249", "r295", "r307", "r427" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic net income (loss) per share (in dollars per share)", "terseLabel": "Basic net income (loss) per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicLineItems": { "auth_ref": [ "r137", "r138", "r140" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r112", "r124", "r125", "r127", "r128", "r130", "r137", "r140", "r141", "r142", "r143", "r248", "r249", "r295", "r307", "r427" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted net income (loss) per share (in dollars per share)", "terseLabel": "Diluted net income (loss) per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r29", "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r117", "r224", "r234" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r10", "r92", "r108", "r109", "r110", "r119", "r120", "r121", "r123", "r131", "r133", "r144", "r164", "r167", "r203", "r216", "r217", "r218", "r231", "r232", "r239", "r240", "r241", "r242", "r243", "r244", "r247", "r258", "r259", "r260", "r261", "r262", "r263", "r267", "r311", "r312", "r313", "r335", "r402" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting error correction.", "label": "Error Correction [Text Block]", "terseLabel": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "ErrorCorrectionTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [ "r124", "r125", "r126", "r130", "r131", "r132", "r133", "r143" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r251", "r252", "r255" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r251", "r252", "r255" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r185", "r205", "r206", "r207", "r208", "r209", "r210", "r252", "r277", "r278", "r279", "r431", "r432", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r251", "r252", "r253", "r254", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r185", "r205", "r210", "r252", "r277", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r185", "r205", "r206", "r207", "r208", "r209", "r210", "r277", "r278", "r279", "r431", "r432", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r250", "r256" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "Initial Public Offering [Member]", "terseLabel": "Initial Public Offering [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r1", "r61", "r79", "r147", "r153", "r157", "r159", "r296", "r305", "r429" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Loss before income tax", "totalLabel": "Income (loss) before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r81", "r89", "r132", "r133", "r151", "r223", "r233", "r309" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r107", "r221", "r222", "r227", "r228", "r229", "r230", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r7" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r7" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r7" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred income taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r7" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses", "negatedTerseLabel": "Change in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r63", "r150" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Interest income - investments held in Trust Account", "negatedLabel": "Income earned on Trust assets" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r308", "r322", "r323", "r324", "r325", "r411", "r412" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments held in Trust Account" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r251" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Marketable securities held in the Trust Account" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]", "verboseLabel": "Sponsor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r116", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r236", "r237", "r238", "r257", "r356", "r428", "r450", "r480", "r492", "r493" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r60", "r78", "r304", "r438", "r466", "r474", "r486" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Temporary Equity and Stockholders' (Deficit) Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS, EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r18", "r97", "r116", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r236", "r237", "r238", "r257", "r438", "r480", "r492", "r493" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r83", "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r113" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r113" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r65", "r66", "r67" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r62", "r67", "r80", "r95", "r105", "r106", "r110", "r116", "r122", "r124", "r125", "r127", "r128", "r132", "r133", "r139", "r147", "r153", "r157", "r159", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r249", "r257", "r306", "r379", "r400", "r401", "r429", "r448", "r480" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (Loss)", "terseLabel": "Allocation of net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator [Abstract]" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r64" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r13", "r77", "r500" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Related parties, outstanding amount" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartyTypeExtensibleEnumeration": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of related party for notes payable.", "label": "Notes Payable, Related Party, Type [Extensible Enumeration]" } } }, "localname": "NotesPayableRelatedPartyTypeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Formation and operating expenses", "terseLabel": "Fee amount", "verboseLabel": "Formation and operating costs" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r147", "r153", "r157", "r159", "r429" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedLabel": "Operating loss", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r473" ], "calculation": { "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Deposit to Trust Account to exercise three-month extension", "negatedLabel": "Deposit into Trust Account for extension", "terseLabel": "Extension deposit", "verboseLabel": "Net proceeds deposited into trust account" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails", "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]", "terseLabel": "Preferred Stock [Abstract]" } } }, "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r55", "r187" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r55", "r358" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r55", "r187" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r55", "r358", "r377", "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r55", "r300", "r438" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r103", "r168", "r169", "r426" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r6" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r6" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r6" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Gross proceeds to be received from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/PrivatePlacementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity [Abstract]", "terseLabel": "Proceeds from Issuance of Equity [Abstract]" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from sponsor note", "terseLabel": "Loan proceeds" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r448", "r503", "r504" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "terseLabel": "Consulting fee" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesConsultingAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r211", "r271", "r272", "r351", "r352", "r353", "r354", "r355", "r376", "r378", "r409" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r50", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related party transaction amount", "terseLabel": "Related party transaction amount" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r271", "r272", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r383", "r384", "r387" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTIES [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r211", "r271", "r272", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r351", "r352", "r353", "r354", "r355", "r376", "r378", "r409", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r268", "r269", "r270", "r272", "r273", "r332", "r333", "r334", "r385", "r386", "r387", "r406", "r408" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTIES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayment of related party loan", "verboseLabel": "Repayment of sponsor note" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r57", "r74", "r303", "r315", "r320", "r331", "r359", "r438" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "(Accumulated Deficit) Retained earnings", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r92", "r119", "r120", "r121", "r123", "r131", "r133", "r164", "r167", "r216", "r217", "r218", "r231", "r232", "r239", "r241", "r242", "r244", "r247", "r311", "r313", "r335", "r505" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r111", "r116", "r148", "r149", "r152", "r155", "r156", "r160", "r161", "r162", "r163", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r257", "r296", "r480" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Operating revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Net proceeds from initial public offering and private placement (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Excise tax payable", "terseLabel": "Excise tax" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Basic and Diluted Net Income (loss) Per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "auth_ref": [ "r28", "r31", "r137", "r138", "r140" ], "lang": { "en-us": { "role": { "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r124", "r125", "r126", "r130", "r131", "r132", "r133", "r143" ], "lang": { "en-us": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "auth_ref": [ "r25", "r26", "r27" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.", "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Effect of Restatement on Each Financial Statement" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Assets and Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r49", "r50", "r383", "r384", "r387" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RelatedPartiesGeneralAndAdministrativeServicesDetails", "http://proof-paci.com/role/RelatedPartiesPromissoryNoteDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": { "auth_ref": [ "r8", "r9", "r35" ], "lang": { "en-us": { "role": { "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option.", "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]" } } }, "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r37", "r38", "r39", "r40", "r41", "r42", "r43", "r72", "r73", "r74", "r100", "r101", "r102", "r145", "r187", "r188", "r189", "r191", "r194", "r199", "r201", "r327", "r328", "r329", "r330", "r433", "r458", "r465" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)", "verboseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share price (in dollars per share)", "terseLabel": "Unit price (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/RelatedPartiesRelatedPartyLoansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.", "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]", "terseLabel": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": { "auth_ref": [ "r8", "r9" ], "lang": { "en-us": { "role": { "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur.", "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]" } } }, "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r91", "r100", "r101", "r102", "r116", "r137", "r138", "r140", "r142", "r145", "r146", "r163", "r176", "r178", "r179", "r180", "r183", "r184", "r187", "r188", "r191", "r194", "r201", "r257", "r327", "r328", "r329", "r330", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r347", "r358", "r380", "r402", "r417", "r418", "r419", "r420", "r421", "r458", "r465", "r471" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/DocumentAndEntityInformation", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/PrivatePlacementsDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails", "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails", "http://proof-paci.com/role/SubsequentEventsDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r10", "r20", "r92", "r108", "r109", "r110", "r119", "r120", "r121", "r123", "r131", "r133", "r144", "r164", "r167", "r203", "r216", "r217", "r218", "r231", "r232", "r239", "r240", "r241", "r242", "r243", "r244", "r247", "r258", "r259", "r260", "r261", "r262", "r263", "r267", "r311", "r312", "r313", "r335", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r119", "r120", "r121", "r144", "r282", "r322", "r347", "r350", "r351", "r352", "r353", "r354", "r355", "r358", "r361", "r362", "r363", "r364", "r365", "r367", "r368", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r378", "r381", "r382", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r402", "r443" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED BALANCE SHEETS [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]", "terseLabel": "Statement of Changes in Stockholders' Deficit [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r119", "r120", "r121", "r144", "r282", "r322", "r347", "r350", "r351", "r352", "r353", "r354", "r355", "r358", "r361", "r362", "r363", "r364", "r365", "r367", "r368", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r378", "r381", "r382", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r402", "r443" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Issuance of Class B common stock to Sponsor (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited", "verboseLabel": "Shares cancelled (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r55", "r56", "r74", "r335", "r402", "r418", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Preferred stock issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r56", "r58", "r59", "r69", "r360", "r377", "r403", "r404", "r438", "r450", "r466", "r474", "r486", "r505" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Total Stockholders' Deficit", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Stockholders' (Deficit) Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/RestatementOfPreviouslyIssuedFinancialStatementsStatementOfChangesInFinancialStatementsDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholder's Deficit [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r71", "r115", "r186", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r200", "r203", "r245", "r405", "r407", "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stock split" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r264", "r275" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r264", "r275" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r264", "r275" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r264", "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r264", "r275" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r274", "r276" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails", "http://proof-paci.com/role/RelatedPartiesFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CommitmentsAndContingenciesDetails", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernLiquidityAndCapitalResourcesDetails", "http://proof-paci.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity:" } } }, "localname": "TemporaryEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Re-measurement of carrying value to redemption value" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r12", "r36" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r176", "r178", "r179", "r180", "r183", "r184", "r219", "r302" ], "calculation": { "http://proof-paci.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Common stock, subject to possible redemption", "periodEndLabel": "Class A common stock subject to possible redemption, Ending Balance", "periodStartLabel": "Class A common stock subject to possible redemption, Beginning Balance", "terseLabel": "Class A common stock subject to possible redemption; $0.0001 par value; 6,443,098 and 27,600,000 shares at redemption value of $10.59 and $10.31 at June 30, 2023 and December 31, 2022, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheets", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": { "auth_ref": [ "r12", "r36" ], "lang": { "en-us": { "role": { "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.", "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)", "terseLabel": "Remeasurement of Class A Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/UnauditedCondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]", "terseLabel": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r12", "r36" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Common stock, subject to possible redemption, par value (in dollars per share)", "terseLabel": "Common Stock, par value (in dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r12", "r36" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Common stock, redemption price per share (in dollars per share)" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Common Stock, shares authorized (in shares)" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Common Stock, outstanding, subject to possible redemption (in shares)", "terseLabel": "Common stock, subject to possible redemption (in shares)", "verboseLabel": "Common stock, subject to possible redemption, shares outstanding (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionDetails", "http://proof-paci.com/role/CondensedBalanceSheetsParenthetical", "http://proof-paci.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernSummaryDetails", "http://proof-paci.com/role/StockholdersEquityDeficitEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r12", "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/ClassCommonStockSubjectToPossibleRedemptionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r220", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r32", "r33", "r34", "r84", "r85", "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]", "terseLabel": "WARRANTS [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants expiration period" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WarrantsAndRightsSubjectToMandatoryRedemptionMember": { "auth_ref": [ "r8", "r9" ], "lang": { "en-us": { "role": { "documentation": "Warrants and rights that embody an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur.", "label": "Warrants and Rights Subject to Mandatory Redemption [Member]" } } }, "localname": "WarrantsAndRightsSubjectToMandatoryRedemptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/StockholdersEquityDeficitWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r136", "r142" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares outstanding, diluted (in shares)", "terseLabel": "Diluted weighted average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r135", "r142" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic weighted average shares outstanding (in shares)", "terseLabel": "Weighted average shares outstanding, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://proof-paci.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails", "http://proof-paci.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "15", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147481116/815-15-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480588/815-10-25-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.E.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480526/815-10-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481679/480-10-45-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "15", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147481051/815-15-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r453": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r454": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r455": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r456": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r457": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147480341/340-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 63 0001140361-23-042304-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-042304-xbrl.zip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�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end

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